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Abstract
Fetal growth restriction is the failure of  a fetus to achieve its full growth potential, resulting in 
a neonate that is small for its gestational age. The aetiology of fetal growth restriction is 
varied and fetal growth restriction secondary to placental insufficiency is attributed to a 
failure of trophoblast invasion leading to under perfusion of the uteroplacental bed. In 
response to the adverse conditions in-utero, fetuses tend to compensate by increasing blood 
flow  to the essential organs such as the brain, heart, and adrenals, at the expense of other 
organs (cerebral redistribution). As a consequence, growth tends to be asymmetric, with 
maintenance of the head growth velocity while the other growth parameters tail off; an effect 
which is also known as the ‘brain sparing effect’. Despite this apparent brain sparing effect, 
children who were growth restricted in utero are at increased risk of developmental delay 
and behavioural problems. 
30 growth restricted and 48 normally grown fetuses were recruited into this study and were 
imaged using both conventional ultrasound with Doppler assessment, as well as fetal MRI 
with ssFSE sequences through the feto-placental unit and fetal brain. A dynamic approach 
was taken when imaging the fetal brain to compensate for the presence of fetal motion. MR 
imaging of the feto-placental unit detected significant differences in placental appearance, 
significantly smaller volumes of intra-abdominal and intra-thoracic organs, and significantly 
smaller regional brain growth among growth restricted fetuses. 
MR studies of the placenta in fetal growth restriction demonstrated a placental phenotype in 
growth restricted pregnancies that is characterised by smaller placental volumes, a 
significant increase in the placental volume affected by apparent pathology on MRI and a 
thickened, globular placenta. Although placental volume increased with gestation in both 
groups, the placental volume remained significantly smaller in the growth restricted fetuses 
(p = 0.003). There was also a significant correlation between the percentage of placental 
volume affected by abnormal heterogeneity and the severity of fetal growth restriction (r = 
3
0.82, p < 0.001), and an increase in the maximal placental thickness to placental volume 
ratio above the 95th centile for gestational age was associated with fetal and early neonatal 
mortality (relative risk = 7, 95%CI = 2.96 – 16.55, p < 0.001) (figure 3.6)
MR studies of fetal intra-thoracic and intra-abdominal volumes showed that although the 
volume of the intra-thoracic and intra-abdonimal organs (heart, lungs, thymus, liver and 
kidney) increased as gestation increased in both groups, the volumes of  all three structures 
remained smaller in growth restricted fetuses (p < 0.01) (Figures 4.7 - 4.9) compared with 
normally grown fetuses. 
MR studies of the fetal brain demonstrated smaller intracranial volume, total brain volume 
and cerebellar volume in growth restricted fetuses. In addition, growth restricted fetuses with 
early onset fetal growth restriction demonstrated smaller vermis height and a corresponding 
increase in the tegmento-vermian angle. Growth restricted fetuses also demonstrated a 
disproportionate decrease in extra- and intra-cerebral fluid.
This thesis showed evidence of changes in regional and global organ growth in growth 
restricted fetuses using high resolution fetal MRI.  It is hoped that future imaging studies 
could offer useful insights into the origins and clinical significance of these findings and its 
consequences for later neurodevelopment.
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Introduction to Thesis
Intrauterine fetal growth restriction (IUGR) is the failure of a fetus to achieve its full growth 
potential, resulting in a neonate that is often small for its gestational age (SGA). The 
aetiology of fetal growth restriction is varied and can include chromosomal abnormalities, 
genetic syndromes, intrauterine infection, placental insufficiency, and in-utero exposure to 
toxins such as alcohol. Placental insufficiency as a cause of  growth restriction is of particular 
interest as identification of  placental insufficiency may allow  for antenatal intervention and 
has the potential for the improvement of outcome compared to other causes of growth 
restriction. 
Fetal growth restriction secondary to placental insufficiency is attributed to a failure of 
trophoblast invasion leading to under perfusion of  the uteroplacental bed1. In response to the 
adverse conditions in-utero, fetuses tend to compensate by increasing blood flow  to the 
essential organs such as the brain, heart, and adrenals, at the expense of other organs 
(cerebral redistribution). As a consequence, growth tends to be asymmetric, with 
maintenance of the head growth velocity while the other growth parameters tail off; an effect 
which is also known as the ‘brain sparing effect’.
Fetuses with growth restriction are at increased risk of  perinatal demise, and of neonatal 
complications such as necrotising enterocolitis, respiratory distress syndrome, and sepsis. In 
the longer term, these children are at further risk of developmental delay and behavioural 
problems. In adulthood, there is an increased incidence of hypertension and diabetes as part 
of the metabolic syndrome. Despite the significant burden of the condition, the 
understanding of the mechanisms leading to fetal growth restriction and the fetal adaptive 
response is still limited. 
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This study aims to further characterise the redistribution phenomenon in the face of adverse 
uterine conditions by studying the adaptation of  the fetus to the redistribution phenomenon 
using: 
 - MRI to identify changes in the feto-placental unit in fetal growth restriction, and
 - 3D MR reconstruction to perform regional fetal volumetry.
Chapter 1 provides a brief  review  of  the pathophysiology and short and longer term 
implications of fetal growth restriction. It also introduces 3-dimensional fetal MRI that will be 
used to study the brain sparing effect in intrauterine fetal growth restriction.
Chapter 2 details the MRI and Ultrasound protocols that were used to acquire and analyse 
the data pertaining to this thesis. The demographics of  the patient population used in this 
study is also detailed.
Chapter 3 explores the use of  MRI to determine the presence of a specific placental 
phenotype in fetal growth restriction.
Chapter 4 explores the use of MRI to perform fetal volumetry with manual volumetric 
segmentation of  fetal intra-thoracic and intra-abdominal organs in fetuses with growth 
restriction.
Chapter 5 explores the use of  3-dimensional reconstruction of MRI images to study  linear 
measures of  brain growth as well as regional volumetric segmentation on the fetal brain in 
fetuses with growth restriction.
Chapter 6 explores the application of automated segmentation software on fetal MRI 
images and the optimisation of MRI sequence acquisition to enable automated volumetric 
estimations of the fetal brain and cortical gray matter.
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Chapter 7 details the pregnancy outcome of growth restricted fetuses in this study, and 
summarises the incidence of perinatal mortality and morbidity.
Chapter 8  presents the results of a meta-analysis investigating the incidence of  perinatal 
mortality and morbidity of growth restricted fetuses in general.
Chapter 9 summarises the main findings of this thesis on the use of  3-dimensional MRI and 
ultrasound to image fetuses with fetal growth restriction. It also highlights future research 
plans and ideas.
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CHAPTER 1: INTRODUCTION
 
The first part of this chapter describes the physiology of  normal pregnancy implantation as 
well as the dysfunctional implantation seen in fetal growth restriction, fetal coping 
mechanisms in the face of an adverse intrauterine environment, and the longer term 
sequelae of fetal growth restriction.
The second part of this chapter documents the physics of  ultrasound and reviews current 
knowledge on the application of ultrasound techniques to the pregnancy complicated by fetal 
growth restriction.
The third part of this chapter documents the physics of MRI and the currently available 
adaptations of MRI sequences to enable MRI of the fetus in utero. It also documents 
knowledge to date on the application of MRI in the growth restricted fetus.
1.1 Fetal Growth Restriction
1.1.1 The feto-placental unit
Early Implantation
First trimester trophoblastic invasion has far reaching consequences for the fetus; failure at 
this stage may result in fetal growth restriction with implications both in the immediate 
perinatal period, as well as throughout development into adulthood. 
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The placenta has multiple functions including the mediation of transfer of respiratory gases, 
water, ions and nutrients, provision of an immunological barrier between the fetus and 
mother, and the production of an array of hormones, cytokines and signalling molecules2. 
Perturbations in placental function may stem from the maternal compartment or placental 
implantation; and this loss in placental function may result in serious short term and longer 
term consequences for the fetus. In normal pregnancies, adhesion of the embryo to the 
uterine luminal epithelium triggers differentiation of the trophoblast, provoking penetration of 
extravillous trophoblast cells into the uterine stroma and myometrium3. 
The first step in establishing a successful pregnancy is decidualization- the transformation of 
the uterine wall in response to modulation by the trophoblast. The process of decidualization 
begins in the secretory phase of  the menstrual cycle, independent of pregnancy, and 
continues in pregnancy where it regulates subsequent trophoblast invasion and placenta 
formation by altering the expression of  regulatory factors that include metalloproteinases, 
cytokines, surface integrins, and major histocompatibility complex molecules3. 
Immunomodulation at the time of  decidualization is a pre-requisite for a successful 
pregnancy, and normal pregnancies demonstrate a shift in the immune response from a Th1 
cytotoxic cell mediated immune response, to a Th2 humoral immune response4. 
Preeclamptic and growth restricted pregnancies fail to achieve this and retain a 
predominantly Th1 cytotoxic response to the invading pregnancy.
The next step in establishing a successful pregnancy is blastocyst implantation. This 
interaction between trophoblast cells and endometrium can only occur during a restricted 
period, termed the ‘window  of  receptivity’, which is thought to span day 20 - 24 of the 
menstrual cycle. Blastocyst attachment depends on the interaction between adhesion 
molecules such as selectins, integrins, and trophinins, expressed on both trophoblast cells 
and uterine epithelium3. 
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Trophoblast differentiation and the formation of anchoring villi begins immediately after 
nidation. Cytotrophoblast stem cells differentiate to form syncytiotrophoblast and extravillous 
trophoblast cells. At day 14 after implantation, cytotrophoblast cells break through the outer 
shell of syncytiotrophoblast to form the extravillous trophoblast which invades uterine stroma 
as trophoblastic cell columns. The invasion of these cells into the myometrium provokes 
changes within the uterine vessels that are crucial in supporting the continuing pregnancy. 
Trophoblast differentiation and invasion is controlled by various transcription factors, genes, 
hormones, growth factors, cytokines and oxygen levels. Early embryonic development is 
characterised by a hypoxic environment, thought to be either due to the presence of 
trophoblast cell plugs occluding the tips of the uteroplacental arteries or incomplete spiral 
artery remodeling3. 
Extravillous trophoblast cells enter the decidua and myometrial stroma. These invade both 
the endometrial vessels and myometrial arteries. They encircle and destroy the smooth 
muscle cells of  spiral arteries replacing it with amorphous fibrinoid material5. Early 
pregnancy implantation and the conversion of maternal spiral arteries from high resistance 
vessels into low  resistance vessels is a crucial step in establishing a successful pregnancy, 
and is reflected clinically in changes in the pulsatility and resistance indices of uterine artery 
Doppler studies.
Formation of the placenta
By 8 weeks of gestation, the trophoblast is characterised by secondary and tertiary villi that 
are anchored in the mesoderm of the chorionic plate, and attached to the maternal decidua 
by the outer cytotrophoblastic shell. By the beginning of the 4th month of  pregnancy, the 
cytotrophoblastic cells disappear leaving only the syncytium and endothelial cells of the 
blood vessels to separate the maternal and fetal circulation. At this time, the decidua also 
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forms a number of  septa which project into the intervillous space but do not reach the 
chorionic plate6.
The Placental Circulation
The placenta receives its blood supply from the spiral arteries that pierce the decidual plate 
and enter the intervillous space. The high pressure in the spiral artery forces the blood deep 
into the intervillous space and bathes the villous tree in oxygenated blood7. Blood then flows 
from the chorionic plate towards the decidua and enters the endometrial vein.
The Fetal Circulation 
Oxygenated blood enters the fetus via the umbilical vein and the first major organ it reaches 
is the liver. The Ductus Venosus acts as a shunt that redistributes blood from the hepatic to 
the central circulation. Umbilical venous blood destined for the hepatic circulation joins with 
the left portal vein to drain into the splanchnic circulation8.  
Blood destined for the central circulation enters the right atrium together with the inferior and 
superior vena cavae, the right, middle, and left hepatic veins, and the coronary sinus. 
Meanwhile, blood from the pulmonary circulation enters the left atrium via the pulmonary 
veins. Blood is then shunted through the foramen ovale so oxygen rich blood from the 
ductus venosus enters the left ventricle preferentially, while oxygen depleted blood enters 
the right ventricle8.
From the left ventricle, oxygen rich blood supplies the myocardium and the brain before re-
joining the right ventricular output at the ductus arteriosus, from where it continues to supply 
the rest of the body. 
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De-oxygenated blood finally travels back to the placenta through the umbilical artery.
1.1.2 Pathophysiology of Fetal Growth Restriction
Defective implantation
Dysfunctional trophoblast differentiation may result in uteroplacental insufficiency and 
diseases such as pre-eclampsia or fetal growth restriction. Defective spiral artery 
remodelling by trophoblast results in an utero-placental circulation that remains in a state of 
high resistance.9 Among the factors implicated in dysfunctional spiral artery remodelling are 
a lack of an appropriate Natural Killer (NK) cell response to trophoblast invasion, defective 
extravillous trophoblast cell differentiation towards an invasive phenotype, an increase in 
trophoblast apoptosis, an imbalance of  migratory and invasive extravillous trophoblast cells, 
and the inability of  cells to adopt an endovascular phenotype9. Studies investigating changes 
in the placental bed in intrauterine fetal growth restriction have found that although interstitial 
invasion of  the extravillous trophoblast occurs, the extravillous trophoblastic cells remain 
outside the muscular media and do not transform the spiral arteries10.
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Figure 1.1: Trophoblastic invasion of the maternal spiral arteries in growth restricted and normal pregnancies11. 
In addition to the deficient conversion of maternal spiral arterioles, fetal growth restriction is 
associated with defects in the development of gas-exchanging villi12. Growth restricted 
fetuses demonstrate a lack of  formation of terminal villi, implying an arrest of non-branching 
angiogenesis. 
Placental lesions
The shallow  invasion of the trophoblast into maternal tissue, and inadequate conversion of 
the spiral arterioles, in combination with inadequate villi formation leads to placental 
ischaemia13-16, and histological examination of  these malperfused placentae demonstrate a 
thickened, globular placenta with gross areas of infarct and abruption17, 18, as well as 
microscopic evidence of chronic inflammation and villitis13, 19. The typical lesions that are 
seen on histology include central infarction in the placental parenchyma, thrombotic 
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vasculopathy with avascular necrosis of  the villi distal to the site of  thrombosis, intervillous 
thrombosis, and perivillous fibrin deposition12.
The presence of placental thrombosis and infarction increases uteroplacental impedance in 
both the fetal and maternal compartment and is reflected by increases in the Doppler 
velocimetry impedance indices of  the umbilical and the uterine arteries respectively on 
ultrasonography20, 21. 
Maternal adaptation to pregnancy
The systemic adaptation to pregnancy is impaired in growth restricted pregnancies, with 
failure of  blood volume expansion demonstrated by the lack of a fall in haemoglobin and 
blood pressure that is characteristically seen in the second trimester. This may be due to the 
lack of local and systemic adaptation signals caused by failed extravillous trophoblast 
invasion12. 
Fetal adaptive mechanisms- The Brain Sparing Effect
An adverse intra-uterine environment is believed to result in adaptive responses that result 
in the development of  a ‘thrifty phenotype’. Blood flow  to the essential organs (brain, heart, 
and adrenals) is increased at the expense of others to facilitate maintenance of their 
growth22, 23. In response to the reduction in pO2, cerebral and myocardial vessels dilate in 
order to maintain delivery of oxygen and metabolic substrates to the fetus24. This is part of 
the fetal auto-regulatory mechanism that permits vasoconstriction or vasodilation to maintain 
constant perfusion of the cerebral tissues and is controlled by metabolic, neural, and 
chemical mediators. Animal models of intrauterine growth restriction have shown that brain 
growth is maintained through these compensatory mechanisms25.
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 This increase in cerebral perfusion is evidenced in clinical practice by a reduction in the 
pulsatility index of the Middle Cerebral Artery, and asymmetric growth with maintenance of 
head growth at the expense of other growth parameters. 
Figure 1.2: Asymmetric growth in fetal growth restriction as a result of the brain sparing effect
As the severity of fetal growth restriction increases, flow  within the cerebral circulation also 
changes as measured by Doppler velocimetry indices26.
 
Figeuroa-Diesel et al 26 found a significant reduction in the Pulsatility Index of the Middle 
Cerebral Artery, Anterior Cerebral Artery, Posterior Cerebral Artery, and the Pericallosal 
Artery once the diagnosis of  fetal growth restriction with cerebral redistribution was made. As 
the disease progressed, they found no difference in the flow  of  the Anterior or Posterior 
cerebral artery, and normalisation of blood flow  in the Pericallosal Artery, and an attempt at 
normalisation of  blood flow  in the Middle Cerebral Artery. Hernandez-Andrade et al27 found a 
diversion of blood flow  from the frontal regions of the brain to the basal ganglia region as the 
severity of growth restriction increased.
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Although the brain sparing effect attempts to compensate for the reduction in oxygen 
delivery to the brain, it is not able to prevent aberrations in the development of the brain, as 
evidenced by the increased incidence of learning difficulties and developmental delay in 
growth restricted children28.
1.1.3 Outcome
The Growth Restriction Intervention Trial (GRIT) found that altering current management 
with respect to timing delivery of growth restricted fetuses did not lead to improvements in 
mortality, however, the risk of  brain damage associated with prematurity remained a 
significant problem at longer term follow  up29, 30. In the immediate perinatal period, growth 
restricted fetuses are at increased risk of  perinatal demise, and of neonatal complications 
such as intraventricular haemorrhage, periventricular leucomalacia, respiratory distress 
syndrome, and necrotising enterocolitis 31-33. 
In the longer term, these children are at further risk of  developmental delay and behavioural 
problems34, and in adulthood, there is also an increased incidence of  hypertension and 
diabetes as part of the metabolic syndrome35. Growth restricted fetuses are at increased risk 
of cardiovascular disease, type 2 diabetes and insulin resistance, hypertension, and obesity 
in adulthood. While growth restriction in itself is a predictor for increased risk of these 
conditions in later life, catch up growth in post natal life also acts as an independent 
predictor for conditions such as type 2 diabetes and cardiovascular disease. This may be 
mediated through the development of increased visceral adiposity and increased insulin 
secretion following in utero programming. In a rat model, fetal growth restriction was 
associated with decreased total body fat content, a relative increase in intra-abdominal fat 
deposition and adipocyte size, an increase in fasting plasma concentrations of leptin, 
triglyceride and free fatty acids, and an increased concentration of triglycerides and 
ceramides in both liver and skeletal muscle36.The exact mechanisms that link disordered 
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growth in utero and adult onset disease are still unclear, and despite improvements in 
neonatal morbidity and mortality following in utero fetal growth restriction, the longer term 
sequelae of fetal growth restriction remain a significant medical problem.
Exact quantification of perinatal risk is difficult due to the small size of  many older studies 
and the lack of  appropriate controls. To further our understanding of the immediate perinatal 
burden faced by fetuses following intrauterine fetal growth restriction, a meta-analysis of the 
studies looking at neonatal outcome of growth restricted fetuses delivered preterm was 
performed. This is described in Chapter 8 of this thesis. The patho-physiology behind the 
increased risk of  immediate perinatal complications is also discussed in further detail in 
Chapter 8. 
1.2 Ultrasound
The first reported use of Doppler ultrasound in pregnancy was in 1977 when an umbilical 
artery waveform was obtained37. The authors in that study rightly concluded that Doppler 
studies may help in the assessment of  conditions such as pre-eclampsia and fetal growth 
restriction as the shape of the waveform changed with variations in perfusion. Doppler 
ultrasound plays a significant role in modern obstetrics, particularly in the management of 
high risk pregnancies such as multiple gestations, fetal anaemia, and fetal growth restriction. 
In particular, new  developments in 3 and 4-dimensional ultrasound technology have enabled 
the acquisition of volumetric flow indices in compromised fetuses.
1.2.1 The History of Ultrasound
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The application and development of  ultrasound in medicine scan be traced back to SONAR 
(SOund NAvigation and Ranging) technology; the technique of measuring distance under 
water using sound waves. The interest in SONAR technology soared following the sinking of 
the Titanic in 1912, and the first patent for an underwater sonar device was filed at the 
British Patent Office by Lewis Richardson within a month of the sinking. The onset of  World 
War I and II further propelled the development of  SONAR technology in the form of naval 
and military technology.
In medicine, ultrasound started off as a therapy rather than a diagnostic tool, and was was 
utilised in a wide range of conditions including rheumatoid arthritis, gastric ulcers, eczema, 
asthma, thyrotoxicosis, haemorrhoids, urinary incontinence, elephantiasis and angina 
pectoris38.
Figure 1.3: Early uses of ultrasonic energy to treat gastric ulcers (left), and arthritis (right)39.
The potential for ultrasound to be used as a diagnostic method was proposed by H Gohr and 
Th Wedeking in 1940, in their paper “Der Ultraschall in de Medizin”, where they proposed 
that ultrasound could be used to detect tumours, exudates, or abscesses40. In 1942, Karl 
Theo Dussik published his experiments attempting to locate brain tumours and cerebral 
ventricles using ultrasound41. From the 1950s onwards, John Wild began using B-mode 
ultrasound to scan for breast lumps38.
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The use of ultrasound in obstetrics and gynaecology was pioneered by Professor Ian Donald 
in Glasgow  who used it to diagnose pelvic masses and tumours, as well as to perform fetal 
cephalometry in 1959.
The first real time ultrasound scanner was manufactured by Siemens Medical systems and 
emerged in 1965, and by the early 1970s, linear array technology was being used to 
produce real time images. One of  the earliest commercially available linear array scanners 
was produced by Advanced Diagnostic Research Corporation in 1973, and contained 64 
crystals in a row42.
Figure 1.4: Images from early real-time scanners43.
Phased array scanning was first described by Jan C Somer in the Netherlands as early as 
196844, but it was only incorporated into commercial machines in 1974. This led to a vast 
improvement in real-time image acquisition and the technology is still used in modern 
machines.
The Doppler effect was first used by Shigeo Satomura and Yasuhara Nimura in Osaka for 
the study of cardiac valvular motion and pulsations in peripheral blood45. The first duplex 
pulsed Doppler scanner developed in 1974 enabled 2D gray scale imaging to be used to 
guide the placement of the beam for Doppler signal acquisition. Further developments led to 
the development of colour Doppler imaging.
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Ultrasound technology has undergone vast improvements since then, and in recent times, 3-
dimensional imaging of  the fetus has become possible. It was first described in 1994 and is 
produced by mechanically moving the arrays in a sweeping or rotating direction to provide 
the third dimension. It can be used to visualise fetal abnormalities as well as provide 
volumetric assessment of fetal organs in conditions such as congenital diaphragmatic 
hernia.
1.2.2 The Physics of Ultrasound
The Ultrasound Wave
Ultrasound is sound waves in a frequency range inaudible to the human ear. Audible sound 
frequencies are in the frequency range of 20 – 20,000Hz, while diagnostic ultrasound is in 
the frequency range of 1 – 12MHz46. These sound waves consist of  waves of  compression 
and decompression within the transmitting medium travelling at a fixed velocity. 
The wavelength of  ultrasound affects the penetration of the wave through the body. Short 
wavelength ultrasound such as that used in transvaginal scanning (7 - 8MHz) offers good 
resolution but poor penetration, while long wavelength ultrasound such as transabdominal 
scanning (3.5 – 5MHz) are able to penetrate the tissues deeply but with poorer resolution46.
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Figure 1.5: A comparison of the penetration and resolution with different ultrasound transducer 
frequencies42.
When ultrasound waves encounter human tissue, the waves are reflected (the effect of  most 
relevance in clinical imaging), refracted and attenuated. If  the tissue happens to be in motion 
(such as blood cells in a vessel), the sound wave is also scattered (the effect of  most 
relevance in Doppler analysis).
Figure 1.6:The four ways that an ultrasound wave interacts with biological tissue42. 
The ability of the sound wave to travel through tissue is dependant on the density and 
elasticity of the tissue in which it is travelling. Ultrasound travels faster in dense tissue, and 
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slower in compressible materials. The speed of ultrasound in bone is 3400m/s, in soft tissue 
it is 1500m/s, and in air it is 330m/s. 
The amount of  reflection the sound wave undergoes is also dependent on the density of the 
reflecting surface, as well as the angle at which the sound wave meets it. In general, the 
greater the density of the tissue or surface, the greater the amount of reflected sound waves. 
Figure 1.7: Biparietal diameter view of the fetal skull demonstrating the increased reflection of 
ultrasound waves at dense bony surfaces
Attenuation of the ultrasound wave is the reduction of  the amplitude of  the wave as it travels 
through the imaging medium. It is the result of absorption, refraction, scattering and 
absorption of the sound wave. It results in a reduction in signal amplitude and can affect 
image quality46. 
Refraction is the change of  direction the sound wave undergoes when it encounters a 
medium through which it travels at a different speed. Refraction occurs at this interface as a 
result of the different velocities of the sound wave in both materials46. 
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1.2.3 The Safety of Ultrasound
The majority of epidemiological studies have supported the safety of ultrasound in 
pregnancy47. A small number of  epidemiological studies have reported an increased 
incidence of low  birth weight, delayed speech, and non right handedness in children 
exposed to ultrasound in utero. The mechanisms thought to be involved in ultrasound 
mediated damage to tissue are the thermal effects and non thermal cavitation.
Part of the ultrasound wave is absorbed by tissue and converted to heat. The amount of 
heat produced depends on the properties of  the tissue and the ultrasound exposure 
conditions. Doppler studies in particular have a high risk of inducing heating effects in tissue. 
This is mainly due to the higher pulse repetition rates, the longer pulse lengths, and the use 
of a stationary beam compared to grey-scale imaging. The greatest temperature rise occurs 
in regions close to bone, with temperature rises increasing as bone density increases48. In 
colour and power Doppler applications, ultrasound energy is distributed over a large volume 
of tissue, and the maximum temperature increase is less compared with pulsed Doppler 
applications49.
The risk of causing a thermal effect increases as gestation increases- this is due to the 
increased ossification of bone as gestation increases, and increased interception of the 
ultrasound beam by fetal bone. Hyperthermia is known to be a teratogen in animals 
experiments and is considered to be teratogenic in humans especially during periods of 
organogenesis50. The thermal index (TI) expresses the potential for a rise in temperature 
with ultrasound exposure, with a TI of 1.0 corresponding to the total acoustic power required 
to raise a maximum temperature increase of 1°C46. A significant increase in temperature can 
occur at or near bone in the fetus with an ultrasound beam held for more than 30 seconds in 
some Doppler applications50. 
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Besides the thermal bioeffect caused by ultrasound, a non-thermal effect may be caused by 
cavitation. Cavitation refers to the creation of  ‘bubbles’ within the liquid medium through 
which ultrasound passes, as a result of negative pressure in areas of  rarefaction and  results 
in fractures or tears in the liquid. The two types of cavitation that may occur are non-inertial 
cavitation, and inertial cavitation. In non-inertial cavitation the bubbles exist for a number of 
acoustic cycles with a radius around an equilibrium value. In inertial cavitation, the bubbles 
oscillate in an unstable manner, expanding in size before collapsing down during a single 
half  cycle51. Non-thermal bioeffects may be more significant in early gestation, when the 
relatively loosely tethered embryonic tissues are exposed to an ultrasound beam in a liquid 
path. The Mechanical Index (MI) indicates the potential for ultrasound to induce inertial 
cavitation in tissues in the presence of gaseous bubbles in an air-water interface 
Current safety regulation from the AIUM (American Institute for Ultrasound in Medicine, 
USA)52 and the BMUS (British Medical Ultrasound Society, UK)53 endorse the self regulation 
of practitioners and monitoring of  the thermal index and time exposure during each 
examination. The threshold for irreversible damage in the fetal brain is a temperature rise of 
4°C maintained over 5 minutes 50.
1.2.4 The Doppler Effect
The Doppler effect theory was developed by Christian Andreas Doppler, and presented by 
him in 1842 to the Royal Bohemian Society of  Science, in a paper entitled “Über das farbige 
Licht der Doppelsterne und einiger anderer Gestirne des Himmels” (“On the coloured light of 
the double stars and certain other stars of the heavens”)54. It refers to the shift in frequency 
and wavelength of a wave as a result of the source moving with respect to the receiver, a 
receiver moving with respect to the medium, or a moving medium. 
The relationship describing the Doppler effect for a moving source is given by the formula: 
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where f2 is the apparent frequency, f1 is the actual frequency, v is the speed of sound in the 
medium, and vs is the speed of the source through the medium. 
The Doppler shift effect within tissue can be calculated with the following formula: 
where v is the velocity, f  is the frequency of the emitted pulse, Ө is the angle between the 
direction of the emitted sound wave and that of  the moving target, and c is the speed of 
sound within the tissue. 
In ultrasonography, the Doppler effect can be used to estimate flow  rate in vessels by 
measuring the change in frequency as the ultrasound waves bounce off  moving red blood 
cells. 
Doppler systems may utilise continuous wave or pulsed wave Dopplers. In continuous wave 
Doppler, there is continuous generation of  ultrasound waves coupled with continuous signal 
reception. Continuous wave Doppler is able to measure high velocities accurately, however, 
it lacks selectivity or depth discrimination.
In pulse wave Doppler, there is alternation of  the transmission and reception of ultrasound 
waves by the transducer. This enables selective gating of  the Doppler shift localised to a 
specific area and effectively ‘ignores’ Doppler signals outside the region of interest. 
However, pulse wave Doppler is unable to record high velocities as a result of  aliasing. With 
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aliasing, the pulse wave Doppler is unable to calculate velocities above its limit, and they are 
placed in the reverse channel.
With Colour Doppler, a two-dimensional map of Doppler signals within the region of interest 
can be displayed. Doppler shifts toward or away from the transducer are visually 
demonstrated as red and blue respectively, with the saturation of  colour relating to the 
velocity of the flow. 
With Power Doppler, an additional component of the Doppler spectrum- intensity, can be 
displayed within the region of interest, at the expense of flow  velocity and direction of  flow55. 
The potential advantages of  Power Doppler over Colour Doppler include the extended 
dynamic range which results in an increased sensitivity to flow, and the independence of the 
beam to the vessel angle which produces better delineation of tortuous vessels55.
1.2.5 Changes in Ultrasound and Doppler indices in growth restricted fetuses
Fetal growth restriction caused by placental insufficiency is characterised by the 
redistribution of the fetal cardiac output (brain sparing effect) whereby blood flow  is 
preferentially diverted to essential organs such as the brain, heart and adrenals, at the 
expense of other organs. This can lead to asymmetric growth, where the cranial 
measurements tend to remain within the normal range, whilst the abdominal circumference 
and femur length measurements display a reduction in growth velocity. The diversion of 
blood away from the kidneys also results in a reduction in amniotic fluid as fetal urine 
production decreases.
Placental dysfunction in fetal growth restriction is triggered by failed trophoblast invasion of 
maternal spiral arterioles, leading to placental ischaemia. This triggers a prothrombotic 
cascade of  endothelial cell dysfunction, inappropriate activation of the coagulation cascade, 
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fibrin deposition, and the occurrence of uteroplacental thrombosis. This increase in 
uteroplacental impedance is evidenced by increases in the Doppler velocimetry of the 
uterine arteries and the umbilical artery. Arterial Doppler index changes in the growth 
restricted fetus have been extensively studied in the uterine, umbilical and middle cerebral 
arteries. 
Uterine artery Doppler indices have been used to identify abnormal placentation and helps 
predict maternal hypertension, pre-eclampsia, fetal growth restriction and fetal demise56. 
Uterine artery Doppler studies in the non pregnant state demonstrate high resistance flow 
with early diastolic notches indicating elastic recoil, and low  volume diastolic flow. As 
implantation of the normal pregnancy progresses, these vessels show  reduced resistance 
with no elastic recoil and an increase in diastolic flow. In growth restricted pregnancies, 
uterine artery Doppler indices exhibit increased resistance, and persistence of an early 
diastolic notch seen at 23 weeks57. The sensitivity of uterine Doppler ultrasound in predicting 
either pre-eclampsia or fetal growth restriction ranges between 7 and 32%, with a positive 
predictive value ranging between 10 and 50%58. This large variation in positive predictive 
value is largely due to the difference in patient population studied, with a higher positive 
predictive value among patients at high risk of  developing pre-eclampsia or fetal growth 
restriction.
Figure 1.8: Uterine artery dopplers in a normal pregnancy demonstrating a low resistance and high volume end 
diastolic flow on the left and uterine artery Dopplers in a growth restricted pregnancy demonstrating an early 
diastolic notch and low volume diastolic flow on the right.
Depending on the severity of the fetal growth restriction, umbilical artery Doppler studies can 
demonstrate positive end diastolic flow, absent end diastolic flow, or reversed end diastolic 
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flow. In normal pregnancy, umbilical artery resistance decreases and the volume of  diastolic 
flow  increases as gestation progresses, reflecting placental perfusion. Increased umbilical 
artery resistance indices and the absence or reversal of  umbilical artery end diastolic flow 
indicates impaired placental perfusion in fetal growth restriction and is a marker of disease 
severity. Although the oxygen content of umbilical venous blood often remains normal, there 
is a reduction in total fetal arterial oxygen delivery as the mean umbilical arterial flow  is 
compromised and a state of chronic hypoxia develops.
Figure 1.9: positive end diastolic flow in the umbilical artery on the left (normal pregnancy), and absent end 
diastolic flow in the umbilical artery on the right (growth restricted pregnancy)
Middle cerebral artery (MCA) Doppler studies provide an indication of cerebral redistribution 
of blood flow. MCA resistance tends to be high throughout gestation. In response to 
abnormal placentation, fetal circulatory changes and the ‘brain sparing’ effect occurs, leading 
to a reduction in cerebral flow  resistance and an increase in diastolic flow. This is thought to 
be mediated by both an increase in fetal blood pressure as well as by cerebral auto-
regulatory shunting mechanisms in response to hypoxaemia and hypercapnia59. 
As the severity of fetal growth restriction increases, this pattern of cerebral redistribution 
changes, with a shift in perfusion from frontal regions of the brain to the brainstem and basal 
ganglia27 as a further protective mechanism. The loss of  the redistribution effect is seen as a 
pre-terminal sign in the fetus that has lost its auto-regulatory capability.
Venous Doppler velocimetry indices measurements provide information about cardiac pump 
function. The ductus venosus acts as a shunt, diverting 80% of oxygenated blood from the 
umbilical vein to the inferior vena cava from where it is diverted to the fetal heart and brain. 
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The Ductus Venosus waveform in normal fetuses shows a biphasic pattern with two peaks 
and two troughs. The first peak (S wave) represents the pressure gradient between the 
venous system and the right atrium during ventricular systole. The second peak (D wave) 
represents filling of  the ventricles in early diastole.The first trough represents the period of 
isovolumetric relaxation between systole and diastole. The final trough (A wave) represents 
atrial systole.
Figure 1.10 The Ductus Venosus waveform
In the compromised anaemic or hypoxic fetus, ductus venosus dilatation results in increased 
shunting of oxygenated blood for central distribution. In addition, cardiac function is often 
impaired in the compromised fetus, and impaired preload handling and diastolic dysfunction 
results in absence or reversal of  the ‘a’ wave in the ductus venosus and the presence of 
pulsatile flow in the umbilical vein. 
As a general rule, the pattern of ultrasound Doppler changes that occur with increasing 
severity of fetal growth restriction are (1) increased pulsatility index in the umbilical artery, (2) 
increased pulsatility index in the umbilical artery and reduced pulsatility index in the middle 
cerebral artery (cerebral redistribution) (3) absent or reversed end diastolic flow  in the 
umbilical artery (4) loss of the cerebral redistribution effect (5) absent or reversed a wave in 
the ductus venosus and / or pulsatility in the umbilical vein. Reversal of end diastolic flow  in 
the umbilical artery, loss of the cerebral redistribution effect, and / or abnormalities of venous 
Doppler studies are pre-terminal changes in the compromised fetus60.
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1.3 MRI
The use of Doppler ultrasound in the assessment of the growth restricted fetus is now 
routine practice, and fetal MRI is used infrequently in the assessment of  growth restriction 
outside of the research setting. However, MRI may prove to be a useful adjunct in the 
management of complex cases of growth restriction at the threshold of  viability as recent 
MRI studies have demonstrated abnormalities in brain development in growth restricted 
fetuses which include smaller cortical gray matter and hippocampal volumes, abnormalities 
in diffusion tensor analysis and proton Magnetic Resonance Spectroscopy analysis34, 61, 62. 
The third part of this chapter sets out to explain basic MRI physics, and the volumetric 
assessment of the feto-placental unit using MRI.
1.3.1 MRI Physics
MRI is based on the principle that the application of a radio-frequency pulse within a 
magnetic field will alter the alignment of hydrogen atoms naturally occurring within the body. 
Removal of  this radio-frequency pulse results in characteristic relaxation of  the hydrogen 
nuclei which produces a signal detectable by the scanner.
Nuclear Spin
The atomic nucleus is composed of the proton (a positively charged elementary particle), 
and the neutron (another elementary particle with a neutral charge). These elementary 
particles are surrounded by electrons that spin around the nucleus. The principles of MRI 
rely on the spin of  protons and neutrons within the nucleus. In nuclei with an equal number 
of protons and neutrons, half  spin in one direction and the other half in the other direction, 
resulting in no net spin. Nuclei such as Hydrogen however, have an extra proton, and as a 
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result, the nucleus demonstrates a net spin. The presence of spin gives rise to a magnetic 
moment.
Clinical MRI utilises the Hydrogen as the active nucleus for imaging due to the abundance of 
the Hydrogen atom within the body, and its relatively large magnetic moment.
The Magnetisation Vector
In the absence of a magnetic field, the magnetic moments of  an atom are randomly 
orientated. However, when a particle is placed in a magnetic field, its nuclear magnetic 
moment responds to the external magnetic field resulting in a change in energy, and the 
particle aligns itself either with or against the magnetic field. 
A small excess of protons will align with the magnetic field, and the net result is 
magnetisation with the external field. This net magnetic moment produces a magnetic vector 
longitudinally. The excess protons that are aligned with the magnetic field increase as the 
strength of the external magnetic field increases, resulting in a larger magnetic vector.
Nuclear Precession
Protons within the magnetic field precess about the axis of  the external magnetic field. The 
frequency of the precession is directly proportional to the strength of  the magnetic field and 
is defined by the Larmor equation which can be represented by 
 
where γ is the gyromagnetic ratio (42.58 MHz/T for proton), and B0 is the magnetic field 
strength.
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Resonance
The application of  a radio-frequency pulse at the Larmor frequency results in the absorption 
of energy and a change in the magnetisation vector. the angle to which the magnetisation 
vector changes direction is known as the flip angle (typically 90º  into a transverse 
magnetisation vector), and this is dependent on the amplitude and duration of  the radio-
frequency pulse. 
In addition to the change in the flip angle, the application of the radio-frequency pulse results 
in the magnetic moments of the Hydrogen atoms moving into phase with each other.
Generation of the MRI signal
The precession of  ‘in phase’ atoms that cuts across the receiver coil results in an induced 
electrical voltage which constituted the MRI signal.
When the radio-frequency pulse is turned off, the magnetisation vector realigns with the 
external magnetic field, gradually resulting in a reduction in the magnitude of voltage 
induced in the receiver coil. 
 
T1 recovery and T2 decay
T1 recovery is also known as the spin-lattice relaxation and refers to the process whereby 
energy absorbed by the excited proton spins is released back into the surrounding tissue, or 
lattice.
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T2 decay is also known as spin-spin relaxation and is caused by nuclei exchanging energy 
with neighbouring nuclei. A proton that comes close to another has the ability to increase or 
decrease the precession of the other proton depending on whether the field of the first 
proton is in concordance or in opposition to that of  the second. This  random interaction is 
only temporary, and results in a cumulative loss of  phase across the excited proton spins 
and an overall loss of signal.
Both T1 recovery and T2 decay are exponential processes.
Image Contrasts
Image contrasts (e.g. T1 and T2 weighted imaging) can be generated by manipulation of the 
flip angle, echo time (TE) and repetition time (TR). An increase in the TE leads to increased 
de-phasing of transverse magnetisation while an increase in the TR allows recovery of 
longitudinal magnetisation.
A T1 weighted image can be created by using a short TE to minimise T2 effects, and a TR 
similar to tissue values. Tissues such as myelin and grey matter have a short T1, and appear 
brighter in a T1 image, while unmyelinated white matter and CSF have longer T1 values, and 
appear darker.
A T2 weighted contrast can be created by using a long TE (allowing enough time for the 
transverse magnetisation decay), and a TR similar to tissue values. Tissues such as CSF 
appear bright in a T2 image as the transverse magnetisation is still present. 
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Figure 1.11: T2 weighted fetal imaging on the left and T1 weighted fetal imaging
1.3.2 Fetal MRI Techniques
Single Shot Fast Spin Echo Sequences (ssFSE)
The principles of  ssFSE sequences form the mainstay of  fetal imaging where ultrafast 
sequences are required to compensate for the presence of fetal motion. 
Fast Spin Echo sequences are accomplished by delivering several 180º refocusing radio-
frequency pulses during each TR interval, and briefly switching on the phase-encoding 
gradient between echoes.
Single shot fast spin echo techniques utilise the same principles, except only a single 90° 
pulse is applied followed by several 180° pulses. By using a single radio-frequency pulse to 
acquire the image, we are creating an essentially infinite TR and eliminating T1 weighted 
information.
Other sequences that can be used to image the fetus include Half-Fourier single shot turbo 
spin echo (HASTE) sequences (which operate on the same principles as ssFSE imaging), 
and Echo Planar Imaging (EPI).
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1.3.3 The safety of MRI 
The potential hazards with MRI may arise from its static magnetic field, the pulsed radio-
frequency field, or the gradient electromagnetic field.
Hazards from the static magnetic field are mainly biological effects, projectiles, and implant 
malfunction or movement. Static magnetic fields are not believed to have serious biological 
effects on humans at the level used routinely63. 
Hazards arising from the radio-frequency field are tissue heating, implant heating or 
interference. Tissue heating is known to be a potential teratogen, and the specific absorption 
rates (SAR) for each sequence is used as an safety limit (SAR limits for whole body scans 
are 0.4W/kg, and a pulse sequence should not increase temperature by more than 1°C). 
Mathematical modelling of SAR in pregnancy has been undertaken by recent studies, and 
these improve our understanding of  heat deposition in the pregnant state and ensure safe 
limits are adhered to64. 
Figure 1.12: Modelling of the maternal and fetal tissues to facilitate understanding of regions particularly sensitive 
to heat deposition (Courtesy of Prof M Rutherford, Robert Stener MRI Unit).
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Hazards arising from the gradient fields are peripheral nerve stimulation, acoustic noise, and 
implant interference. Studies on the safety of  magnetic gradients have found no increased 
risk of biological effects65. Gradient noise generated by the presence of a current within the 
coils located in the static magnetic field may be a particular source of  concern in fetal 
imaging due to the lack of hearing protection for the unborn fetus, however, a study by 
Ruckhäberle et al found no risk to fetal hearing by studying the intrauterine transmission of 
sound in pregnant ewes66.
The majority of studies have found no adverse effect from imaging the fetus in-utero. 
Although some animal studies have found an increased incidence of  fetal weight reduction48, 
reduced crown-rump length67, abnormalities68, and mortality rates68 following prolonged (6-8 
hour) MR exposure, others have found no difference in mortality, abnormalities69, cell 
proliferation or migration70, and postnatal growth71, even with exposures to magnetic fields 
up to 4T. 
Fetal MR imaging in The Robert Steiner MRI Unit (Imperial College London) is restricted to 
60 minutes and performed using a 1.5T magnet. Patients are metal checked prior to the 
scan and informed consent is sought. As fetal temperature is closely linked to maternal 
temperature, and is typically 0.5°C higher72, temperature measurements prior to and 
following the scan are taken using a digital ear thermometer.  
Three year follow  up of children imaged in utero have shown no demonstrable increase in 
disease or disability73. Other studies have investigated changes in fetal heart rate during a 
scan, and found no difference in fetal heart rate during a scan74, 75. A further study surveyed 
exposure to fringe magnetic fields among female technologists, and found no difference in 
pregnancy outcome76. 
Current safety guidelines on patient exposure to MRI are from the Medicines and Healthcare 
products Regulatory Agency (MHRA)77.
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1.3.4 Volumetric assessment of the fetus using MRI
In the past studies have attempted to calculate MR fetal organ volume using the Cavalieri 
principle. The Cavalieri principle was published in 1635, and offered an alternative to the 
Archimedes’ water displacement principle of  volume estimation. The Cavalieri principle 
states that the volume of an object can be estimated from the area of  the object on cut 
sections. It involves both random and systematic cuts through the space of interest, 
providing a systematic uniform random sampling method. Integration of the areas then gives 
volume estimation for the object. 
Using this technique, Gong et al.78 measured fetal body volume and fetal total brain volume 
in a population of eighteen normal and eight abnormal fetuses. Similarly Garden et al.79 
measured fetal body volume, fetal lung, fetal liver and total brain volume in 4 normal fetuses. 
Improved fetal imaging techniques have enabled more accurate volume measurements to 
be undertaken and some studies have used 2-dimensional single shot sequences to 
calculate volumes of individual brain structures. Kazan Tannus et al80 used ssFSE 
sequences to calculate cortical, ventricular, and cerebellar volumes in fetuses with 
ventriculomegaly, Hatab et al781used ssFSE sequences to calculate fetal cerebellar volume 
in 93 normal fetuses, and Andreas et al82 used HASTE sequences to measure total brain 
volume in a small number of fetuses.
EPI imaging is capable of  acquiring whole fetal body volumetric data with a scanning time 
between 7.5 and 12.5 seconds83. However, it is limited by the low  signal to noise ratio, and 
its inability to provide adequate detail for measuring various regions of the brain.
Although the acquisition of a single slice through the brain takes less than a second, and the 
total acquisition takes less than 30 seconds, fetal motion is often apparent in the dataset and 
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this hampers the clinical analysis of the image, and obviates objective volumetric 
assessment of the image. 
One way to overcome the limitations of volumetric assessment using the methods detailed 
above is to perform a 3D reconstruction of the dataset post acquisition.  
In our unit, 3D reconstruction is performed using a recently developed technique known as 
snapshot volume reconstruction technique (SVR)84. Dynamic single shot scanning is 
undertaken to repeatedly sample the spatial region containing the brain with multiple 
overlapping slices. This ensures that every part of the brain is sampled, even when there is 
significant motion. Image registration is then used to align the imaging data into a common 
co-ordinate system to producing a volumetric dataset which can be re-sliced into any desired 
plane. Further detail on the use of  Snapshot Volumetric Reconstruction in growth restricted 
fetuses is detailed in Chapter 2 of this thesis.
MR volumetry of the fetal brain has not previously been undertaken in a systematic 
reproducible fashion, due to the difficulties in achieving reliable high resolution high signal to 
noise datasets of  the fetal brain in the presence of fetal motion. This study aims to perform 
regional brain volumetry in fetuses with fetal growth restriction using 3-dimensional MR 
reconstruction. 
1.4 Summary
This introductory chapter provides a brief review  of the pathophysiology and longer term 
implications of fetal growth restriction. It also introduces the imaging modalities, doppler 
ultrasound and 3-dimensional fetal MRI that will be used to study the brain sparing effect in 
intrauterine fetal growth restriction as part of this thesis.
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CHAPTER 2: PROTOCOLS
2.1 Introduction
Two different imaging modalities were used to assess growth restricted fetuses in this study-
fetal MRI, and Doppler ultrasound. This chapter describes in detail the acquisition and post-
acquisition processing of MRI and ultrasound images used in this study.
2.2 Patient population
 
Ethical approval for in utero fetal MR imaging was obtained from the Hammersmith Hospital 
Research Ethics Committee (Rec No: 2003/6375 and 07/H0707/105) and written maternal 
consent was sought in all cases. Two groups of  women were recruited from Queen 
Charlotte’s and Chelsea Hospital between May 2007 and May 2010.
 
Women with fetal growth restriction secondary to placental insufficiency were approached 
upon referral to the Centre for Fetal Care at Queen Charlotte’s and Chelsea Hospital. For 
the purposes of this study, fetal growth restriction was defined as an estimated fetal weight 
below  the 5th centile, measured on ultrasound. A less restrictive definition of below  the 10th 
centile has been used to define fetal growth restriction by some groups, but we chose to 
define it as growth below  the 5th centile to exclude fetuses with less severe fetal growth 
restriction. 
Exclusion criteria were (1) multiple pregnancy, (2) aneuploidy, (3) the presence of in-utero 
infection, (4) the presence of  additional structural abnormalities, and (5) suspected genetic 
syndromes. The severity of fetal growth restriction was graded in order of  increasing severity 
as (1) a Pulsatility Index above the 95th centile in the Umbilical Artery (UA) (2) a Pulsatility 
Index above the 95th centile in the UA as well as a Pulsatility Index in the Middle Cerebral 
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Artery (MCA) below  the 5th centile (cerebral redistribution) (3) absent end diastolic flow 
(AEDF) in the UA (4) reversed  end diastolic flow  (REDF) in the UA and (5) absent or 
reversed ‘a’ wave in the Ductus Venosus (DV) and/or pulsatility in the Umbilical Vein (UV) 
(venous Doppler changes).
Severity Grade Doppler Ultrasound Findings
1 Umbilical Artery PI > 95th centile
2 Umbilical Artery PI > 95th centile & Middle 
Cerebral Artery PI <5th centile
3 Umbilical Artery Absent End Diastolic Flow
4 Umbilical Artery Reversed End Diastolic Flow
5 Venous Doppler Changes
 Table 2.1 : Severity grade of IUGR patients
Women with structurally normal fetuses were approached in the ultrasound department of 
Queen Charlotte’s and Chelsea Hospital at the time of their second trimester anomaly scan. 
Women were scanned serially with ultrasound to ensure fetal growth was maintained, and 
were scanned once using MRI during their pregnancy. 
The patient numbers included in each chapter of  this thesis varies as not all patients had the 
full repertoire of MRI and ultrasound sequences, or the sequences that had been obtained 
did not cover the region of interest completely and had to be disregarded. Further detail is 
given about patient demographics in each chapter of this thesis.
Table 2.2 details the of the patient population included in the study as a whole and their 
inclusion in each chapter of this thesis.
Patient ID Type Gestational Age
Placental 
Volumetry
Whole Body 
Volumetry
Brain 
Volumetry
RP2163 IUGR-4 20.43 Yes Yes Yes
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ED2379 IUGR-4 20.86 Yes Yes Yes
PO1148 IUGR-2 22.28 Yes No No
EM2248 IUGR-4 23.71 Yes Yes Yes
DCL1108 IUGR-4 23.86 Yes Yes Yes
FK784 IUGR-3 24 No Yes Yes
BP1104 IUGR-5 24 No Yes Yes
SR858 IUGR-6 24.57 No No Yes
MB2396 IUGR-6 24.86 Yes Yes Yes
SH1585 IUGR-3 25.43 Yes Yes Yes
DD2494 IUGR-4 25.57 No No Yes
JS1014 IUGR-6 26.43 No Yes Yes
MZ1126 IUGR-2 26.43 Yes Yes Yes
RM2265 IUGR-6 26.57 Yes Yes Yes
KN596 IUGR-4 27.14 No Yes No
HY577 IUGR-6 27.29 Yes Yes Yes
AA1417 IUGR-4 27.57 Yes No Yes
TB2481 IUGR-4 28 Yes No Yes
IR2293 IUGR-4 28 Yes Yes Yes
RV2322 IUGR-3 28 Yes Yes Yes
AO1174 IUGR-2 28.57 Yes No No
SD1265 IUGR-3 29 No No Yes
CS2547 IUGR-4 29 Yes No Yes
KN629 IUGR-4 29.14 No No Yes
BC1307 IUGR-4 31.56 Yes Yes Yes
ML2140 IUGR-5 32 Yes Yes Yes
RF2017 IUGR-3 32.38 Yes Yes Yes
FH932 IUGR-4 32.57 Yes Yes Yes
SS2546 IUGR-4 32.57 No No Yes
NOD1107 IUGR-2 33 No No Yes
ZN598 IUGR-3 34.14 No No Yes
AO1174 IUGR-2 35.71 No No Yes
TR2508 Normal 23.86 Yes No Yes
CM1830 Normal 24.57 Yes Yes Yes
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ER821 Normal 24.71 No No Yes
KM2381 Normal 24.71 Yes Yes Yes
LH1586 Normal 25.00 Yes No Yes
AF2201 Normal 25.14 Yes No Yes
ABT1055 Normal 25.42 Yes No Yes
CC1125 Normal 26.71 No No Yes
VTR1173 Normal 26.86 No No Yes
SN1206 Normal 27.00 Yes Yes Yes
PW2540 Normal 27 No No Yes
MW2429 Normal 27.42 No No Yes
LG2283 Normal 27.56 Yes Yes Yes
NM1935 Normal 27.57 Yes Yes Yes
TF2063 Normal 27.86 No Yes Yes
SA1901 Normal 28.00 Yes Yes Yes
AK2284 Normal 28.56 Yes Yes Yes
CK1101 Normal 29 No No Yes
FI2425 Normal 29 No No Yes
LD1149 Normal 29.14 Yes Yes Yes
KM1861 Normal 29.28 Yes Yes Yes
SOM2557 Normal 29.28 No No Yes
TD1382 Normal 29.43 No No Yes
CG1130 Normal 29.57 No No Yes
MU2312 Normal 29.71 Yes Yes Yes
TB2159 Normal 29.86 No Yes Yes
SM2154 Normal 29.86 Yes Yes Yes
MG2316 Normal 30.28 Yes Yes Yes
MW2313 Normal 30.28 No No Yes
FJ2351 Normal 30.42 Yes No Yes
CT2180 Normal 31.43 Yes Yes Yes
SG1999 Normal 31.71 No No Yes
NS1867 Normal 32.00 Yes Yes No
KK1887 Normal 32.14 Yes Yes Yes
JT2493 Normal 32.14 Yes No Yes
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SB2365 Normal 32.28 No No Yes
AP2401 Normal 32.57 Yes No Yes
JS1637 Normal 33.00 Yes No Yes
CR2339 Normal 34.14 No No Yes
MS2206 Normal 34.43 No No Yes
AM2324 Normal 35.43 No No Yes
AH1973 Normal 35.86 Yes Yes Yes
LE2438 Normal 35.86 Yes No No
NH2116 Normal 36 No No Yes
KO1992 Normal 36.00 Yes No Yes
LV2560 Normal 36.14 No No Yes
CB1347 Normal 36.28 Yes No No
NS1953 Normal 37 No No Yes
CF1671 Normal 37.71 Yes No Yes
Table 2.2: Patients included in each section investigated within this thesis
2.3 MRI scanning: practical aspects 
Fetal MRI was performed in the Robert Steiner MRI unit at the Hammersmith Hospital, 
Imperial College Healthcare Trust from July 2007 till July 2010. A 1.5T Philips MRI system 
(Philips Achieva; Philips Medical Systems, Best, the Netherlands) with a SENSE wrap-
around 5 channel cardiac coil was used. Women were consented for participation in the 
research study prior to the examination and a safety metal check questionnaire was filled 
prior to the scan. 
Palpation of the abdomen was done prior to the examination to ensure the coil was optimally 
placed over the fetal head. This was to ensure that the maximal signal to noise ratio was 
achieved during the examination. In cases where the region of  interest was not over the fetal 
head, the coil was repositioned over the region of  interest prior to continuing the 
examination.
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The fetal MRI examination was conducted with the mother in a left lateral tilt position and the 
entire examination was limited to one hour. No fetal or maternal sedation was used for the 
examination, and specific absorption rate (SAR) limits were adhered to, as per departmental 
protocols. The examination was stopped if  there was maternal discomfort or claustrophobia 
limiting entry into the scanner. Maternal temperature was checked prior to and following the 
examination to ensure the examination did not result in a temperature rise that was above 
recommended guidelines. Sequences that demonstrated significant artefact as a result of 
fetal motion were repeated.
A typical fetal MRI examination included (1) ssFSE sequences (parameters similar to the 
whole uterus sequence detailed below) of the fetal brain in the coronal, sagittal, and axial 
plane, (2) dynamic overlapping ssFSE sequences (parameters detailed below) of the fetal 
brain in the coronal, sagittal, and axial plane, (3) ssFSE sequence of  the whole uterus 
(parameters detailed below) taken in the maternal sagittal plane, (4) cine imaging of  the 
fetus to observe fetal motion, (5) T1 weighted imaging of  the fetal brain in the axial plane, 
and (6) MR spectroscopy of the fetal brain at three different echo times.
All images were checked by a consultant perinatal radiologist (MR) and a formal report sent 
to the referring consultant and general practitioner. Patients were offered the opportunity to 
attend for a postnatal MRI at term equivalent age, and longer term follow  up at 1 and 2 years 
as part of a larger study. 
Due to logistic constraints, serial scanning was not routinely undertaken and repeat MRI 
scans were only performed on 2 IUGR (AO1038 and 1174, KN629 and 596) and 1 normally 
grown fetus (NS1867 and 1953). Data from serial scans was not included in the analysis of 
each chapter. 
2.4 Uterine acquisition 
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A single shot approach was used to acquire data on the uterine feto-placental unit. This was 
to enable assessment of placental growth, and global fetal growth. 
Placental volume, maximal placental thickness, the placental thickness to volume ratio, the 
placenta to amniotic fluid signal intensity ratio, and the presence of abnormal signal intensity 
consistent with placental pathology was measured. 
This acquisition also allowed for calculation of the fetal whole body, lung, thymic, cardiac, 
liver, and renal volumes.
2.4.1 Whole uterus sequence 
A T2 weighted single shot turbo spin echo sequence through the entire uterus (TE: 98ms, 
TR: 1000ms, NSA: 2, matrix: 400 × 178, FOV: 360 ×  400mm, slice thickness: 4mm; slice 
gap: 0.4mm; acquisition time: 20 seconds) was the standard protocol used until May 2008, 
after which an alternative sequence (TE : 98ms, TR : 1000ms NSA: 2, matrix: 400 × 512, 
FOV: 430mm, slice thickness: 4mm; slice gap: 0 mm; acquisition time: 40 seconds) was 
used. Although the alternative sequence took longer to acquire compared to the initial 
sequence, this was counter-balanced by the benefit of having a gap-less sequence through 
the uterus.
There were difficulties acquiring data at mature gestations when the field of view  was 
insufficient to cover the entire uterus with an adequate signal to noise ratio (figure 2.1). 
These difficulties sometimes persisted following re-positioning of  the coil. In cases where the 
acquisition did not cover the uterus from end to end, or where the acquisition had a low 
signal to noise ratio, the data was not used for analysis.
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There was no post acquisition processing to correct for the presence of fetal motion. In 
cases where the acquisition demonstrated evidence of  significant motion, the sequence was 
repeated and the data used if a satisfactory acquisition was obtained.
Figure 2.1: Loss in the MR signal at advanced gestation due to distance of the region of interest from the coil.
2.4.2 Placental assessment
Placental Volume
Placental volume was assessed by manually drawing the region of interest on each slice 
with placental tissue present using ImageJ (ImageJ, ver 1.41o. NIH: Bethesda, MD). The 
area of the region of interest in each slice was measured automatically by summing the 
Figure 2.1a: Poor signal to noise ratio (as 
visualised by increased heterogeneity in a 
homogenous region) due to advanced 
gestation in a 35+6 week fetus (AH1973)
Figure 2.1b: Good signal to noise ratio at 
immature gestations in a 23+6 week fetus 
(DCL 1108)
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number of pixels covering the region of interest and multiplying this number by the area 
corresponding to a pixel. This was then multiplied by the sum of the slice thickness and slice 
gap (if present) to give the volume.
Placental Pathology
The presence of placental pathology was assessed by the signal intensity, localisation, and 
morphology of the lesions using the T2 weighted MRI specific appearance of placental 
lesions as characterised by Linduska et al85. The presence of placental infarct was 
documented in cases where there was an intraplacental lesion with a core region of 
increased signal intensity surrounded by a diffuse region of reduced signal intensity, or 
where there were diffuse regions of  reduced signal intensity on T2 weighted images (figure 
2.2a). The presence of a retroplacental haemorrhage was recorded in cases where there 
was a retroplacental circumscribed lesion with reduced signal intensity on T2 weighted 
images (figure 2.2b). The presence of subchorionic haemorrhage was recorded in cases 
where there was a subchorionic circumscribed lesion demonstrating reduced signal intensity 
(figure 2.2c). The MRI images were assessed for the presence of placental infarct, 
retroplacental haemorrhage, and subchorionic haemorrhage with the observer (MD) blinded 
to the histopathological diagnosis of placental pathology.   
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Figure 2.2: Typical appearance on placental pathology on MRI
Placental signal intensity ratio
Placental signal intensity was assessed in relation to the amniotic fluid signal intensity by 
measuring the signal intensity in the largest possible region of interest on the slice that 
Figure  2.2a: Placental Infarct in a 33+2 week 
fetus with fetal growth restriction demonstrating a 
core region of increased signal intensity 
surrounded by a more diffuse region with reduced 
signal intensity (SB1912)
Figure 2.2b: Retroplacental haemorrhage in a 
20+3 week fetus demonstrating a circumscribed 
retroplacental lesion with reduced signal intensity 
(RP2163)
Figure 2.2c: Subchorionic haemorrhage in a 23+6 
week fetus with fetal growth restriction 
demonstrating a circumscribed subchorionic  
lesion with reduced signal intensity (DCL1108)
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contained the maximal area of both placenta and amniotic fluid with no image artefact 
present (figures 2.3a & b). In the case of growth restricted fetuses, where there was a region 
of obvious placental pathology, this was not included within the region of interest, or if no 
regions of normal signal intensity could be identified, regions with an appearance closest to 
normal was used.   
Placental thickness
Maximal placental thickness was taken as the thickness of the placental parenchyma at the 
point of  central umbilical cord insertion as the placental parenchyma is thickest at this point 
(figure 2.3c). The placental thickness was measured by connecting the central umbilical cord 
insertion to the uterine wall with a line that was at 90° angle to the uterine wall directly 
opposite the central cord insertion.The images were viewed in rView  (Image Registration 
Toolkit, ver 1, Ixico Ltd) which enabled images to be viewed in the three orthogonal planes. 
In cases where the cord insertion was eccentric, the placental thickness was taken at the 
thickest portion visualised.
The placental thickness to volume ratio was calculated by dividing the maximal placental 
thickness by the placental volume. This was taken as a surrogate marker for the inverse of 
placental area based on the formula: Volume = Area × Depth (or thickness).
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Figure 2.3a: Calculation of the placental signal intensity 
Figure 2.3b: Calculation of the amniotic fluid signal intensity 
Figure 2.3c: Measurement of maximal placental thickness at the 
insertion of umbilical cord 
Figure 2.3: Measurement of the placental and amniotic fluid signal intensities, and of the placental thickness 
(CM1830)
2.4.3 Fetal body assessment
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Fetal total body, cardiac, thymic, lung, renal, and liver volume was assessed by manually 
drawing the region of  interest on each slice with tissue present using MRIcro software86.The 
area of the region of interest in each slice was measured automatically by counting the 
number of pixels covering the region of interest and multiplying this number by the area 
corresponding to a pixel. This was then multiplied by the sum of the slice thickness and slice 
gap (if present) to give the volume. The observer (MD) was blinded to the patient’s identity, 
gestational age at scan, and whether or not the patient had FGR. 
Figure 2.4a: Manual segmentation of 
the fetal heart
Figure 2.4b: Manual segmentation of 
the fetal thymus
Figure 2.4b: Manual segmentation of 
the fetal lung
69
Figure 2.4c: Manual segmentation of 
the fetal liver
Figure 2.4d: Manual segmentation of 
the fetal kidney
Figure 2.4e: Manual segmentation of 
the fetal body
Figure 2.4: Demonstration of manual segmentation of the fetal body and intra-thoracic and intra-abdominal 
organs in a 31+4 week fetus (BC 1307)
3-dimensional reconstruction of the fetal body was undertaken following segmentation to 
ensure the dataset was not distorted by motion artefact. Datasets distorted by the presence 
of fetal motion were disregarded. To confirm that visual assessment for significant motion 
was adequate and that fetal motion was not a significant source of  error in the datasets used 
in the study, the sequence was repeated three times in two fetuses to calculate the 
differences in volumetric segmentation. Additionally, an analysis correlating brain volumes 
acquired using this whole uterus sequence and a motion corrected reconstructed image 
(details of motion correction and reconstruction given below) was undertaken. The results of 
this analysis is detailed in Chapter 4 of this thesis.
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Figure 2.5: 3-dimensional reconstruction of the fetal body (AP2401)
2.5 Motion correction and 3D image reconstruction (Snapshot Volumetric 
Reconstruction)
As fetal head movements are more marked and frequent compared to fetal body 
movements, and this has an effect on the smaller volumes being measured, a dynamic 
oversampling approach with post acquisition motion correction and 3D image reconstruction 
(previously published as Snapshot Volumetric Reconstruction84) was taken. 
Although this approach could be applied to imaging of the whole fetus, acquisition of 
dynamic imaging covering the entire fetus would be time consuming and it is likely that the 
images would suffer from poor signal to noise ratio with increasing gestation, similar to that 
faced with the whole uterus acquisition.
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2.5.1 Dynamic ssFSE Sequence of the fetal brain
Data was acquired using dynamic T2 weighted single shot turbo spin echo sequences (TE: 
110ms, TR: 1500ms, NSA: 1, matrix: 256 × 272, FOV: 430mm × 353mm × 88mm, slice 
thickness: 2.5mm, slice gap: -1.25mm, acquisition time: 4 minutes, slices: 64 – 80, dataset 
loops: 2 - 4). 4 overlapping dataset loops were acquired in the transverse plane, 2 in the 
sagittal plane, and 2 in the coronal plane and all dataset loops were used in the 
reconstruction process. The overall acquisition time of a complete dynamic dataset was 
between 20 and 30 minutes with additional time required for scanner preparation and to plan 
the acquisition following each sequence.
2.5.2 Snapshot Volumetric Reconstruction
Repeated sampling of  the slice planes is undertaken by acquiring 4 loops of  data in the 
transverse plane, 2 in the coronal plane, and 2 in the sagittal planes. The data is acquired 
with a slice thickness of 2.5mm, and an overlapping gap of -1.25mm. By using this 
approach, the probability that every part of the brain is sampled, even in the presence of 
significant fetal motion is increased. 
The acquired data was converted from the native Phillips .par and .rec formats into NIFTI 
files using a dicom to nifti converter packaged with mriCRON, (v 7 July 2009) dcm2nii86. The 
transverse, sagittal, and coronal acquired datasets were viewed in mriCRON and image 
intensity settings adjusted to a standard with a slope of 1 and an intercept of 0 for all images.
As motion is often present in both the fetal brain and the surrounding maternal tissue, the 
maternal tissue was excluded from the image prior to registration and reconstruction of  the 
image to limit the presence of  motion artefact within the images prepared for reconstruction. 
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The images were cropped to exclude the surrounding maternal tissue, and the composite 
loops separated into the individual loops (named T1 - T4, C1 - C2 and S1 - S2) (Figure 2.6 a 
and b). 
Figure 2.6a: Original dataset of 
a  25+4 week fetus (DD2494)
acquired in the transverse 
plane
Figure 2.6b: Exclusion of 
maternal tissue from the region 
of interest prior to image 
reconstruction
Figure 2.6: Demonstration of the exclusion of maternal tissue from the region of interest prior to image 
reconstruction.
A target volume was created by compounding the slice data of all loops in relation to the 
target loop- the loop of data with the least motion present. The target loop was selected by 
viewing each loop in rView  and selecting the loop based on two criteria- the first was that the 
target loop had to have the least motion artefact when the image was automatically 
reconstructed in the other two planes, and the second was that the target loop covered the 
brain from end to end. A dataset acquired in the transverse plane was typically used as the 
target loop to reduce the number of loops that needed to be re-aligned to that plane. In 
cases where the transverse loops showed excessive motion, or did not cover the brain from 
end to end, a dataset acquired in the sagittal or coronal plane was used instead. 
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Figure 2.7a: A dataset loop 
acquired in the transverse 
plane in a 22+2 week fetus 
(PO1148) with minimal 
distortion of the image when 
viewed in the  sagittal and 
coronal planes. This loop was 
used as the target loop. 
Figure 2.7b: A dataset loop 
acquired in the transverse 
plane for the same fetus above 
showing significant  distortion 
of the image when viewed in 
the sagittal and coronal planes 
as a result of fetal motion.
Figure 2.7: Demonstration of the selection of a target loop
The target loop was further segmented to exclude surrounding maternal and fetal tissue 
from the image, leaving the fetal brain only in the image. The next step in the process was to 
realign all the loops into the same orientation as the target loop. Using the target loop as a 
reference, rView  was used to create a transformation file for all the other loops, by both 
rotating the image in the x, y, and z planes, as well as by translating the image. The 
composite data of  the target loop and the transformation of the other loops was used as the 
target volume.
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Figure 2.8a: Target loop 
orientation
Figure 2.8b: Original 
sagittal loop orientation 
(note acquisition shift out of 
sagittal plane due to fetal 
motion)
Figure 2.8c: Transformation 
applied to the sagittal loop 
above to match the 
orientation of the target 
loop
Figure 2.8: the application of a transformation to align all other dataset loops to the target dataset loop in the 
same fetus as Figure 2.7 (PO1148).
A text file was created with a list of images within each individual loop to be excluded from 
the reconstruction as they were corrupted by the presence of artefact.
The reconstruction of the anatomical volume was obtained using matlab (v.7.9, Mathworks 
Inc. Natick, MA, USA) using a multi-level B-Spline approximation of the registered slices into 
the target coordinate space. The resulting 8 loops of data were considered as 4-dimensional 
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data ordered sequentially in time, with a number of control slices at regular time intervals. 
The transformations of the control slices were adjusted to minimise the cost function 
between the spatio-temporal data and the target volume using a gradient-descent method. 
Once all transformations were optimised, the number of  control slices was increased and the 
process repeated until each slice was registered individually. The correct location of each 
slice within the 8 loops of data was then determined using a slice-to-volume registration to 
an estimated target volume of the brain anatomy.
Figure 2.9a: ssFSE of a 30 week fetus acquired in the transverse 
plane showing evidence of significant motion artefact when viewed in 
the coronal and saggital planes following reconstruction of the 
dataset.
Figure 2.9b: SVR of the same fetus as above showing correction of 
the motion artefact and a consistent dataset when viewed in all three 
planes.
Figure 2.9: Snapshot volumetric reconstruction of fetal brain imaging (MG2316)
The SVR process creates a reconstruction that is aligned in the same alignment as the 
target loop. If the target loop was not acquired in a true orthogonal plane, the reconstructed 
image was realigned in rView  along the anterior commissure : posterior commissure line to 
create an image that was true in all three orthogonal planes.
The SVR process creates a reconstructed file that maps to a voxel size of 1.2mm × 1.2mm × 
1.2mm slice thickness. This was re-sampled using a resample packaged within the rView 
Image Registration Toolkit to a voxel size of 0.2mm × 0.2mm × 1mm slice thickness prior to 
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manual segmentation to reduce pixelisation artefact of the dataset when viewed in a high 
zoom order. 
2.5.3 Manual Segmentation of the fetal brain
Manual segmentation was undertaken using mriCRO up till January 2010, and itk-SNAP 
thereafter. In cases where accurate segmentation required visualisation of the image in all 
three planes, itk-SNAP was used, as unlike mriCRO, it allows for visualisation of  images with 
anisotropic voxel sizes. 
Reliability analysis showed a strong correlation between volumetric measurements 
undertaken with itk-SNAP and mriCRO, with an interclass correlation coefficient of  0.99, p 
<0.001. Volumetric segmentation obtained from using mriCRO was re-analysed using 
itkSNAP, and confirmed perfect agreement between the two methods. 
Manual segmentation of  the whole brain volume was done using mriCRO by drawing around 
the outer cortical boundary of  the brain, to include the cortical gray matter, white matter, and 
deep gray matter. Ventricular spaces were excluded from the segmentation. The level of the 
midbrain was taken as the first slice where both the tectum and tegmentum were visualised, 
and midbrain / brainstem was exclude from the segmentation in all subsequent slices.
Manual segmentation of the cerebellar volume was done using mriCRO, and both lobes of 
the cerebellum and the cerebellar vermis were included in the segmentation. 
Manual segmentation of the intracranial cavity was done using itk-SNAP. Segmentation was 
done in the transverse plane around the inner boundary of  the cranium to the level of the 
spinal column. The orbits were excluded from the segmentation.
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Manual segmentation of  the ventricular system was done using itk-SNAP. Segmentation was 
done in the transverse plane and included the lateral ventricles, third ventricle, and the 
cavum septum pellucidum.
Figure 2.11a: Manual 
segmentation of the whole 
brain including cortical gray 
matter, white matter, and deep 
gray matter.
Figure 2.11b: Manual 
segmentation of the whole 
brain demonstrating 
identification of the tectum and 
tegmentum as the level of the 
midbrain
Figure 2.11c: Manual 
segmentation of the 
cerebellum including both 
lobes and the vermis
Figure 2.11d: Manual 
segmentation of the 
intracranial cavity
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Figure 2.11e: Manual 
segmentation of the ventricular 
system including the lateral 
ventricles, third ventricle, and 
cavum septum pellucidum
Figure 2.10: Demonstration of manual segmentation of the brain in a 31+4 week fetus (BC1307)
2.6 Fetal 2D and Doppler ultrasound
Assessment of placental location, Grannum classification, and estimates of fetal growth, 
liquor volume and Dopplers were obtained transabdominally using a 6MHz curvilinear 6C2 
transducer on a Siemens ultrasound system (Siemens Acuson Sequoia 512; Siemens, 
Germany). 
Ultrasound depth, gain and focal zone were adjusted prior to each scan to provide optimal 
visualisation of  fetal structures. The field of view  was narrowed and the image zoomed in 
prior to measurement of  fetal biometry. Tissue harmonics imaging (where ultrasond is 
received at a frequency different to that at which it is transmitted) was utilised in cases of 
increased maternal BMI when visualisation of fetal structures was limited. 
Doppler ultrasound gain, frequency, scale and baseline were adjusted prior to Doppler 
examination to ensure a good signal to noise ratio and appropriate visualisation of the 
Doppler waveform.
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2.6.1: Fetal Growth measurements
Fetal growth was measured using these parameters (1) head circumference measured 
around the calvarium with the anatomical landmarks of  a midline falx, symmetrical thalami, 
and visualisation of the septum pellucidum at one third of the fronto-occipital distance, (2) 
the biparietal diameter measured from the inner to outer edge of  the cranium at the same 
landmarks as above, (3) the abdominal circumference measured with the anatomical 
landmarks of  a 90º  transverse view  of  the spine at 3 or 9 o’clock, a stomach bubble on the 
fetal left, symmetrical appearance of  the ribs, and visualisation of the junction of the right 
and left portal vein, and (4) the femur length measured with the transducer perpendicular to 
the long axis of the bone.
Each growth parameter was measured three times and the average measurement used to 
chart fetal growth. Fetal growth was charted at each scan using Astraia (astraia software 
gmbh, München, Germany). The estimated fetal weight was calculated on Astraia using the 
formula proposed by Hadlock et al87: 
The amniotic fluid index was calculated as the sum of the deepest vertical pool of amniotic 
fluid in all four quadrants of the maternal abdomen.
2.6.2: Fetal Doppler assessment
All Doppler measurements were undertaken in the absence of fetal breathing movements. A 
waveform was considered to be of  sufficient quality when five consecutive uniform 
waveforms with a good signal to noise ratio was obtained. The average of three waveforms 
was taken for each Doppler measurement.
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Doppler measurements were undertaken from a free loop of  the Umbilical Artery in all 
patients. Colour Doppler was used to identify pulsation of the umbilical artery and the 
Doppler sample volume was placed parallel to the flow within the artery.
Doppler measurements of the Middle Cerebral Artery were obtained in all growth restricted 
pregnancies. A view  of the Middle Cerebral Artery was obtained by moving from the 
transverse view  of  the brain used to measure fetal biometry towards the base of the skull. 
Colour flow  imaging was used to visualise the circle of Willis, and the middle cerebral artery 
was taken as the major lateral branch of the circle of Willis running anterolaterally at the 
borderline between the anterior and middle cerebral fossa. The angle of  insonation was kept 
to < 30º, and the Doppler sample gate was placed in the proximal portion of the Middle 
Cerebral Artery with minimal pressure on the maternal abdomen to prevent compression of 
the fetal head. Angle correction was used in cases where the angle of  insonation was 
between 10 - 30º.
Doppler assessment of  the umbilical vein was obtained in all growth restricted pregnancies. 
Colour Doppler was used to identify pulsation of the umbilical artery and the Doppler sample 
volume was placed in the adjacent umbilical vein. The presence or absence of  pulsations in 
the umbilical vein was noted.
Doppler measurement of  the ductus venosus was obtained in all growth restricted 
pregnancies. Visualisation of the ductus venosus was done in the oblique transverse 
abdominal plane using colour Doppler imaging to track the umbilical vein through the portal 
sinus to the site of the ductus venosus. The ductus venosus was identified by colour aliasing 
due to the increase in blood flow  velocity at the origin of this vessel. The absence or reversal 
of the a wave in the ductus venosus waveform was considered abnormal.
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2.7 Statistical methods
Statistical analysis was performed using SPSS Version 17.0 for Windows (SPSS, Chicago, 
ILL). 
Reliability analysis for the volumetric measurement tools (mriCRO and itk-SNAP), and inter 
and intra observer variability in performing volumetric measurements was undertaken using 
a Bland-Altman plot. 
Normality tests were undertaken using the Kolmogorov-Smirnov test on SPSS with a 
significant result indicating lack of a normal distribution.
Linear regression was used to correct for the effect of  gestation as a confounding factor. In 
cases where the data did not follow  a linear distribution, data was logarithmically 
transformed prior to linear regression. 
Parametric data was tested using Student’s T-test and non parametric data was tested using 
the Mann-Whitney U test. Spearman’s Rank Correlation was used to test the effect of 
increasing severity of fetal growth restriction on volumetric measurements. ROC analysis 
was used to test the ability of MRI findings to predict adverse outcome.
2.8 Summary
This chapter detailed the ultrasound and MRI protocols that were used as part of this thesis 
to investigate the pathophysiology and the cerebral redistribution phenomenon in cases of 
fetal growth restriction. 
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CHAPTER 3: MRI OF THE PLACENTA IN FETAL GROWTH RESTRICTION
3.1 Introduction
First trimester trophoblastic invasion has far reaching consequences for the fetus; failure at 
this stage may result in fetal growth restriction with morbidity both in the immediate perinatal 
period, as well as throughout development into adulthood. Pregnancies complicated by fetal 
growth restriction are characterised by shallow  invasion of  the trophoblast into maternal 
tissue, and inadequate conversion of the spiral arterioles, leading to placental ischaemia 13, 
14. Histological examination of  these malperfused placentae demonstrate a thickened, 
globular placenta with gross areas of infarct and abruption 18, as well as microscopic 
evidence of chronic inflammation and villitis 13, 19. This increases uteroplacental impedance 
in both the fetal and maternal compartment as evidenced by an increase in the Doppler 
velocimetry of the umbilical and the uterine arteries respectively on ultrasonography 21, 88.
Ultrasound assessment of the placenta typically includes an assessment of placental 
location and maturity, and the presence of placental haemorrhages or intervillous lakes 89. 
Although volumetric assessment of  the placenta may be performed using 3D ultrasound in 
the first trimester, it becomes increasingly difficult to perform as gestation progresses due to 
limitations in the field of view. 
Fetal MRI is now  established as an adjunct to ultrasonography in the diagnosis of  fetal 
abnormalities 90, 91. MRI assessment of  the placenta was first used in cases of suspected 
placenta praevia in 1986 92. Its role has since expanded and now  ranges from the 
assessment of placental invasion in cases of suspected placenta accreta / increta / percreta 
in the clinical setting 93-95 to studies on spectroscopy and perfusion of the placenta in the 
84
research setting 96, 97. Research on the use of MRI in the diagnosis of  placental pathology in 
fetal growth restriction however has been limited to research analysing placental function 98. 
My hypothesis was that MRI imaging of  the placenta could demonstrate a specific placental 
phenotype in growth restricted fetuses that correlates with the severity of  fetal growth 
restriction, and that specific MRI findings at the time of  scan may be used to predict perinatal 
mortality. 
3.2 Materials and Methods
Imaging of the placenta was undertaken using the MRI whole uterus and ultrasound 
protocols as documented in Chapter 2 of this thesis.
Assessment of  the placental volume, placental thickness, placenta to amniotic fluid signal 
intensity ratio, placental appearance, and the presence of  placental pathology on MRI was 
undertaken with the observers (MD and EE) blinded to the patient’s identity, gestation at 
scan, and patient group.  In each case, regions of placental tissue with abnormal 
heterogeneity that were identified as indicating regions of  placental pathology were 
delineated and the percentage of abnormal placental volume was calculated. 
The maximal placental thickness to placental volume ratio was calculated by dividing the 
maximal placental thickness by placental volume. This was interpreted as a surrogate 
marker for the inverse of placental surface area.
As a secondary aim of  this study, where available, results of  histological examination of the 
placenta were obtained.  Placentae were examined at the Wigglesworth Perinatal-Paediatric 
Pathology Service based at Imperial College Healthcare NHS Trust (JWA). At least 21 
macroscopic factors including weight, infarcts, subchorionic haemorrhage, and 
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retroplacental haemorrhage were checked and recorded.  From each placenta, a minimum 
of 12 areas were sampled, fixed in 10% buffered formalin, and embedded in paraffin. 
Paraffin embedded tissue sections were cut into four micron sections, deparaffinized, and 
stained with haematoxylin and eosin prior to histologic examination. 
MRI assessment of  placental appearance was taken to be accurate if  the histopathology 
report demonstrated evidence of placental infarct, retroplacental haemorrhage, or 
subchorionic haemorrhage. The placental MRI findings were not used to decide on optimal 
timing for delivery in either group. 
Fetal mortality was defined as an intrauterine death or an iatrogenic termination of 
pregnancy for severe fetal growth restriction from 20 weeks gestation. Early neonatal death 
was defined as neonatal death in the first week of life.
As the ultrasound scans and MRI scans were at times several days apart, no comparison 
was drawn between the placental appearance on ultrasound and that on MRI.
3.3 Results
3.3.1 Patient demographics
A total of 20 growth restricted fetuses were imaged using fetal MRI. Three women had fetal 
growth restriction severity grade 1, three women grade 2, ten women grade 3, one women 
grade 4, and three woman grade 5. All 20 women delivered fetuses below  the 5th centile on 
customised birthweight charts, of which 18 delivered fetuses below  the 1st centile on 
customised birthweight charts. The mean gestational age at the time of MRI was 26.9 
weeks, with a range from 20.4 to 32.6 weeks.
86
28 women with structurally normal fetuses were approached in the ultrasound department of 
Queen Charlotte’s and Chelsea Hospital at the time of their second trimester anomaly scan. 
Women were scanned serially with ultrasound to ensure fetal growth was maintained, and 
were scanned once using MRI during their pregnancy. All infants were born with a 
birthweight in the normal range for gestational age (between the 5th and the 95th centile). 
There were no ultrasound Doppler abnormalities in the UA or MCA in these women, and no 
reduction in the growth velocity following serial ultrasound. There were no postnatal 
complications.  The mean gestational age at the time of MRI was 30 weeks, with a range 
from 23.8 to 37.7 weeks. The characteristics of both groups are summarised in Table 3.1 
and described in more detail in Table 3.2.
Table 3.1: Patient Demographics
Fetal Growth Restricted (n = 20) Normal Control (n = 28)
Gestation at MRI (mean ± s.d.) 26.96 ± 3.6 30.04 ± 3.97
Parity (% primiparous) 65% 53.6%
Maternal BMI (mean ± s.d.) 23.8 ± 3.4 22.7 ± 2.7
Gestation at delivery (mean ± s.d.) 29.5 ± 4.1 39.3 ± 2.0
Birthweight at delivery, g (mean ± s.d.) 945 ± 542 3275 ± 561
Birthweight centile (mean ± s.d.) 
[range]
0.4 ± 1.2
[0.01 - 5.4]
47.2 ± 28.1
[9.2 - 98]
Outcome
Termination of Pregnancy 1 0
Intrauterine Death 6 0
Livebirth 12 28
Neonatal Death 1 0
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RP2163 IUGR-4 20.43 0.071 0 0.44 44.38 SB 21.57 122
ED2379 IUGR-4 20.86 0.157 0 0.62 45.73 SB 26 340
PO1148 IUGR-2 22.28 0.211 0 0.48 47.17 SB 23.86 332
EM2248 IUGR-4 23.71 0.242 100 0.56 43.10 LB 28.14 750
DCL1108 IUGR-4 23.86 0.641 0 0.56 63.91 TOP 25 400
MB2396 IUGR-6 24.86 0.251 0 0.14 41.16 SB 28 578
SH1585 IUGR-3 25.43 0.399 95.5 0.55 49.72 LB 34.86 1870
MZ1126 IUGR-2 26.43 0.208 0 0.49 57.93 SB 28 526
RM2265 IUGR-6 26.57 0.324 50.5 0.60 56.69 NND 26.57 690
HY577 IUGR-6 27.29 0.114 0 0.36 37.97 SB 28 475
AA1417 IUGR-4 27.57 0.325 75.3 0.68 34.66 LB 27 815
TB2481 IUGR-4 28 0.586 47.3 0.73 51.08 LB 32 1020
IR2293 IUGR-4 28 0.285 0 0.57 58.00 LB 29.28 680
RV2322 IUGR-3 28 0.366 46.9 0.51 47.27 LB 30.14 980
AO1174 IUGR-2 28.57 0.674 29.2 0.49 49.97 LB 36 2032
CS2547 IUGR-4 29 0.309 0 0.29 52.27 LB 31 1045
BC1307 IUGR-4 31.56 0.474 89 0.50 29.85 LB 32.56 1205
ML2140 IUGR-5 32 0.341 0 0.49 40.00 LB 32 1250
RF2017 IUGR-3 32.38 0.716 97 0.43 77.62 LB 37.56 1888
FH932 IUGR-4 32.57 0.378 27.6 0.56 52.74 LB 32.57 1300
TR2508 Normal 23.86 0.484 100 0.57 43.96 LB 40 3245
CM1830 Normal 24.57 1.407 100 0.59 75.60 LB 39 3492
KM2381 Normal 24.71 0.384 100 0.52 23.51 LB 40 3606
LH1586 Normal 25.00 0.638 100 0.67 41.00 LB 40 3342
AF2201 Normal 25.14 0.399 100 0.35 42.65 LB 40.28 3094
ABT1055 Normal 25.42 0.365 100 0.81 55.89 LB 43 4420
SN1206 Normal 27.00 0.220 84.09 0.66 24.35 LB 37 2920
LG2283 Normal 27.56 0.448 100 0.61 26.35 LB 41.43 3196
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NM1935 Normal 27.57 0.473 97.18 0.38 47.16 LB 39.28 2790
SA1901 Normal 28.00 0.661 90.07 0.40 73.00 LB 34 1956
AK2284 Normal 28.56 0.518 100 0.61 40.21 LB 41.28 3610
LD1149 Normal 29.14 0.478 100 0.46 43.90 LB 37 2496
KM1861 Normal 29.28 0.609 100 0.68 32.13 LB 40 3408
MU2312 Normal 29.71 0.644 100 0.56 48.28 LB 41.14 3526
SM2154 Normal 29.86 0.822 100 0.49 45.45 LB 39 3010
MG2316 Normal 30.28 0.811 100 0.51 35.08 LB 41.14 3856
FJ2351 Normal 30.42 0.390 100 0.56 36.50 LB 37.71 2602
CT2180 Normal 31.43 0.625 100 0.62 26.66 LB 35 2360
NS1867 Normal 32.00 1.055 93.88 0.41 36.70 LB 39 3420
KK1887 Normal 32.14 1.118 100 0.52 63.29 LB 38 3394
JT2493 Normal 32.14 0.648 100 0.56 49.38 LB 40 2800
AP2401 Normal 32.57 0.621 100 0.36 53.38 LB 40.71 3685
JS1637 Normal 33.00 0.762 100 0.57 45.26 LB 40 3660
AH1973 Normal 35.86 1.398 98.95 0.34 48.00 LB 41 3862
LE2438 Normal 35.86 0.802 100 0.69 34.26 LB 39 3420
KO1992 Normal 36.00 1.620 100 0.51 56.00 LB 39 3090
CB1347 Normal 36.28 0.983 100 0.59 40.38 LB 41 4398
CF1671 Normal 37.71 1.205 100 0.50 39.09 LB 37 3526
Table 3.2: Patient Results
3.3.2 MRI Placental appearance
In 19 of  20 growth restricted fetuses and in 2 of 28 normally grown fetuses in this study, the 
MRI placental appearance was of  a thickened globular structure when assessed subjectively 
as opposed to the typical appearance of a flattened disc with tapering edges (figure 3.1 a 
and b, and figure 3.2 a and b). The MRI placental appearance in the remaining 1 growth 
restricted and 26 normally grown fetuses was of a typical flattened disc with tapering edges. 
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Figure 3.1: 3-dimensional reconstruction of the placenta in a normally grown (SA1901) and growth restricted 
fetus (TB2481) at  28 weeks gestation demonstrating a flattened disk with increased surface area in figure 3.1a 
and a thickened globular placenta with reduced surface area in figure 3.1b. The green arrows show the maximal 
transverse diameter of  the placenta in both cases, and the yellow arrow show the maximal placental thickness in 
both cases.
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Figure 3.2a: the thickened, globular 
placental appearance found in the fetal 
growth restricted group (TB2481).
Figure 3.2b: the typical appearance in a 
normal placenta with tapering edges and a 
large surface area of attachment to the 
uterus (SA1901).
Figure 3.2: MR placental appearance demonstrating both a thickened, globular placenta, and the normal 
placental appearance.
The presence of  a thickened, globular placenta was significantly associated with an 
increased incidence of fetal or neonatal mortality (relative risk = 1.615, 95% CI = 1.15 – 
2.25, p= 0.001).
Placental histology of the two normally grown fetuses with globular placentae following birth 
showed focal haemorrhage and infarct in both with additional chorioamnionitis in one. 
Placental histology of normally grown fetuses is not routinely performed, and in this instance, 
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was done as the first patient had fetal distress at labour and a suspected placental abruption 
and the second patient was in preterm labour at 34 weeks gestation.
3.3.3 Inter and Intra-observer Variability
The accuracy of volumetric estimation was limited by the error in delineating the area of 
interest in each slice. Intra and inter observer variability (MD and EE) in calculating placental 
volume resulted in an interclass correlation coefficient of  0.99 and 0.98 respectively 
(p<0.001). A Bland - Altman plot confirmed good agreement between the two observers 
(Figure 3.3)
Figure 3.3: Bland-Altman Plot of agreement between two observers measuring placental volume
Inter and intra observer variability (MD and EE) in calculating the percentage of placental 
volume affected by apparent abnormal heterogeneiety resulted in an interclass correlation 
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coefficient of  0.99 and 0.93 respectively (p<0.001). A Bland- Altman plot confirmed good 
agreement between the two observers (Figure 3.4)
Figure 3.4: Bland-Altman plot of agreement between two observers measuring the presence of abnormal 
heterogeneiety within the placenta
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3.3.4 MRI Placental pathology
There was a significant difference in the percentage of  placental volume affected by 
apparent pathology as defined by the presence of  abnormal heterogeneity within the 
placenta between both groups (p<0.001). Five normally grown fetuses (17.8%) 
demonstrated areas of abnormal heterogeneity within the placenta. Four of  these had less 
than 10% of placental volume affected by abnormal heterogeneity while one had 15% of 
placental volume affected by abnormal heterogeneity. 
One of 20 growth restricted fetus had no areas of abnormal heterogeneity within the 
placenta. This was the same fetus that did not demonstrate a globular placental appearance. 
Two out of 20 growth restricted fetuses (10%) had less than 10% of the placental volume 
affected by abnormal heterogeneity. Three out of  20 growth restricted fetuses (15%) had up 
to 50% placental volume affected by abnormal heterogeneity. The remaining 14 fetuses had 
more than 50% placental volume affected by abnormal heterogeneity. In ten of  these cases 
(50%), there were no regions where the placenta showed normal heterogeneity. 
There was a significant correlation between the percentage of  placental volume affected by 
abnormal heterogeneity and the severity of fetal growth restriction (r = 0.82, p < 0.001). 
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Figure 3.5: Percentages of pathological placental appearance in growth restricted and normally grown fetuses
7 of 12 pregnancies with >60% of placental volume affected by areas of abnormal signal 
intensity (58%) resulted in perinatal mortality. 
3.3.5 Placenta to amniotic fluid signal intensity ratio
There was a reduction in the placental to amniotic fluid signal intensity ratio in normally 
grown fetuses with increasing gestation, and a non significant trend towards reduction in the 
placenta to amniotic fluid signal intensity ratio in growth restricted fetuses.
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3.3.6 Placental thickness
There was a significant increase in maximal placental thickness to placental volume ratio in 
the growth restricted group (p<0.001), and a significant correlation between the maximal 
placental thickness to placental volume ratio and the severity of fetal growth restriction (r = 
0.71, p <0.001). An increase in the maximal placental thickness to placental volume ratio 
above the 95th centile for gestational age was associated with fetal and early neonatal 
mortality (relative risk = 7, 95%CI = 2.96 – 16.55, p < 0.001) (figure 3.6)
 
Figure 3.6 
 
Figure 3.6: Maximal placental thickness to volume ratio in growth restricted and normally grown fetuses in 
relation to perinatal mortality
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3.3.7 Placental volume
Measurement of placental volume was possible in all 48 pregnancies examined. Although 
placental volume increased with gestation in both groups, the placental volume remained 
significantly smaller in the growth restricted fetuses (p = 0.003) (figure 3.7). There was also a 
significant correlation between placental volume and estimated fetal weight at ultrasound 
scan done within one week of the MRI examination for all patients (r = 0.71, p <0.001) 
(figure 3.8), between placental volume and the severity of  fetal growth restriction (r = 0.64, p 
<0.001), and between placental volume and whole body volume (r = 0.69, p<0.001) (figure 
3.9).
  
Figure 3.7 
 
Figure 3.7: Placental Volume in fetal growth restricted and normally grown fetuses
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Figure 3.8 
 
 Figure 
3.8: Correlation between placental volume measured using MRI and estimated fetal weight measured using 
ultrasound done within a week of each other.
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Figure 3.9: Correlation between placental and whole body volume measured on MRI
3.3.8 Placental histology
The MRI appearance was correlated with the histopathological appearance in thirteen 
growth restricted fetuses and 3 normally grown fetuses. At the time of MRI, the MRI 
appearance was suggestive of  a retroplacental haemorrhage and placental infarction in 12 
growth restricted and 1 normally grown fetus; however, histopathological analysis found 
evidence of  retroplacental haemorrhage and placental infarction in all 16 placentae in this 
study. At the time of  MRI, the MRI appearance was suggestive of a subchorionic 
haemorrhage in 3 growth restricted pregnancies; this was confirmed in one case following 
delivery, and not found in the other two. 
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Figure 3.10: Prediction of the presence of placental pathology: MRI vs histopathology
3.4 Discussion
This was the first study investigating the placental appearance in growth restricted and 
normal fetuses using MRI. It has demonstrated a placental phenotype in growth restricted 
pregnancies that is characterised by smaller placental volumes, a significant increase in the 
placental volume affected by apparent pathology on MRI and a thickened, globular placenta. 
As the severity of fetal growth restriction increased, the changes in placental volume, 
thickness to volume ratio, and appearance of  placental pathology on MR imaging increased. 
There was good agreement in those cases where the MRI appearance  was compared with 
histopathological examination.
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3.4.1 Changes in Placental Volume
This study found significantly smaller placental volume in growth restricted fetuses. This is 
supported by histopathological studies that have found smaller placental weight and volume 
in fetal growth restricted placentae when compared with normally grown fetuses 99, 100. 
Increased frequency of apoptosis has been found in intramural and endovascular 
trophoblast in fetal growth restriction 101 and focal loss of endovascular trophoblast may be 
the cause of the smaller dysfunctional placentae seen in fetal growth restriction. 
Poor trophoblast invasion in the first trimester generates chronic hypoxic conditions within 
the placenta, which also acts to induce trophoblast apoptosis and limits placental growth in 
the second and third trimesters 102, 103. Studies evaluating placental perfusion in the hypoxic 
state using MRI, have already been conducted in both animal models and human studies104, 
105,  and these contribute to our understanding of the pathophysiology of fetal growth 
restriction. 
The in utero placental volume of  normal pregnancies across gestation has not previously 
been described. This study found that placental volume increased with increasing 
gestational age in both normally grown and growth restricted fetuses, and is likely to be a 
reflection of fetal growth. With the limitations of current technology, MRI is the only tool that 
is able to accurately assess placental volume throughout gestation as although 3D 
ultrasound is capable of measuring placental volume in the first trimester 106, it is limited by 
the field of view and the angle required for acquisition in later gestations. 
3.4.2 Changes in placental appearance
In 19 of 20 growth restricted fetuses in this study, the MRI placental appearance was of  a 
thickened globular structure as opposed to the appearance of a flattened disc with typical 
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tapering edges in the normal pregnancies.  Fisteag-Kiprono et al. 107 found an association 
between sonographically detected globular placentae and adverse perinatal outcome, 
including fetal growth restriction. In this study the appearance of  a globular thickened 
placenta was easy to identify on MRI. 
Increased placental thickness is known to be associated with fetal growth restriction 108, and 
all 8 pregnancies that resulted in perinatal mortality  demonstrated a globular placenta at the 
time of MRI scan (p<0.01). Two normally grown fetuses had the appearance of  a thickened, 
globular placenta at the time of  MRI scan and both were found on histopathology to have 
focal haemorrhage and infarct with added chorioamnionitis in the second. It is possible that 
these 2 patients had an underlying placental pathology that was not of sufficient severity to 
result in fetal growth restriction; however, it may have contributed to the complications they 
faced in labour. 
3.4.3 Changes in the placental thickness to volume ratio
There was a significant increase in the maximal placental thickness to placental volume ratio 
in growth restricted fetuses in this study. This may be a reflection of reduced placental 
surface area, and further work is required to confirm this finding using more accurate 
stereological analysis of the placenta in utero.  
3.4.4 Changes in the placental signal intensity ratios
The placenta to amniotic fluid signal intensity ratio has not been investigated previously in 
growth restricted pregnancies. In agreement with our findings, Blaicher et al. 109 described a 
reduction in the placental to amniotic fluid signal intensity ratio with increasing gestation  in 
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normal pregnancies, which was thought to be a reflection of normal morphological changes 
during placental ageing that lead to a loss of placental tissue density. 
We chose to exclude areas of  the placenta with obviously abnormal heterogeneity to enable 
a comparison of  apparently non-diseased areas of placenta without overt focal pathology 
between both groups.  However, in a number of cases, there was a diffuse abnormality in 
placental appearance that we were not able to exclude.  We found a trend towards reduction 
in the placenta to amniotic fluid signal intensity ratio in the fetal growth restricted group that 
may be a reflection of more subtle microscopic changes such as perivillous fibrin deposition 
outside areas of obvious pathology. 
3.4.5 Correlation between MRI phenotype and severity of fetal growth restriction
There was a significant correlation between the severity of  fetal growth restriction and the 
appearance of  placental pathology, the placental volume and the maximal placental 
thickness to placental volume ratio. Increasing severity of  fetal growth restriction in this study 
was defined using changes in the fetal dopplers which are an indication of  the fetal 
compensatory mechanisms. 
3.4.6 Correlation between MRI findings and histopathological analysis
In this study, the MRI appearance of suspected retroplacental haemorrhage, placental 
infarct, and subchorionic haemorrhage was confirmed by placental histology in 100%, 100%, 
and 33% of cases respectively. One limitation of  this study is the lack of histological 
examination on all the fetuses studied, and the delay between antenatal MRI assessment of 
placental pathology and postnatal histological examination of the placenta. The MRI 
examination occurred several weeks before birth, and it is likely that the discrepancy 
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between the MRI examination and histopathological findings is due to the MRI being 
performed on an evolving condition. 
Histopathological assessment of  the placenta in growth restricted pregnancies is routine in 
our hospital, however, as the fetal care unit functions as a tertiary referral centre, not all 
growth restricted pregnancies were delivered in the hospital, and placental histological 
analysis was not obtained for 7 growth restricted fetuses. Likewise, placental histology of 
normally grown fetuses is not usually performed at our hospital, but in this study, 3 normally 
grown fetuses had their placentas sent for histological analysis as one patient was in 
premature labour at 34 weeks, one had fetal distress in labour and suspected placental 
abruption, and a third had a placenta praevia and was delivered by caesarean section. 
Accurate correlation between the antenatal detection of placental pathology using imaging 
techniques and postnatal histopathological diagnosis of placental pathology may additionally 
be limited by the changes in placental circulation, structure and shape following birth. 
Perfusion studies comparing fetal growth restricted and normal pregnancies have been 
limited to date but may prove to be useful in analysing the evolution of placental dysfunction 
in these complicated pregnancies 105.
3.4.7 Limitations
Segmentation of placental volume was completed within 10 minutes in all cases.  Difficulties 
arose in the calculation of the placenta to amniotic fluid signal intensity ratio in certain cases 
where, due to fetal position, there was a limited region of  amniotic fluid within the same slice 
as placenta, and in growth restricted cases, there were large areas of  abnormal 
heterogeneity. In these cases, care was taken to ensure that the region of  placenta 
segmented was free from aberrations in signal intensity, and that the maximal possible 
region of amniotic fluid was obtained to provide a representative sample.  
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A second limitation of this study is the lack of  histological examination on all the placentae 
studied, for the reasons detailed above.
3.5 Summary
This chapter details the use of  MRI to determine the presence of a specific placental 
phenotype in fetal growth restriction. Although at present ultrasound remains the optimal tool 
for the evaluation of the placenta in fetal growth restriction, there is growing evidence that 
MR imaging plays a role in the assessment of the growth restricted fetus. 
In this study, MRI was able to predict fetal and neonatal death with a relative risk of 7 
(95%CI = 2.96 – 16.55) using a measure of maximal placental thickness to volume ratio. 
This is comparable to Ultrasound Doppler studies of the middle cerebral artery and the 
ductus venosus which are able to predict perinatal mortality with an odds ratio of  10.2 
(95%CI = 1.8 – 57) 110. Recent MRI studies have also demonstrated abnormalities in brain 
development in growth restricted fetuses which include smaller cortical gray matter and 
hippocampal volume, abnormalities in diffusion tensor analysis and proton Magnetic 
Resonance Spectroscopy analysis 62. These changes within the fetal brain may have 
implications for longer term developmental outcome and MR imaging may contribute to 
management decisions in cases at the threshold of viability in the future.
In units where MR imaging of the growth restricted fetus occurs, the assessment of the 
placenta should be included , as it may provide additional information on disease severity. A 
number of animal studies have recently studied the use of treatments including melatonin 
and growth hormone in animal models of fetal growth restriction, with evidence of potential 
improvement in outcome following treatment 111, 112.  As the origins of  fetal growth restriction 
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lie in the diseased placenta, MRI could be used in the future as a monitor for interventions 
designed to improve placental function.  
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CHAPTER 4: MRI OF THE FETUS IN FETAL GROWTH RESTRICTION: A 
VOLUMETRIC APPROACH 
4.1 Introduction
The intra-uterine environment is a key factor in determining metabolic and neuro-endocrine 
set points that are involved in programming post-natal life. It is becoming apparent that an 
adverse intra-uterine environment has long term implications on organ growth and 
development as fetuses exposed to an adverse intrauterine environment are at increased 
risk of insulin resistance and type 2 diabetes, obesity, hyperlipidaemia, hypertension, and 
cardiovascular disease 113-119.
In the presence of  adverse intrauterine conditions, brain and cardiac growth is typically 
preserved as blood is diverted to these essential organs, at the expense of growth of other 
fetal organs120.
 
Fetal volumetry has previously been used to estimate the fetal total body, brain, liver,  lung, 
cardiac and renal volume using both MRI83, 121, 122 and 3D ultrasound123-125 in both normally 
grown fetuses and fetuses affected by pathology, however, comprehensive studies 
describing fetal organ growth in relation to whole body growth in both growth restricted and 
normally grown fetuses have been limited. 
This part of  the study aims to quantify fetal total body, brain, lung, thymus, cardiac, liver and 
renal volume measurements in growth restricted and normally grown pregnancies. The 
hypothesis was that fetal brain and cardiac growth will be maintained in growth restricted 
pregnancies, at the expense of the lung, thymic, liver and renal volume. 
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4.2 Materials and Methods
Imaging of  the fetal body and brain was undertaken using the MRI whole uterus protocol as 
documented in Chapter 2 of this thesis.
In cases where the acquisition demonstrated evidence of  significant motion or when the 
presence of motion artefact was noted, the sequence was repeated and the data used only if 
a satisfactory acquisition was obtained. 3-dimensional reconstruction of the fetal body 
following manual segmentation was used to check for the absence of significant motion 
distorting the fetal anatomy (ref: figure 2.5 in Chapter 2). Following these measures, post 
acquisition processing to correct for the presence of  fetal motion was not performed prior to 
volumetric analysis of the fetus.
Fetal total body, cardiac, thymic, lung, renal, and liver volume was assessed by manually 
segmenting the region of interest on each slice with tissue present using MRIcro software86 
(ref: figure 2.4 in Chapter 2).The volume of  the region of interest in each slice was measured 
automatically using MATLAB® (v.7.9, Mathworks Inc. Natick, MA, USA) by counting the 
number of pixels covering the region of interest and multiplying this number by the volume 
corresponding to a pixel. The observer (MD) was blinded to the patient’s identity, gestation at 
scan, and patient group. Inter and intra observer reliability in calculating fetal organ volumes 
(MD & EE) was measured by measuring the inter-class correlation coefficient. 
To allow  for more accurate segmentation of  the fetal brain, 3D reconstruction of the fetal 
brain was performed using a technique developed by the Imaging Sciences Department at 
Imperial College London, and described previously as snapshot volumetric reconstruction.84 
(ref: figure 2.9 in Chapter 2 of this thesis). 
Fetal total brain volume was assessed by manually segmenting the region of  interest on 
each slice of  the reconstructed brain aligned to the anterior commissure : posterior 
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commissure line using MRIcro software as above. The observer (MD) was blinded to the 
patient’s identity, gestation at scan, and patient group. Total brain volume included white 
matter, cortical grey matter and deep grey matter, and cerebellar lobes and vermis. 
Ventricular space and the extracerebral space were excluded from the region of interest. 
Inter and intra observer reliability in calculating total fetal brain volume (MD & PP) was 
measured by measuring the inter-class correlation coefficient. 
The following outcome data was collected- perinatal mortality (defined as intrauterine or 
neonatal death), and early morbidity including the presence of neonatal respiratory distress, 
hypoglycaemia, neuroimaging abnormalities, necrotising enterocolitis and sepsis.
4.3 Results
4.3.1 Patient Demographics
A total of  19 fetuses with fetal growth restriction were imaged using fetal MRI. The severity of 
fetal growth restriction was graded as severity grade 1 in one woman, grade 2 in four 
women, grade 4 in two women, and grade 5 in four women. All women delivered fetuses 
below  the 5th centile on customised birthweight charts. Eighteen women with structurally 
normal fetuses were included as normal controls. All eighteen infants were born with a 
birthweight in the normal range for gestational age (between the 5th and the 95th centile) 
and there were no postnatal complications.  The characteristics of both groups are 
summarised in Table 4.1.
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Fetal Growth Restricted (n = 19) Normal Control (n = 18)
Gestation at MRI (mean ± s.d.) 26.6 ± 3.5 29.2 ± 2.7
Parity (% primiparous) 60% 53 %
Maternal BMI (mean ± s.d.) 23.8 ± 3.5 24.1 ± 4.2
Gestation at delivery (mean ± s.d.) 29.5 ± 4.0 38.7 ± 2.3
Birthweight at delivery, g (mean ± s.d.) 916.1 ± 528.4 3057.6 ± 587.1
Birthweight centile (mean ± s.d.)
0.1 ± 0.3 38.4 ± 27.3
Pregnancy Outcome
Termination of Pregnancy 2 0
Intrauterine Death 6 0
Livebirth 11 18
Neonatal Outcome
Respiratory Distress 2 0
Necrotising Enterocolitis 2 0
Sepsis 5 0
Neuroimaging changes 
(periventricular flares, germinal   
matrix haemorrhage, or 
intraventricular haemorrhage)
6 0
Hypoglycaemia 5 0
Neonatal Death 1 0
Table 4.1 Patient Demographics of fetal growth restricted and normally grown fetuses included in fetal body and 
organ volume measurements
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RP2163 IUGR-4 20.4 0.142 0.0015 0.0057 0.0003 0.0066 SB 21.57 122
ED2379 IUGR-4 20.9 0.136 0.0011 0.0042 0.0077 SB 26 340
EM2248 IUGR-4 23.7 0.412 0.0045 0.0164 0.0007 0.0179 0.009 LB 28.14 750
DCL1108 IUGR-4 23.9 0.298 0.0029 0.0082 0.0002 0.012 0.0067 TOP 25 400
FK784 IUGR-3 24 0.293 0.0035 0.0066 0.0004 0.014 LB 33 1160
BP1104 IUGR-5 24 0.387 0.006 0.0107 0.0005 0.0228 SB 24
MB2396 IUGR-6 24.9 0.402 0.0053 0.015 0.0014 0.0207 SB 28 578
SH1585 IUGR-3 25.4 0.615 0.0029 0.0229 0.0012 0.0356 0.0079 LB 34.86 1870
JS1014 IUGR-6 26.4 0.46 0.0048 0.0101 0.0009 0.0195 0.0093 TOP 28 500
MZ1126 IUGR-2 26.4 0.443 0.0051 0.0168 0.0009 0.0204 0.0076 SB 28 526
RM2265 IUGR-6 26.6 0.616 0.0131 0.0272 0.0019 0.031 0.0205 NND 26.57 690
KN596 IUGR-4 27.1 0.498 0.005 0.0164 0.0025 0.0247 LB 29.86 690
HY577 IUGR-6 27.3 0.42 0.0042 0.0109 0.0009 0.015 0.0077 SB 28 475
IR2293 IUGR-4 28 0.605 0.0075 0.0222 0.0027 0.0357 LB 29.28 680
RV2322 IUGR-3 28 0.868 0.0101 0.0432 0.0028 0.047 0.0182 LB 30.14 980
BC1307 IUGR-4 31.6 1.07 0.0086 0.0469 0.003 0.0473 0.0136 LB 32.56 1205
ML2140 IUGR-5 32 1.16 0.02 0.042 0.0026 0.0535 0.0351 LB 32 1250
RF2017 IUGR-3 32.3 1.35 0.0156 0.086 0.0064 0.0598 0.0268 LB 37.56 1888
FH932 IUGR-4 32.6 1.29 0.0113 0.0665 0.0029 0.044 0.0206 LB 32.57 1300
CM1830 Normal 24.6 0.671 0.0069 0.0293 0.0023 0.037 0.0142 LB 39 3492
KM2381 Normal 24.7 0.685 0.0051 0.0211 0.0009 0.0364 0.015 LB 40 3606
SN1206 Normal 27 0.858 0.0096 0.0365 0.0038 0.047 0.0224 LB 37 2920
LG2283 Normal 27.6 1.06 0.006 0.0334 0.0076 0.0435 0.0172 LB 41.43 3196
NM1935 Normal 27.6 0.964 0.0062 0.0315 0.0053 0.0553 0.016 LB 39.28 2790
TF2063 Normal 27.9 1.04 0.0142 0.0377 0.0026 0.0561 0.0279 LB 39.71 2868
SA1901 Normal 28 1.05 0.0109 0.0523 0.0018 0.0602 0.0272 LB 34 1956
AK2284 Normal 28.6 0.882 0.0067 0.0279 0.0017 0.0482 0.0191 LB 41.28 3610
LD1149 Normal 29.1 1.27 0.0139 0.046 0.0057 0.057 0.033 LB 37 2496
KM1861 Normal 29.3 1.5 0.0171 0.0712 0.0061 0.0676 0.0314 LB 40 3408
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MU2312 Normal 29.7 1.33 0.0146 0.0523 0.0087 0.079 0.0259 LB 41.14 3526
TB2159 Normal 29.9 1.18 0.0125 0.0308 0.012 0.0593 0.0223 LB 36.42 2178
SM2154 Normal 29.9 1.27 0.0127 0.0537 0.0082 0.0504 0.0214 LB 39 3010
MG2316 Normal 30.3 1.71 0.0196 0.0584 0.0129 0.0958 0.0373 LB 41.14 3856
CT2180 Normal 31.4 1.65 0.0178 0.062 0.0052 0.0897 0.0301 LB 35 2360
NS1867 Normal 32 1.84 0.0221 0.0665 0.0085 0.0959 0.0374 LB 39 3420
KK1887 Normal 32.1 2.02 0.0292 0.068 0.0162 0.107 0.0551 LB 38 3394
AH1973 Normal 35.9 2.65 0.0313 0.128 0.0065 0.138 0.0618 LB 41 3862
Table 4.2: Patient Results
The calculation of  fetal organ volume was not overtly impaired by the presence of  fetal 
motion in any of  the datasets used in this study. In 7 growth restricted fetuses, it was not 
possible to measure renal volume due to poor image resolution of the relatively small organ 
in very small fetuses (GA at MRI = 24.2 ± 2.85, estimated fetal weight = 391.0 ± 168.7g).  
In two fetuses, the sequence was repeated 3 times and volumetric segmentation of the fetal 
organs showed a maximal difference of  10%. This difference was less than 5% in the 
majority (87.5%) of repeated measurements. There was good correlation between brain 
volumes calculated by manual brain segmentation prior to and following SVR (ICC = 0.99, 
p<0.001, n = 15), confirming that fetal motion was not a significant problem in these 
datasets.
4.3.2 Reliability Analysis
Intra and inter observer reliability (MD & EE) in calculating fetal total body, cardiac, thymic, 
lung, liver and renal was high (p<0.001, ICC range = 0.89 - 1.0, n = 15), as was that for fetal 
brain volumes (MD & PP) (p<0.001, ICC = 0.99 in both cases, n =15). Bland altman analysis 
confirmed good agreement between the observers.
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Figure 4.1: Bland Altman plot of agreement between two observers measuring body volume
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Figure 4.2: Bland Altman plot of agreement between two observers measuring organ volumes
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Figure 4.3: Bland-Altman plot of agreeement between two observers measuring brain volume
4.3.3 Fetal body volume measurement
Total body volume increased with gestation in both growth restricted and normally grown 
fetuses. As expected, total body volume was significantly smaller in growth restricted fetuses 
across gestation compared with the cohort of normal fetuses (p<0.001) (figure 4.3). 
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Figure 4.4: Changes in total body volume in normally grown and growth restricted fetuses across gestation
There was a significant correlation between fetal volume measured during MRI and the 
estimated fetal weight from ultrasound scan done within a 7 day interval (correlation 
coefficient = 0.98, p<0.001) (figure 4.4).
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 Figure 4.5: Correlation between estimated fetal weight measured at ultrasound scan and whole body volume 
measured at MRI within a 7-day interval.
 
4.3.4 Fetal brain volume measurement
In both groups of fetuses total brain volume increased as gestation increased.  Growth 
restricted fetuses demonstrated a significant increase in the percentage of body volume 
occupied by the fetal brain when compared to normal fetuses (figure 4.5) 17.47% vs. 11% 
(p<0.01, 95% CI of the increase in brain volume = 4.86 – 7.88%). 
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Figure 4.6: Changes in the percentage of body volume occupied by the fetal brain in growth restricted and 
normally grown fetuses across gestation
4.3.5 Fetal intra-thoracic organ volume measurement
Although the volume of the intra-thoracic organs (heart, lungs and thymus) increased as 
gestation increased in both groups, the volumes of  all three structures remained smaller in 
growth restricted fetuses (p < 0.01) (Figures 4.7 - 4.9) compared with normally grown 
fetuses. There was no significant difference between both groups in the percentage of  body 
volume occupied by the heart, lungs or thymus indicating growth that is in line with that of 
the fetal body. 
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The decrease in thymic volume was not associated with an increased risk of  developing 
sepsis in the neonatal period among growth restricted fetuses.
Figure 4.7: Cardiac volume in growth restricted and normally grown fetuses across gestation
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Figure 4.8: Changes in Lung volume in growth restricted and normally grown fetuses across gestation
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Figure 4.9: Changes in thymic volume in growth restricted and normally grown fetuses across gestation
4.3.6 Fetal intra-abdominal organ volume measurement
The volume of the intra-abdominal organs (liver and kidneys) increased as gestation 
increased, and both liver and renal volumes remained smaller in growth restricted fetuses 
(p<0.001) (Figures 4.10 and 4.11). There was no significant difference in the percentage of 
body volume occupied by the liver or kidney. 
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Figure 4.10: Changes in liver volume in growth restricted and normally grown fetuses across gestation 
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Figure 4.11: Changes in Renal Volume in growth restricted and normally grown fetuses across gestation
There was no relationship between liver volume and the incidence of  neonatal 
hypoglycaemia . All but 2 growth restricted fetuses had a brain:liver ratio above the 95th 
centile of the normally grown fetuses in this study. 
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Figure 4.12: The Brain : Liver Ratio in Growth Restricted and Normally Grown fetuses across gestation by 
perinatal outcome 
4.4 Discussion
This is the first study utilising whole body MRI scans and 3 dimensional MRI reconstruction 
of the fetal brain to compare organ growth in normally grown and growth restricted fetuses. 
The results have demonstrated smaller total body, intra-thoracic and intra-abdominal organ 
volumes in growth restricted fetuses, and that an increase in the brain : liver ratio measured 
using MRI is an indication of perinatal mortality. 
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4.4.1 Volumetry of the fetal brain
Gong et al78 performed volumetry of 18 normal fetuses by applying the Cavalieri principle to 
MRI imaging, and found volumes of  the whole fetus and of the fetal brain that were in the 
same range as those found in this study. Studies utilising 3-dimensional brain reconstruction 
techniques that enable accurate volumetric analysis in the fetus however have been limited 
to date, and one study 83 has found smaller total brain volumes in fetuses with growth 
restriction with the use of  echo planar MRI imaging. Chapter 5 of this thesis describes 
regional segmentation of the fetal brain in growth restricted fetuses in further detail.
4.4.2 Volumetry of the fetal heart
In this study, overall cardiac volume was significantly smaller in growth restricted fetuses, 
indicating that cardiac growth is not spared in growth restriction as previously believed. In 
utero cardiac volume in normal fetuses has previously been measured by Chang et al 126 
and Peralta et al 125 using 3-D ultrasound. The cardiac measurements acquired using MRI 
imaging in this study are in line with the normograms published by Peralta et al 125.  
The relative cardiac volume of growth restricted fetuses however was not smaller, indicating 
growth that is in line with that of  the whole fetus. This is in keeping with a sheep model of 
fetal growth restriction 127. 
Doppler studies of growth restricted fetuses have found evidence of impairments in 
cardiac function by way of a reduction in ventricular ejection force and impaired 
diastolic filling128, 129. Growth restricted rats have also been found to have both an 
increased rate of apoptosis of cardiomyocytes and a decrease in cardiomyocyte 
number at birth130, 131. This cardiac remodelling and diastolic dysfunction has been 
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found to predispose the growth restricted rat to ischaemic injury during adult 
life132, and it is likely that disordered growth of cardiac tissue in fetal life, in 
combination with a predisposition to insulin resistance exaggerates the risk of 
cardiovascular disease in adults who were growth restricted in utero. 
4.4.3 Volumetry of the fetal lungs
In this study, growth restricted fetuses had smaller lung volumes when compared to normal 
controls. In utero lung volume in normal fetuses has previously been measured by Peralta et 
al125 and Ruano et al133 using 3D ultrasound, and by Cannie et al134 using fetal MRI. The 
lung volume measurements acquired in this study are in line with those published in the 
studies above. 
Studies investigating lung development in growth restricted fetuses have found that lung 
function in later life is related to in utero growth as studies have shown a positive correlation 
between birth weight and functional lung assessment in later life135, 136.  Cock et al.137 found 
that growth restricted sheep fetuses demonstrated decreased lung weight when compared 
to normally grown sheep fetuses, and that growth restriction results in changes in lung 
structure and development such as a lower alveolar number, and an increase in septal 
thickness, which become more pronounced postnatally. 
In  addition to the disordered lung structure as a consequence of in utero growth restriction, 
growth restricted fetuses also face additional pulmonary insult as a result of premature 
delivery. These include developmental arrest of the lungs and a reduction in functional 
surface area, and ventilation induced lung injury138. The combination of disordered in utero 
lung development and postnatal complications are likely to contribute to the increased risk of 
chronic lung disease in adulthood.
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4.4.4 Volumetry of the fetal liver
In this study, growth restricted fetuses had smaller liver volumes when compared to normally 
grown fetuses.  
Chang et al 139 and Boito et al 140measured liver volume in normal fetuses using 3 D 
ultrasound and demonstrated values lower than those in this study. Previous ultrasound 
studies141, 142 and animal studies have found a decrease in liver weight following fetal growth 
restriction.143. There is evidence of  decreased glucose transfer and hepatic storage in-utero 
in the presence of  fetal growth restriction which is likely to be a contributor to the smaller 
liver volume144. 
The liver is also thought to be the principal organ for the synthesis of IGF-1 in response to 
growth hormone, and growth restricted fetuses demonstrate a decrease in IGF-1 levels in 
cord blood145. Hepatic gluconeogenesis plays a key role in the fetal response to growth 
restriction, and changes in programming of the IGF axis may be an important link between 
fetal growth restriction and adult onset diseases such as type 2 diabetes146. 
4.4.5 Volumetry of the fetal kidneys
In this study, growth restricted fetuses had smaller renal volume when compared to normally 
grown fetuses. Normograms of renal volume measured using 3D ultrasound by Tedesco et 
al147 and Yu et al148 demonstrate values lower than those in this study. This is supported by 
Kent et al149, who found that 3D ultrasound underestimates renal volume when compared to 
MRI. 
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Previous ultrasound studies have found a decrease in renal volume following fetal growth 
restriction 141. Studies have also demonstrated that this decrease in renal volume in utero 
persists following birth into adulthood150, and that renal size is a reflection of renal 
function151.  Both human and animal studies of  fetal growth restriction have shown a 
decrease in nephron number following growth restriction in rats152, 153. This decrease in 
nephron number in combination with inappropriate activation of  the renal-angiotensin-
aldosterone system is thought to be one of the mechanisms by which adults who were 
growth restricted in utero are at increased risk of developing hypertension154.
4.4.6 Volumetry of the fetal thymus
In this study, growth restricted fetuses had smaller thymic volume when compared to 
normally grown fetuses. Although studies of thymic volume in utero have been limited, 
thymic size in normally grown fetuses has been measured previously by ultrasound 
measures of  the thymic perimeter155 and thymic diameter156. Additionally, Cromi et al 157 
found a decrease in thymic perimeter in growth restricted fetuses when compared to normal 
fetuses. 
Thymic involution is known to occur with increasing age, as well as during periods of stress 
158. Stress mediated involution occurs with the activation of the hypothalamic-pituitary-
adrenal axis with corticosteroids promoting apoptotic cell death of cortical thymocytes159. In 
the presence of adverse intrauterine conditions, alterations in the hypothalamic-pituitary axis 
may induce thymic involution as part of  an adaptive response to direct resources to more 
essential competing organs; and thymic involution may be a mediator of the development of 
atopic, autoimmune and infectious diseases in childhood or adulthood 157.
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4.4.7 Limitations
One limitation of  this study is that the acquisition of an ssFSE sequence through the heart 
required an average of 8 slices, and took on average 5 seconds. This would have been over 
multiple cardiac cycles and introduces an element of non-systematic error into this data. 
Further studies using technology such as spatio-temporal image correlation (STIC) on 3-
dimensional ultrasound imaging and cine loop gradient echo cardiac MRI may enable more 
accurate cardiac volume acquisition over one cardiac cycle. 
A second limitation in this study was the difficulty in segmenting renal tissue in growth 
restricted fetuses at very immature gestations, when the acquisition of an ssFSE sequence 
through the kidney could sometimes be achieved with as few  as 2 or 3 slices. As a result, 
there were 7 cases where segmentation of the renal tissue was not possible and 1 case 
where segmentation of  the thymic tissue was not possible.. Further studies to confirm this 
finding may be conducted using a similar sequence with thinner slices or using 3-
dimensional ultrasound.  
4.5 Summary
This chapter provides a comprehensive overview  of  the changes in brain, lung, thymic, 
cardiac, liver, and renal volume in relation to total body volume in fetuses with fetal growth 
restriction. 
The exact mechanisms that link disordered growth in utero and adult onset disease are still 
unclear, and despite improvements in neonatal morbidity and mortality following in utero fetal 
growth restriction, the longer term sequelae of fetal growth restriction remain a significant 
medical problem. Monitoring the growth of these organs in utero may be useful in assessing 
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disease severity as well as the effects of  any future interventions in decreasing morbidity 
associated with disordered fetal programming in other organ systems. 
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CHAPTER 5: MRI OF THE FETAL BRAIN IN FETAL GROWTH RESTRICTION: A 
VOLUMETRIC APPROACH
5.1 Introduction
Growth restricted fetuses are at increased risk of perinatal demise, and of  neonatal 
complications such as intraventricular haemorrhage, periventricular leucomalacia, 
respiratory distress syndrome, and necrotising enterocolitis 31-33. Despite evidence of 
compensatory mechanisms in the form of the ‘brain sparing effect’, these children are at 
increased risk of developmental delay and behavioural problems in childhood 34; specifically 
difficulties in fine and gross motor skills, cognitive function, language, abstract reasoning, 
concentration, and mood. The exact neurostructural correlates of these observed 
neurodevelopmental disabilities has yet to be elucidated, however, several animal and 
postnatal studies have demonstrated alterations in brain development in fetal growth 
restriction34, 61, 62.
MR volumetry of the fetal brain in growth restricted fetuses has not previously been 
undertaken in a systematic reproducible fashion, due to the difficulties in achieving reliable 
high resolution high signal to noise datasets of  the fetal brain in the presence of  fetal motion. 
Fetal studies have been limited to two studies utilising EPI sequences to perform whole 
brain volumetry78, 83. Postnatal studies however have shown decreased regional brain 
volumes in growth restricted infants34.
We hypothesized that with the use of advanced 3-dimensional MRI reconstruction, subtle 
differences in regional brain growth may be detected within fetuses with growth restriction.
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5.2 Materials and Methods
Imaging of the fetal brain was undertaken using the dynamic ssFSE SVR protocol as 
documented in Chapter 2 of this thesis.
To allow  for more accurate segmentation of  the fetal brain, 3D reconstruction of the fetal 
brain was performed using a technique developed by the Imaging Sciences Department at 
Imperial College London, and described previously as snapshot volumetric reconstruction.84 
(ref: figure 2.9 in Chapter 2 of this thesis). 
Fetal regional brain volume was assessed by manually segmenting the region of  interest on 
each slice of  the reconstructed brain aligned to the anterior commissure : posterior 
commissure line. Fetal intracranial, total brain, cerebellar, and extra- and intra-cerebral fluid 
space volumes were assessed by manually segmenting the region of  interest on each slice 
with tissue present using MRIcro software86 (ref: figure 2.11 in Chapter 2).The volume of the 
region of interest in each slice was measured automatically using MATLAB® (v.7.9, 
Mathworks Inc. Natick, MA, USA) by counting the number of pixels covering the region of 
interest and multiplying this number by the volume corresponding to a pixel. 
The observer (MD) was blinded to the patient’s identity, gestation at scan, and patient group. 
Inter and intra observer reliability in calculating fetal brain volumes (MD & PP) was 
measured by measuring the inter-class correlation coefficient, and confirmed with a Bland-
Altman plot (ref Figure 4.3). 
Intracranial volume included brain tissue and extra- and intra-cerebral fluid within the skull 
up to the level of the foramen magnum
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Total brain volume included white matter, cortical grey matter, deep grey matter, and the 
cerebellar lobes and vermis. Intracerebral and the extracerebral fluid spaces were excluded 
from the region of interest. 
Cerebellar segmentation included both cerebellar lobes and the cerebellar vermis.
Intracerebral fluid spaces included the lateral ventricles, the cavum septum pellucidum, and 
the third ventricle.
Cortical maturity was assessed formally using the grading system proposed by Abe et al160 
where stage 1 corresponds to the presence of an identifiable right and left hemisphere only, 
stage 2 corresponds to the presence of a Sylvian fissure separating the frontal and temporal 
lobes, stage 3 corresponds to the visualisation of  the inferior frontal and superior temporal 
sulci as shallow  indentations, stage 4 corresponds to the visualisation of 2 shallow 
indentations in the frontal lobe, and the superior temporal gyrus is clearly visualised, stage 5 
corresponds to the clear division of the frontal lobe by the superior and inferior frontal sulci, 
stage 6 corresponds to the clear division of the temporal lobe by the superior and inferior 
temporal sulci, stage 7 corresponds to the visualisation of  secondary sulci in the temporal 
and frontal lobes, and stage 8 corresponds to the the cortex being covered by gyri and sulci 
and the Sylvian fissure is almost closed (figure 5.1).
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Figure 5.1: Cortical maturity staging as described by Abe et al160.
Stage 1 cortical maturity in a 21 week fetus  
(ED2379)
Stage 2 cortical maturity in a 24 week fetus 
(EM2248) with a clearly visible Sylvian fissure 
(blue arrow). 
Stage 3 cortical maturity in 28 week fetus 
(TB2481) with a visible inferior frontal sulcus 
(black arrow) and superior temporal sulcus 
(blue arrow)
Stage 4 cortical maturity in a 29 week fetus 
(LD1149) with 2 shallow indentations visible in 
the frontal lobe (blue arrow) and a clearly 
visualised superior temporal gyrus (black 
arrow)
Stage 5 cortical maturity in a 29 week fetus 
(KN629) with clear indentations of the frontal 
lobe (black arrows)
Stage 6 cortical maturity in a 32 week fetus 
(SG1999) with two clear indentations in the 
frontal and temporal lobes (black and blue 
arrows respectively)
Stage 7 cortical maturity in a 34 week fetus 
(CR2339) with secondary sulci in the frontal 
and temporal lobes
Stage 8 cortical maturity in a 38 week fetus 
(CF1671) with the cortical surface covered by 
multiple sulci and gyri and the Sylvian fissure is 
almost closed
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Linear measurements of head and brain growth were done according to the standards 
developed for preterm neonates within the Robert Steiner MRI unit (developed by Isotta 
Guidot, unpublished data). 
In the transverse plane, the single-slice head area (along the outer boundary of the skull), 
bone biparietal diameter (from the two inner boundaries of the skull), cerebral biparietal 
diameter, and bone occipito-frontal diameter (in the midline passing through the third 
ventricle, from the two inner boundaries of the skull) were measured at the mid-thalamic 
level (figure 5.2).  
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Figure 5.2: Linear measurements of head and brain growth obtained in the transverse plane (BC1307)
Measurement of the single slice 
head area along the outer boundary 
of the skull at the mid thalamic plane
Measurement of the transverse bone 
biparietal diameter 
Measurement of the transverse 
cerebral biparietal diameter
Measurement of the transverse bone 
occipito-frontal diameter
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In the sagittal plane, the bone and brain occipito-frontal diameter was measured in the 
midline, passing through the rostrum and splenium of the corpus callosum (figure 5.3).
Figure 5.3: Linear measurements of head and brain growth obtained in the sagittal plane (BC1307)
In the coronal plane, the bone and brain biparietal diameters were measured in the mid 
thalamic slice, at the level of the temporal horns of the lateral ventricles (figure 5.4).
Measurement of the sagittal bone 
occipito-frontal diameter
Measurement of the sagittal cerebral 
occipito-frontal diameter
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Figure 5.4: Linear measurements of head and brain growth obtained in the coronal plane (BC1307)
Linear measurements of cerebellar growth were done according to the standards developed 
by IG as above.
In the transverse and coronal planes, the maximal transcerebellar diameter was measured 
(figure 5.5). 
In the mid-sagittal plane, the cerebellar vermis height, anterior-posterior length, and 
tegmento-vermian angle were measured (figure 5.6). 
Measurement of the coronal bone 
biparietal diameter
Measurement of the coronal cerebral 
biparietal diameter
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Measurement of the 
transverse transcerebellar 
diameter
Measurement of the 
coronal transcerebellar 
diameter
Figure 5.5: Linear measurements of the transcerebellar diameter in the transverse and coronal planes (BC1307)
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Measurement of the sagittal 
vermis height
Measurement of the sagittal 
vermis width
Measurement of the sagittal 
tegmento-vermian angle
Figure 5.6: Linear measurements of the vermis in the sagittal plane (BC1307)
5.3 Results
5.3.1 Patient Demographics
A total of  29 fetuses with fetal growth restriction were imaged using fetal MRI. The severity of 
fetal growth restriction was  graded as severity grade 1 in three woman, grade 2 in six 
women, grade 3 in thirteen women, grade 4 in two women, and grade 5 in five women. All 
women delivered fetuses below  the 5th centile on customised birthweight charts. 45 women 
with structurally normal fetuses were included as normal controls. All 45 infants were born 
with a birthweight in the normal range for gestational age (between the 5th and the 95th 
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centile) and there were no postnatal complications.  Intraobserver reliability in calculating 
fetal 2D measures was high (p<0.001, ICC = 0.89 n = 15), as was that for fetal brain 
volumes (MD & PP) (p<0.001, ICC = 0.99 for both intra and inter observer variability, n =15). 
Bland altman analysis confirmed good agreement between the observers (ref  Fig. 4.3). The 
characteristics of both groups are summarised in Table 5.1.
Fetal Growth Restricted (n = 29) Normal Control (n =45 )
Gestation at MRI (mean ± s.d.) 27.8 ± 3.92 30.0 ± 3.7
Parity (% primiparous) 55.5 54.3
Maternal BMI (mean ± s.d.) 24.7 ± 3.74 24.5 ± 6.3
Gestation at delivery (mean ± s.d.) 30.4 ± 4.1 38.9 ± 6.7
Birthweight at delivery, g (mean ± s.d.) 997.7 ± 550.5 3201 ± 496.1
Pregnancy Outcome
Termination of Pregnancy 2 0
Intrauterine Death 6 0
Livebirth 21 45
Table 5.1: Patient Demographics
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RP2163 IUGR-4 20.43 1 0.0400 0.0288 0.0008 0.0089 0.0015
ED2379 IUGR-4 20.86 1 0.0458 0.0296 0.0009 0.0138 0.0015
EM2248 IUGR-4 23.71 2 0.0924 0.0597 0.0021 0.0289 0.0017
DCL1108 IUGR-4 23.86 2 0.0821 0.0569 0.002 0.0207 0.0025
FK784 IUGR-3 24 2 0.0800 0.0559 0.0015 0.0208 0.0018
BP1104 IUGR-5 24 2 0.0994 0.068 0.0023 0.0287 0.0003
SR858 IUGR-6 24.57 2 0.0919 0.0597 0.0018 0.0277 0.0027
MB2396 IUGR-6 24.86 2 0.0853 0.0569 0.0019 0.0241 0.0025
SH1585 IUGR-3 25.43 2 0.1185 0.0795 0.0032 0.0338 0.002
DD2494 IUGR-4 25.57 2 0.0823 0.0027 0.0027
JS1014 IUGR-6 26.43 2 0.1244 0.0818 0.0029 0.0361 0.0036
MZ1126 IUGR-2 26.43 2 0.1152 0.0804 0.0028 0.0311 0.0009
RM2265 IUGR-6 26.57 3 0.102 0.0042 0.0036
HY577 IUGR-6 27.29 3 0.1197 0.0904 0.0031 0.0238 0.0024
AA1417 IUGR-4 27.57 3 0.1600 0.108 0.0042 0.0459 0.0019
RV2322 IUGR-3 28 3 0.1848 0.13 0.004 0.049 0.0019
IR2293 IUGR-4 28 0.1503 0.117 0.0041 0.0278 0.0014
TB2481 IUGR-4 28 3 0.1625 0.0933 0.0036 0.0599 0.0057
SD1265 IUGR-3 29 3 0.2162 0.137 0.0058 0.0714 0.0019
CS2547 IUGR-4 29 4 0.2215 0.149 0.0073 0.0589 0.0063
KN629 IUGR-4 29.14 5 0.1728 0.119 0.0047 0.0474 0.0017
BC1307 IUGR-4 31.56 6 0.2378 0.164 0.0083 0.0639 0.0015
ML2140 IUGR-5 32 6 0.2360 0.176 0.0079 0.0511 0.001
RF2017 IUGR-3 32.28 6 0.2468 0.164 0.0083 0.0717 0.0027
FH932 IUGR-4 32.57 6 0.2270 0.161 0.0094 0.0555 0.001
SS2546 IUGR-4 32.57 6 0.2841 0.184 0.0098 0.0838 0.0065
NOD1107 IUGR-2 33 7 0.2955 0.21 0.0107 0.0716 0.0032
ZN598 IUGR-3 34.14 7 0.2272 0.179 0.0097 0.0378 0.0007
AO1174 IUGR-2 35.71 8 0.3049 0.235 0.0133 0.0543 0.0024
TR2508 Normal 23.86 2 0.1057 0.066 0.0024 0.0349 0.0024
CM1830 Normal 24.57 2 0.1320 0.0753 0.0026 0.0517 0.0024
ER821 Normal 24.71 2 0.0746 0.0028 0.0018
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KM2381 Normal 24.71 2 0.1320 0.0753 0.0026 0.0517 0.0024
LH1586 Normal 25 2 0.1427 0.0813 0.0026 0.0537 0.005
AF2201 Normal 25.14 2 0.1443 0.0867 0.0028 0.0527 0.0021
ABT1055 Normal 25.42 2 0.1427 0.0832 0.0028 0.054 0.0027
CC1125 Normal 26.71 2 0.1666 0.106 0.004 0.0551 0.0015
VTR1173 Normal 26.86 3 0.1871 0.117 0.0041 0.0625 0.0035
SN1206 Normal 27 3 0.1489 0.0853 0.0032 0.0553 0.005
PW2540 Normal 27 3 0.1932 0.11 0.0041 0.0748 0.0043
MW2429 Normal 27.42 4 0.2099 0.128 0.0045
LG2283 Normal 27.56 3 0.2099 0.117 0.0043 0.0856 0.003
NM1935 Normal 27.57 3 0.2135 0.119 0.003
TF2063 Normal 27.86 3 0.1806 0.104 0.0042 0.0674 0.005
SA1901 Normal 28 3 0.1999 0.111 0.0043 0.081 0.0036
AK2284 Normal 28.56 4 0.1688 0.114 0.0046 0.0479 0.0024
CK1101 Normal 29 4 0.2386 0.13 0.006 0.0945 0.0081
FI2425 Normal 29 3 0.2020 0.12 0.0061 0.0724 0.0036
LD1149 Normal 29.14 4 0.2254 0.136 0.0049 0.0801 0.0044
KM1861 Normal 29.28 3 0.2313 0.122 0.0057 0.098 0.0056
SOM2557 Normal 29.28 6 0.1949 0.123 0.0048 0.0627 0.0045
TD1382 Normal 29.43 4 0.153 0.0075
CG1130 Normal 29.57 6 0.2481 0.153 0.0081 0.0827 0.0043
MU2312 Normal 29.71 4 0.2412 0.148 0.0058 0.083 0.0043
SM2154 Normal 29.86 6 0.2346 0.143 0.006 0.0805 0.005
TB2159 Normal 29.86 6 0.2594 0.151 0.0059 0.0972 0.0053
MG2316 Normal 30.28 6 0.2899 0.179 0.0081 0.0955 0.0073
MW2313 Normal 30.28 6 0.2691 0.169 0.0079 0.0883 0.0038
FJ2351 Normal 30.42 0.2594 0.151 0.0059 0.0972 0.0053
CT2180 Normal 31.43 6 0.2573 0.158 0.0078 0.0889 0.0026
SG1999 Normal 31.71 6 0.2961 0.186 0.0095 0.0941 0.0064
KK1887 Normal 32.14 7 0.3185 0.198 0.0119 0.1054 0.0033
JT2493 Normal 32.14 6 0.2907 0.195 0.01 0.082 0.0038
SB2365 Normal 32.28 7 0.3184 0.22 0.0107 0.0806 0.0072
AP2401 Normal 32.57 6 0.3460 0.216 0.0114 0.113 0.0057
JS1637 Normal 33 7 0.3236 0.215 0.0118 0.0916 0.0052
CR2339 Normal 34.14 7 0.4064 0.274 0.015 0.1119 0.0054
MS2206 Normal 34.43 7 0.3175 0.221 0.0109 0.0811 0.0046
AM2324 Normal 35.43 7 0.3696 0.269 0.0158 0.0809 0.0039
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AH1973 Normal 35.85 8 0.3625 0.271 0.0148 0.0738 0.0029
NH2116 Normal 36 7 0.4092 0.295 0.0154 0.0933 0.0055
KO1992 Normal 36 7 0.4105 0.28 0.015 0.1128 0.0027
LV2560 Normal 36.14 7 0.4403 0.304 0.0131 0.1177 0.0056
NS1953 Normal 37 7 0.3712 0.282 0.0155 0.0702 0.0036
CF1671 Normal 37.71 8 0.4642 0.361 0.0045
Table 5.2: Patient volumetry results 
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RP2163 IUGR-4 20.4 1909 42.8 40.8 47.7 44.6 42.3 43.4 37.8 19 17.6 8.5 5.9 29.3
ED2379 IUGR-4 20.9 1974 40 39.2 43 47.9 43.4 41.8 35.9 19.4 17.6 8 4.7 21.9
EM2248 IUGR-4 23.7 3267 54 48.2 65.4 60.6 46.2 53.8 45.4 24.6 24.4 10.5 8 21.9
DCL1108 IUGR-4 23.9 3041 52.2 47.6 63.6 60.9 50.8 50 43.2 22.6 21 9.8 8.2 3.1
FK784 IUGR-3 24 2734 47.8 43 63.6 63.1 58.4 43.6 40.6 20.2 19.4 10.3 7.2 12.2
BP1104 IUGR-5 24 3505 56.6 51.6 68.6 63 51.4 58 51.3 27.6 25.8 11.8 10.3 19.7
SR858 IUGR-6 24.6 2971 51.1 46.5 64.5 70.1 65.5 47.6 44.2 22 20.8 12.4 7.4 11.5
MB2396 IUGR-6 24.9 3138 53.8 49.8 64 60.5 52.8 51.8 46.6 23.4 23 11.8 6.7 4.1
SH1585 IUGR-3 25.4 3416 54.4 51.1 71.5 74.9 70.6 52.2 48.2 26.5 26 12.5 9.6 0.8
DD2494 IUGR-4 25.6 3868 57.2 52.6 76.6 66.8 54.6 51 28 27.8 10.8 8.2 16.3
JS1014 IUGR-6 26.4 3775 56.9 51.6 71.2 67.5 60.9 56 51.8 26.6 27.6 12.4 9.8 12.8
MZ1126 IUGR-2 26.4 3490 56.8 51.8 68.2 71.7 61.6 53 49.2 28.2 28.2 12.8 8.2 8.4
RM2265 IUGR-6 26.6 4148 61.8 58 75.6 71.7 62.4 59.6 55.8 29.4 29.4 14.2 8.7 15.9
HY577 IUGR-6 27.3 3749 60.4 54.8 72.4 67.5 61 57.4 52.2 28.2 27 14.1 8.3 4.2
AA1417 IUGR-4 27.6 4777 67.2 58.8 80.5 76.3 68.4 64 58.4 30.2 30 14.2 10.4 7.4
RV2322 IUGR-3 28 4707 68.4 61.4 81.2 78.3 70.6 67.2 59.4 30.2 30 13.2 9.6 14.1
IR2293 IUGR-4 28 4165 61.2 56.2 78.4 77.5 71.5 59.4 55.4 32 30.8 17.2 10.4 12.2
TB2481 IUGR-4 28 4534 65.6 57.4 77.8 77 70.7 63.4 56.4 29.4 27.8 12.2 9.6 14.8
SD1265 IUGR-3 29 5649 72.8 64 87.7 88.6 79.2 73.4 62.2 32.8 32.6 15.3 10.2 13.3
CS2547 IUGR-4 29 5775 74.7 68 84.3 82.7 79 70.7 65 36.2 35.7 16.4 9 15.4
KN629 IUGR-4 29.1 4605 67 59.6 78.9 79.5 72.4 63.8 58.4 32.2 31.6 14.2 10.6 8.7
BC1307 IUGR-4 31.6 6024 77.4 69.6 88 83.2 78.3 73.4 68.2 37.8 40.2 16.6 11.3 10
ML2140 IUGR-5 32 6060 77.2 70 88.6 88.8 82.4 73.4 68.7 37.2 36.8 17.4 13.7 3.3
RF2017 IUGR-3 32.3 6191 77.4 75.8 90.4 91 87.4 76.3 70.6 39.1 38.5 20.9 12.8 0.3
FH932 IUGR-4 32.6 6104 72.2 67.4 95.4 94.2 83.8 67.8 65 39.4 39.4 20.4 14.5 0.6
SS2546 IUGR-4 32.6 6474 78.29 72.4 91.3 92.9 82.3 76.4 69 40.4 40.6 19.6 13.3 7.5
NOD1107IUGR-2 33 7110 85.6 76.8 97.6 89.8 85.3 82.2 76.8 41.8 41 19.2 12.4 12.7
ZN598 IUGR-3 34.1 5800 71.8 68.8 91.8 91 85.2 70.7 67.3 39.4 40.6 22.2 14.2 0.7
AO1174 IUGR-2 35.7 5847 71.8 68.8 92.6 91.6 85.4 68.6 64.5 45.6 45.8 21.3 14.2 1.5
TR2508 Normal 23.9 3621 58.4 52.4 69.6 69.6 60.4 57.2 48 24.4 24.6 12.6 8.5 5.4
CM1830 Normal 24.6 4431 63.4 56.6 76.2 77.4 64.8 62 53.4 25.8 26.8 13.1 8.4 11.2
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ER821 Normal 24.7 3935 69 70.67 56.6 28.6 27.8 12.8 8.1 8.7
KM2381 Normal 24.7 4156 61.4 53.8 76.2 75.4 69.3 59.8 50.8 26 26.8 14.2 8.9 13
LH1586 Normal 25 4431 63.4 56.6 76.2 77.4 64.8 62 53.4 25.8 26.8 13.1 8.4 11.2
AF2201 Normal 25.1 4454 62.4 54.8 78.6 77.1 63.9 59.8 52.4 25.6 25.9 13.6 9.2 2.6
ABT1055Normal 25.4 4549 63.6 57 77 78.2 62.2 63 52.4 26.4 27.2 12.3 8.8 3
CC1125 Normal 26.7 4813 72 61.6 78.8 78.4 64.4 62.6 54.4 29.8 26.8 15.6 10.6 4.7
VTR1173Normal 26.9 5254 70.4 58.4 82.7 83.2 70.5 68.2 58.1 29.9 29.6 15.4 11.5 4.3
SN1206 Normal 27 4254 64.2 55.4 76.4 76.8 70 60 52.7 28.5 29 14.4 9.4 4.4
PW2540 Normal 27 4975 69.8 60.4 80.8 82.2 68.7 63.9 57 29.6 30.1 15.7 10.8 18.4
MW2429 Normal 27.4 5230 71.4 62.4 84.4 84.5 71.7 66.8 57.2 31.6 32 16.2 10.2 6.7
LG2283 Normal 27.6 5045 68.6 61.8 84 83.4 72.9 64.8 58 30.2 30.6 15.4 11.6 14.5
NM1935 Normal 27.6 5777 74.4 60.2 85.8 82.3 65.5 69.7 58.5 31 30.9 14.6 8.9 7
TF2063 Normal 27.9 5315 67.4 59.6 84.4 83 68.6 68.2 58.4 31.6 31.6 15.7 9.6 7.7
SA1901 Normal 28 5598 72 62.7 86.7 87.8 72.9 72.5 60 32.2 32.2 15.2 9.4 1.2
AK2284 Normal 28.6 4728 67.8 59.2 79.6 79.9 68.8 67 58.8 32.2 32 14.8 11.5 2.3
CK1101 Normal 29 5855 74.4 60.1 88.5 91.3 74.5 72.3 64.6 35.6 35 14.8 11.8 5.8
FI2425 Normal 29 5569 71.4 64.8 89 85.9 72.9 69.8 62 33.2 33.4 15.4 11.4 1.4
LD1149 Normal 29.1 6234 76.1 60.2 88.6 85.6 74.1 70 63.3 34.7 35 15.2 11.1 6.1
KM1861 Normal 29.3 6302 77.3 64.4 92.2 91.5 76.6 75.2 60.8 33.8 33.6 18.6 11.4 1.7
SOM2557Normal 29.3 5310 68 60.8 84.8 89 83.3 67.4 57.4 31.4 31.3 15.6 10.8 3.2
TD1382 Normal 29.4 6154 76.4 67.3 90.6 89.2 74.9 75.5 65.3 38.1 36.7 19 10.9 19.4
CG1130 Normal 29.6 6237 77.2 69.6 92.8 91 74.1 74.2 67.4 37.3 36.8 17.9 11.4 1.9
MU2312 Normal 29.7 6002 77.4 66.2 89.9 90.4 77.8 74 63.4 34.1 34.4 14.8 10.9 9.3
SM2154 Normal 29.9 6351 78.3 67 91.2 91.3 77.2 73.4 63.4 33.6 33.2 15.7 11.5 5.2
TB2159 Normal 29.9 5970 77 67.8 86.8 85.8 76.8 74 67.2 34.7 34.6 17 10.5 4
MG2316 Normal 30.3 7042 83.9 73.2 96 94.9 80.4 80 72 36.8 37.3 18.1 13.1 5
MW2313 Normal 30.3 6554 78.4 71.8 94.2 93.4 81.8 72.6 68 35.4 36.6 18.2 14 8.6
FJ2351 Normal 30.4 7044 80.8 76.2 99.2 94.9 75.4 80.3 72.2 43.4 43.6 19.2 13.7 7.1
CT2180 Normal 31.4 6167 76.8 69 91.4 89.3 79.8 74 67.6 38.2 38.4 18.4 13.9 12.9
SG1999 Normal 31.7 6954 81.3 72.8 94.1 92.6 78.4 78.6 72.5 41.3 41.8 19.4 12.7 5.9
KK1887 Normal 32.1 7044 80.8 76.2 99.2 94.9 75.4 80.3 72.2 43.4 43.6 19.2 13.7 7.1
JT2493 Normal 32.1 7020 81.8 76.8 96.3 97.4 81.4 80 74 41.8 41.2 19 13.3 2.4
SB2365 Normal 32.3 7447 84.2 75.4 99.8 96.6 88 78.8 74.4 43.6 44 16.3 13.4 7
AP2401 Normal 32.6 7813 85 78.8 105 100.7 91.3 81.2 75 43 43.7 20.5 12.6 8.6
JS1637 Normal 33 7863 85.8 77.6 103.3 107 100.4 85.8 76 43 45.2 19.1 13 11.9
CR2339 Normal 34.1 8726 94.5 89.8 108.1 108.1 95.1 89.3 82.3 46.5 47 22.5 16.7 1.7
MS2206 Normal 34.4 7129 82.4 77.4 100.5 99.9 92.3 81 75.4 41.2 40.2 18 14.4 7.8
AM2324 Normal 35.4 8534 90.4 83.2 104.2 103.9 94 85.3 83.4 44.8 45 21.8 14.4 4.7
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AH1973 Normal 35.9 7465 85.4 80.3 98.1 101.8 101.8 85.4 85.4 46.9 46.4 19.3 15 8.4
NH2116 Normal 36 8710 92.8 88.2 105.8 106.1 93.3 89.3 88.5 47.7 46.9 22.6 13.8 13.2
KO1992 Normal 36 8259 92 79.3 104.3 102 91.7 89 80.8 46.2 45.6 20.2 19.4 5
LV2560 Normal 36.1 8917 93.8 86.9 108.8 108.3 96.3 85.3 79.7 46.1 45.8 17.6 14.4 12.4
NS1953 Normal 37 8363 89.8 85.9 105.3 107.5 94.6 85.5 85.5 47.7 46.2 20.2 17 5.34
CF1671 Normal 37.7 9618 97.2 92.8 113.4 108.6 99 92.5 92.5 51.9 52.2 21.6 18.6 6.3
Table 5.3: Patient 2D measurements results
5.3.2 Whole brain segmentation
Changes in whole brain appearance with increasing gestational age
Figure 5.7 - 5.10 details the changes in brain development and cortical maturity in growth 
restricted and normally grown fetuses at the gestational ages 24, 28, 32, and 36 weeks. 
148
Figure 5.7: Changes in Brain development  in a 24 week normally grown (TR2508) and an growth restricted 
(EM2248) fetus demonstrating the development of the interhemispheric fissure separating the two hemispheres 
(yellow arrow), parieto-occipital fissure separating the parietal and occipital lobes( blue arrow), and the 
hippocampal sulcus  extending from the splemium of the corpus callosum to the tip of the temporal lobe(green 
arrow)
Figure 5.8 Changes in brain development in a 28 week normally grown (SA1901) and an growth restricted 
(TB2481) fetus demonstrating the development of the central sulcus separating the frontal and parietal lobes(red 
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arrow), inferior frontal sulcus (green arrow), calcarine fissure on the medial surface of the occipital lobe (blue 
arrow), and cingulate sulcus midway between the corpus callosum and the cortical margin (yellow arrow)
Figure 5.9 Changes in brain development in a 32 week normally grown (AP2401) and growth restricted (RF2017 
images) fetus demonstrating the  development of the inferior (red) and superior (blue) central sulcus
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Figure 5.10 Changes in brain development in a 36 week normally grown (AM2324) and growth restricted 
(AO1174) fetus demonstrating the development of the superior temporal sulcus (blue arrow) and the intraparietal 
sulcus separating the parietal gyri (green arrow)
There was no significant difference in cortical maturity score between both groups of fetuses 
across gestation (figure 5.11).
Changes in measures of cortical maturity with increasing gestational age
Figure 5.11: Cortical maturity score in growth restricted and normally grown fetuses across gestation
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Changes in intracranial volume with increasing gestational age
Intracranial volume was significantly smaller among growth restricted fetuses across 
gestation when compared to normally grown fetuses (p<0.001, figure 5.12). This difference 
in intracranial volume was still present after correcting for total brain volume, suggesting that 
a smaller cerebral fluid spaces is an additional contributory factor. There was a significant 
correlation between smaller intracranial volumes and the severity of fetal growth restriction (r 
= -0.5, p <0.001).
Figure 5.12 Changes in intracranial volume across gestation
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Changes in whole brain volume with increasing gestational age
Brain volume was significantly smaller among growth restricted fetuses when compared to 
normally grown fetuses (p<0.001, figure 5.13). There was a significant correlation between 
the severity of fetal growth restriction and smaller fetal brain volume (r = -0.4, p<0.001). The 
mean decrease in brain volume was -13% (range = -42.44% to 13.08%). 
Figure 5.13: Changes in whole brain volume across gestation
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There was a significant increase in the brain volume in growth restricted fetuses when 
normalised to the single slice head area (a marker for head circumference) (p<0.001), 
suggesting that the other components of  the intracranial space were smaller (i.e. extra-and 
intra-cerebral fluid spaces). 
Figure 5.14 Changes in total brain volume normalized to single slice head area
Linear measurements of head and brain growth with gestational age
All linear measures of brain growth were significantly smaller in growth restricted fetuses 
when compared to normally grown fetuses (p<0.01, figure 5.14). There was a significant 
correlation between the severity of fetal growth restriction and the decreased linear 
measures of  brain growth (r = -0.43 - -0.57, p<0.001). There was a highly significant 
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correlation between linear measures of brain growth and actual brain volume (r = 0.91 - 
0.98, p<0.001), with the single slice head area measured along the outer boundary of the 
skull demonstrating the highest correlation with actual brain volume. 
 
 
 Figure 5.15: Changes in linear measurements of head growth across gestation
5.3.3 Changes in cerebellar growth with gestational age
Changes in cerebellar volume with increasing gestational age
Cerebellar volume was significantly smaller among growth restricted fetuses when 
compared to normally grown fetuses across gestation (p<0.001, figure 5.15). There was no 
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significant difference between both groups in the cerebellar : whole brain volume ratio, 
indicating that cerebellar growth is in line with whole brain growth in growth restricted 
fetuses. There was a significant correlation between the severity of fetal growth restriction 
and the decreased cerebellar volume (r = -0.4, p<0.001). The mean decrease in cerebellar 
volume was -13.5% (range = -46.1 to 32.8%)
 
 
 Figure 5.16: Changes in cerebellar volume across gestation
Changes in linear measures of cerebellar growth with increasing gestational age
Linear measures of transcerebellar diameter were significantly smaller among growth 
restricted fetuses when compared to normally grown fetuses across gestation (p<0.005, 
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figure 5.16). There was a significant correlation between the severity of fetal growth 
restriction and linear measures of cerebellar growth (r = -0.39 - -0.41, p<0.001). There was a 
highly significant correlation between linear measures of cerebellar growth and actual 
cerebellar volume (r = 0.98, p<0.001).
Figure 5.17: Changes in linear measures of cerebellar growth across gestation
Changes in linear measures of vermis growth with increasing gestational age
The width of  the cerebellar vermis was significantly smaller among growth restricted fetuses 
across gestation when compared to normally grown fetuses (p <0.001, figure 5.17). There 
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was a significant correlation between width of the vermis and actual cerebellar volume (r = 
0.92, p<0.001), and between width of the vermis and the severity of fetal growth restriction (r 
= -0.41, p<0.001). 
Figure 5.18: Changes in linear measurements of vermis width across gestation
Measurements of  cerebellar vermis height were smaller among growth restricted fetuses at 
earlier gestations (prior to 30 weeks, p<0.001) (figure 5.18). At later gestations, growth 
restricted fetuses demonstrated cerebellar vermis height measurements in line with those of 
normally grown fetuses. 
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Figure 5.19: Changes in linear measures of vermis height across gestation
Measurements of  the tegmento-vermian angle demonstrated an increase in the tegmento 
vermian angle at earlier gestations (prior to 30 weeks, p = 0.01) (figure 5.19). At later 
gestations, growth restricted fetuses demonstrated tegmento-vermian angle measurements 
in line with those of normally grown fetuses. 
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Figure 5.20: Changes in the tegmento-vermian angle across gestation
Among growth restricted fetuses, there was a significant correlation between vermis height 
measurements and the tegmento-vermian angle (r = -0.57, p = 0.001), suggesting that the 
increase in tegmento-vermian angle at early gestations in growth restricted fetuses is related 
to a decrease in growth of cerebellar vermis height (figure 5.20).
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Figure 5.21: Correlation between tegmento-vermian angle and vermis height among growth restricted fetuses
 
5.3.4 Extra- and intra-cerebral fluid spaces
Extra-cerebral fluid space volume was significantly smaller among growth restricted fetuses 
across gestation when compared to normally grown fetuses (p<0.001, figure 5.21). The 
decrease in extra-cerebral fluid space correlated significantly with the severity of  fetal growth 
restriction (r = -0.69, p<0.001). There was a strong correlation between brain volume and the 
volume of extra-cerebral fluid (r = 0.74, p<0.001).  
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Figure 5.22: Changes in extra-cerebral fluid space across gestation
The extracerebral fluid : brain ratio was significantly smaller in growth restricted fetuses at 
earlier gestations when compared to normally grown fetuses (p<0.001, figure 5.22), 
indicating a disproportionate decrease in extracerebral fluid volume in fetuses with early 
onset fetal growth restriction. 
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Figure 5.23 Changes in the extra-cerebral fluid : brain volume ratio across gestation
Ventricular volume was significantly smaller across gestation among growth restricted 
fetuses (p<0.001, figure 5.23). There was a significant correlation between the severity of 
fetal growth restriction and the decrease in ventricular volume (r = -0.5, p<0.001).
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Figure 5.24: Changes in ventricular volume across gestation 
There was a significant correlation between extracerebral fluid volume and ventricular 
volume across gestation in both growth restricted and normally grown fetuses (r = 0.67, 
p<0.001).
The ventricular : brain volume ratio was significantly smaller in growth restricted fetuses 
across gestation compared to normally grown fetuses, indicating a disproportionate 
decrease in ventricular volume among growth restricted fetuses across gestation.
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Figure 5.25: Changes in ventricular : brain volume ratio across gestation
There was a significant difference in the extra-cerebral fluid : ventricular fluid volume ratio 
between growth restricted and normally grown fetuses across gestation (p <0.001), with 
growth restricted fetuses demonstrating a decrease in the extra-cerebral fluid : ventricular 
volume ratio at earlier gestations, and an increase in the extra-cerebral fluid : ventricular 
volume ratio at higher gestations (figure 5.25).
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Figure 5.26: Changes in the extra-cerebral : ventricular volume fluid ratio across gestation
5.4 Discussion
This is the first study utilising snapshot volumetric reconstruction 3 dimensional MRI 
reconstruction of  the fetal brain to compare regional brain volumetry in growth restricted and 
normally grown fetuses. These results have demonstrated smaller intracranial volume, total 
brain volume and cerebellar volume in growth restricted fetuses. In addition, growth 
restricted fetuses with early onset fetal growth restriction demonstrated smaller vermis 
height and a corresponding increase in the tegmento-vermian angle. Growth restricted 
fetuses also demonstrated a disproportionate decrease in extra- and intra-cerebral fluid.
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5.4.1 Brain volume
Total brain volume was significantly smaller among growth restricted fetuses in this study 
across gestation. The mean decrease in brain volume was -13% (range = -42.44% to 
13.08%). Benavides-Serralde et al123 used 3-dimensional ultrasonography to calculate 
intracranial volumes (as a surrogate for brain volume) in growth restricted and normally 
grown fetuses from the gestational age range 28 to 34 weeks, and found volumes similar to 
those found in this study. Additionally in their study, the frontal region of the brain was further 
segmented out, and was found to be disproportionately smaller when compared to the 
intracranial volume. Duncan et al 83 used EPI MRI sequences to calculate brain volume in 
growth restricted fetuses and found smaller whole brain volume among growth restricted 
fetuses in the order of that found in this study.
Other studies have also found aberrations in regional brain volumetry among growth 
restricted neonates using MRI; Logydensky et al61 found smaller hippocampal volume, 
Thompson et al161 found smaller whole brain volume, as well as specifically the  parieto-
occipital and inferior-occipital regions of the brain, Tolsa et al34 found smaller intracranial and 
whole brain volume, and more specifically the cortical gray matter, and Toft et al162 found 
smaller whole brain volume, and more specifically, the ratio of gray to white matter.
This is in contrast to the commonly held notion that the brain sparing effect and the increase 
in cerebral blood flow  translates into preservation of brain volume in growth restricted 
fetuses. The smaller brain volume in this study correlated with the severity of fetal growth 
restriction and it is likely that the brain sparing effect facilitates brain growth and 
compensates for the presence adverse intrauterine conditions in mild fetal growth restriction, 
and is unable to compensate fully as the severity of growth restriction increases.
Olivier et al163 studied the changes in brain development following ligation of the uterine 
artery in rats and found an increase in angiogenesis within the brain parenchyma consistent 
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with the redistribution of blood flow  and the brain sparing effect. In addition, they found an 
increase in the number of astroglia and immature oligodendrocytes, and a decrease in the 
number of  oligodendrocytes leading to a transient delay in myelination. Although in that 
study there was no increase in apoptosis in the brains of growth restricted fetuses (as 
measured by the level of Caspase-3 immunoreactive cells), a study by Lane et al found that 
uterine artery ligation in pregnant rats led to an increase in the expression of  Bcl-2 (which 
acts upstream of Caspase-3 in the apoptosis cascade), which may increase vulnerability 
towards cerebral apoptosis in the presence of hypoxia. 
Despite increased angiogenesis as a result of  the brain sparing effect, placental insufficiency 
leads to a state of chronic hypoxia as oxygen delivery to cerebral tissue is reduced. In a 
sheep model of  chronic placental insufficiency, Rees et al164 found evidence of immature 
cortical development, a decrease in cell number and cell size, and evidence of necrosis in 
cells within the cortex and hippocampal region. 
In addition, fetal development in a resource-scarce environment tends to deviate towards a 
thrifty phenotype with modification of  the hypothalamo-pituitary-adrenal axis, and increases 
in the levels of corticotrophin-releasing hormone and fetal cortisol levels. Tolsa et al 
suggested that the changes seen in cortical development in growth restricted fetuses may 
be related to the neuroendocrine changes seen in growth restriction as fetuses that have 
had repeated antenatal glucocorticoid and postnatal corticosteroid therapy have similar 
reductions in brain surface and cortical gray matter volume34. Similarly, IGF-1 levels are 
known to stimulate neurite outgrowth, and it is possible that the low  levels of  IGF-1 in growth 
restricted fetuses may play a role in the reduction in growth of neural processes165.
When single slice head area (marker for head circumference) was adjusted for, there was a 
significant increase in brain volume among growth restricted fetuses but no significant 
difference in the intracranial volume. This increase in brain volume in growth restricted 
fetuses is by default a reflection of  the smaller extra-and intracerebral fluid spaces as the 
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total intracranial volume is not altered in fetal growth restriction after adjusting for single slice 
head area.
  
5.4.2 Linear measures of brain growth
In this study, linear MRI measures of  head growth strongly correlated with MRI measures of 
brain volume. In all instances, linear measures of cerebral growth (i.e. cerebral biparietal 
diameter and occipito-frontal diameter) correlated more strongly with brain growth compared 
to linear measures of bone growth (i.e. bone biparietal diameter and occipito-frontal 
diameter). 
Duncan et al 83 compared linear ultrasound measures of head growth and MRI measures of 
brain volume and found that linear ultrasound measures of head growth were a poor 
predictor of MRI brain volumes. In contrast, in this study, we found a strong correlation 
between linear measures of brain growth using MRI and MRI measures of brain volume (ref 
Figure 5.14). This is likely to be a reflection of the accuracy of  the 3D dataset following 
reconstruction and alignment of the data into a standard plane.  
5.4.3 Cortical Maturity
There was no significant difference in cortical maturity score between growth restricted and 
normally grown fetuses. This is consistent with the study by Abe et al160 who studied cortical 
gyrus and sulcus formation in fetuses with growth restriction. 
Neonatal studies however have found aberrations in cortical development among growth 
restricted fetuses with Dubois et al166 and Tolsa et al 34 finding decreased cortical volume 
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and thickness, and Dubois et al166 also finding  a reduction in the sulcation index among 
growth restricted neonates. The increased cortical sulcation in relation to cortical thickness 
and surface area may be an early marker for the developmental delay in growth 
restriction166. Samuelsen et al167 studied post-mortem brain samples of growth restricted 
fetuses and found a significant decrease in the number of cells within the fetal cortex in 
fetuses beyond 27 weeks gestation. 
It is possible that although cortical maturity as measured by sulcus formation is not 
significantly affected in growth restricted fetuses, cortical thickness and volume is 
significantly smaller, and may be the precursor to developmental delay in growth restricted 
fetuses. Reductions in cortical thickness are a feature of  adult onset neuro-psychiatric 
diseases such as Alzheimer's disease168, and Schizopherenia169 as well as of developmental 
problems such as ADHD170, autism spectrum disorder171 and cognitive difficulties172.
Due to limitations in current fetal automated segmentation methods, volumetric assessment 
of the cortex was not undertaken. Optimisation of  the acquired sequences to enable 
automated segmentation is discussed further is Chapter 6 of this thesis.
5.4.4 Cerebellar volume
We found smaller total cerebellar volume among growth restricted fetuses that was in 
proportion to the whole brain volume. This is in agreement with the 3-D ultrasound study by 
Benavides-Serralde et al123 who found smaller cerebellar volume in growth restricted 
fetuses that was in proportion to head size. We also found smaller linear measures of 
cerebellar growth. Other ultrasound studies have also found a decrease in linear measures 
of cerebellar growth among growth restricted fetuses, with Vinkesteijn et al173 and Snijders et 
al174 finding smaller transcerebellar diameters.
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In a guinea pig model of growth restriction, Mallard et al175 demonstrated a reduction in the 
number of cerebellar Purkinje neurones, the volume of the molecular layer, the internal 
granular layer, and the volume of  cerebellar white matter, which is likely to contribute to the 
smaller total cerebellar volume. 
In this study, cerebellar volume growth was in proportion with whole brain growth. The 
cerebellar blood supply is derived from the vertebral and basilar arteries prior to them 
forming the Circle of Willis. Akalin-Sel et al176 proposed the presence of a ‘lower limb 
vasoconstriction reflex’ as part of the redistribution phenomenon where blood is 
preferentially diverted to the cardiac vessels and all cerebral vessels. This may occur via 
diversion of  blood into the subclavian arteries prior to blood flow  entering the descending 
aorta, and would result in an increase of blood flow  into the carotid and vertebral arteries 
supplying both the cerebrum and cerebellum, explaining the relative sparing of  both regions. 
One Doppler ultrasound study found evidence of a ‘cerebellar-sparing’ mechanism in fetal 
growth restriction with a reduction in the pulsatility index of the superior cerebellar artery177. 
This reduction in the pulsatility index of cerebellar vessels is likely to correlate with the 
reduction in the pulsatility index of the middle cerebral artery and explains the relative 
sparing of  the cerebellum in fetal growth restriction that is in line with the degree of brain 
sparing. 
5.4.5 Linear measures of vermis growth
We found a significantly smaller vermis width among growth restricted fetuses across 
gestation that correlated strongly with cerebellar volume measurements. 
The cerebellar vermis develops from a thickening in the alar plate of the rhombencephalon, 
in the anterior membranous roof of the rhombencephalic vesicle. The vermis forms in the 
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midline by proliferation of  the the median primordium, and enlarges rostrally.  At 16 weeks, 
the vermis folds along the fastigial point and begins to cover the roof  of the fourth ventricle. 
By 19 weeks, the vermis usually develops sufficiently to cover the fourth ventricle, and the 
tegmento-vermian angle approaches 0178. 
In this study, there was a significantly smaller vermis height and a significant increase in 
tegmento-vermian angle among growth restricted fetuses below  30 weeks gestation, 
suggesting a delay in the development of the cerebellar vermis in fetuses with early-onset 
fetal growth restriction. That this delayed development only occurred in the crania-caudal 
direction implies a different stimulus and prioritisation of  vermis growth in the anterior-
posterior direction.
 
Several studies have used ultrasound to measure vermis growth among growth restricted 
fetuses and neonates. Zucotti et al179measured vermis height among small for gestational 
age fetuses and found measurements similar to those found in this study. 
In contrast to the findings of  a smaller vermian height at earlier gestations and normalisation 
of vermian height measurements post 30 weeks gestation, Huang et al180 studied vermis 
measurements in growth restricted neonates and found smaller vermis height and width 
among growth restricted fetuses at later gestations (38 - 41 weeks), but not in those at 
earlier gestations. Goldstein et al181 however studied vermis measurement among growth 
restricted fetuses, and found no decrease in vermis width measurements among growth 
restricted fetuses across gestation. The variations between the findings and that of these 
studies may be a reflection of the post-processing available to us following reconstruction of 
fetal images which included resampling into a 0.2mm2 voxel, and alignment into a standard 
plane.
5.4.6 Extra- and intra- cerebral fluid volume
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We found a significantly smaller extracerebral fluid volume in growth restricted fetuses when 
compared to normally grown fetuses. In addition, there was a significantly smaller 
extracerebral fluid : whole brain volume ratio that was more apparent at earlier gestations. 
The finding of a decrease in extracerebral fluid volume is in contrast to a study by Tolsa et 
al34 who studied brain volumes in preterm growth restricted infants and found no significant 
difference in the volume of extracerebral fluid when compared to normally grown infants. 
We also found significantly smaller ventricular volumes and the ventricle : whole brain 
volume ratio among growth restricted fetuses. Again, this is in contrast to a study by Mallard 
et al who studied a guinea pig model of growth restriction and found an increase in the size 
of the lateral ventricles among growth restricted guinea pigs; as well as a study by Kriss et 
al182 who found mild asymptomatic ventriculomegaly in premature growth restricted infants. 
This may be a reflection of white matter injury and subsequent atrophy in these studies 
where imaging was undertaken at a delayed time point following the insult. 
Cerebrospinal fluid production of occurs in the choroid plexus, the brain parenchyma, and 
ependymal lining of the ventricles183. In adults, it is then absorbed primarily through the 
arachnoid villi and granulations184. In fetuses however, these pathways are immature, and 
Mollanji et al showed that in fetal sheep, extracranial lymphatic drainage, probably through 
the cribiform plate plays an important role in cerebrospinal fluid outflow.
As cerebrospinal fluid formation declines and lymphatic drainage increases at high levels of 
intracranial pressure184, it is possible that the reduction in cerebral vessel pulsatility indices 
and the increased cerebral blood flow  in fetal growth restriction leads to an increased level of 
intracranial pressure and a reduction in cerebrospinal fluid formation.
The contrast between the findings and those of  other studies may be a reflection of  the post-
processing available to us following reconstruction of  fetal images which included 
resampling into a 0.2mm2 voxel, and alignment into a standard plane; as well as the 
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measurement of whole ventricular volume (including the cavum septum pellucidum) as 
opposed to a single linear measurement of ventricular size. Additionally, there is evidence 
that postnatally, cerebrospinal fluid drainage via the arachnoid villi increases, and that via 
the cribiform plate lymphatic drainage decreases. The mild transient ventriculomegaly noted 
in growth restricted neonates by Kriss et al182 may be a reflection of transient delay in 
maturity of the arachnoid villi system. 
5.4.7 Limitations
The snapshot volumetric reconstruction technique and manual segmentation of the fetal 
brain is a resource intensive process, with preparation of the acquired MRI images for 
reconstruction requiring approximately 1 hour, the reconstruction process run on a Intel 
2.33GHz Dual Core Processor requiring approximately 3.5 hours, and manual segmentation 
of whole brain volume requiring between 0.5 to 1 hour depending on the maturity of  the 
fetus.
The reconstruction technique was successful in all cases, however, the quality of the 
reconstruction was dependant on the amount of  fetal motion present in the dataset, and was 
not the same in all fetuses.    
Manual segmentation of cortical volume is a resource intensive process and requires 
between 2-3 hours per fetus. In addition, there is often insufficient contrast between the 
different signal intensities to perform segmentation of  the cortex, especially in regions where 
the cortex runs parallel to the plane of visualisation. An automated segmentation script that 
identifies fetal cortical gray matter, white matter, and fluid spaces developed at Imperial 
College London and has been used successfully in a small number of  cases to segment 
fetal cortical gray matter (Aljabar et al, unpublished data). The use of this software is still 
limited by partial voluming and insufficient contrast in signal intensity values to allow 
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accurate segmentation in datasets other than those of  the highest quality. Chapter 6 of this 
thesis describes optimisation of the dynamic dataset that was acquired in an attempt to 
increase the quality of the reconstructed dataset for the purposes of  automated 
segmentation.  
Although the snapshot volumetric reconstruction technique provides us with motion 
corrected relatively high resolution, high signal to noise ratio fetal datasets, the image 
resolution is insufficient to perform accurate segmentation of structures such as the 
cerebellar vermis or the hippocampus. In addition, post-processing of  the datasets to enable 
segmentation of specific regions of the brain is limited by the lack of a MRI fetal brain atlas in 
the same sense that a neonatal Talairach atlas exists. Fetal studies such as those by 
Benavides-Serralde123 where the frontal region of  the brain was segmented out used cranial 
markers to subdivide intracranial volume as a surrogate for the frontal lobe of  the brain on 
ultrasound images rather than more accurate cortical markers to identify the different lobes 
of the brain. Work to develop an MRI fetal brain atlas is ongoing at Imperial College London.
The datasets used in this study were from only one timepoint in the pregnancy and serial 
MRI scanning was not undertaken in this study. Serial imaging confers the benefit of 
understanding the changes that occur as the severity of fetal growth restriction increases, 
and although ethical approval for serial MRI imaging was obtained, it was not possible to 
perform serial imaging of  many of these fetuses. This was mainly due to the limited use of 
the MR scanner which was shared with a clinical list, and the time constraints of being able 
to perform repeat scans in patients many of  whom had severe fetal growth restriction with 
rapid disease progression.
Although postnatal MRI imaging is offered to all patients recruited into this study, the uptake 
rate for postnatal imaging was poor as fetuses were often delivered at the referring hospital, 
and many were delivered preterm. A comparison between fetal and postnatal imaging was 
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not possible and as such it was not possible to follow  the developmental course of  structures 
known to be deficient such as the vermis in growth restricted fetuses.
5.5 Summary
This chapter provides a comprehensive overview  of the changes in regional and whole brain 
volumetry in fetuses with fetal growth restriction following 3D reconstruction of MRI images. 
The neurodevelopmental correlates for the neurostructural alterations occurring as a 
consequences of the chronic hypoxia secondary to disordered placentation in early 
pregnancy are still unclear. As the majority of  severely growth restricted fetuses are 
delivered preterm and face significant neuromorbidity in the immediate neonatal period as 
well as in longer term development, identifying the presence of aberrant brain development 
early on may enable appropriate counselling of parents with pregnancies at the threshold of 
viability, as well as the identification of  children most in need of  additional support in 
childhood.
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CHAPTER 6: OPTIMIZATION OF DYNAMIC SEQUENCE ACQUISITION FOR 
AUTOMATED CORTICAL SEGMENTATION
6.1 Introduction
Reconstruction and volumetric quantification of the whole brain as described in chapter 5 of 
this thesis is a resource intensive and time consuming process.  Automated segmentation 
methods for the neonatal brain already exist, and these are able to differentiate between 
cerebrospinal fluid, gray matter, and white matter, based on average signal intensity values.  
A modified automated segmentation method for fetal imaging was developed by the 
Computing Department of  Imperial College (Paul Aljabar, unpublished data), and this 
enabled rapid automated segmentation of  the brain in fetuses where the quality of the 
reconstruction was especially good. Using the current acquisition sequences, good contrast 
in signal intensity values is present at earlier gestations, but as cortical maturity and 
complexity occurs, the contrast between grey and white matter is less distinct and the 
automated segmentation programme performed less well in mature fetuses as its function is 
dependent on large signal intensity differences between different tissue types (figure 6.1). 
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Figure 6.1: Reconstructed images of a 24, 28, 32, and 36 week fetus demonstrating changes in the contrast 
between cortical gray matter and white matter, and the difficulties in applying automated segmentation methods 
to fetal imaging. 
24 week fetus (TR2508)  
demonstrating good 
contrast between the 
cortical layer and the white 
matter. The figure on the 
right demonstrates the 
application of the 
automated segmentation on 
the image.
28 week fetus (SA1901) 
demonstrating good 
contrast between the 
cortical layer and the white 
matter. The figure on the 
right demonstrates the 
application of the 
automated segmentation on 
the image
32 weeks fetus (AP2401)
demonstrating some areas 
of reduced contrast 
between the cortical gray 
matter and white matter 
(arrow). The figure on the 
right demonstrates the 
application of the 
automated segmentation on 
the image
36 week fetus (NH2116)
demonstrating the reduced 
contrast between cortical 
gray matter and white 
matter in mature fetuses 
(arrows). The figure on the 
right demonstrates the 
application of the 
automated segmentation on 
the image
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6.1.1 Approaches to Improving Image Quality
Approaches to improving MRI image quality may be directed towards improving the image 
resolution (through altering the matrix, field of view, or slice thickness), the image contrast 
(through altering the echo time in T2 weighted imaging or repetition time in T1 weighted 
imaging), and the signal to noise ratio (dependent on bandwidth and signal averaging). 
The image matrix refers to the number of  data points that are collected in the three 
directions, and is dependent on the field of view  (size of the imaging field), and the 
acquisition voxel size. An increase in the image matrix corresponds to an increase in the in-
plane resolution.
The echo time (TE) represents the time in milliseconds between the application of  the 90° 
pulse and the peak of the echo signal. Figure 6.2 depicts a T2 decay curve and 
demonstrates an increase in tissue contrast as the TE increases.
Figure 6.2: The T2 decay curve with an increase in tissue contrast as the TE increases185
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This chapter describes a pilot study into optimisation of the MR acquisition sequence to 
allow  the use of automated segmentation methods in the majority of fetal scans by robust 
differentiation of  adjacent tissues for fetuses across all gestational ages. The work in this 
chapter was undertaken in collaboration with Paul Aljabar (Computing Department), and 
under the guidance of Profesor Jo Hajnal (Robert Steiner MRI Unit).
6.2 Materials and Methods
6.2.1 Data acquisition
The strategies used to improve image quality were conducted using two approaches; first to 
increase the image resolution by using smaller voxels to acquire the images, and the second 
approach was to explore the use of different echo times to achieve optimal gray / white 
contrast within the images.
The voxel size used in the sequence is usually 1.25 × 1.25 × 2.5mm. We chose to explore 
the use of both a larger voxel (1.5 × 1.5 × 3.0mm) and a smaller voxel (1.1 × 1.1 × 2.2mm)
The standard echo time used in the dynamic T2 weighted single shot fast spin sequence is 
140ms. We chose to explore a range of echo times from 120 to 200ms.
6.2.2 Automated Segmentation
Pre-processing of the SVR file involved extraction of the brain with the brain extraction tool 
on FSL v4.0 (FMRIB, Oxford, UK)186, and intensity non-uniformity correction using N3 on 
MIPAV v5.0 (National Institutes for Health, Bethesda, Maryland).
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A fetal automated segmentation matlab script was used to perform automated segmentation 
on three fetuses at the gestational age 24, 30, and 36 weeks. The script performed on the 
principles of expectation maximisation to estimate a Gaussian model for tissue signal 
intensities from an unsupervised clustering step (of  k-mean values) to four groups of image 
intensities. In cases where automated calculation of  image intensities did not result in 
accurate segmentation,  manual adjustment of the k-mean values was done. 
6.3 Results
6.3.1 Approach 1: Improving Image Resolution
The Field of View  (FOV) used for dynamic fetal brain imaging is 430 × 353 × 88. When using 
a standard voxel size of 1.25mm × 1.25mm × 2.5mm (voxel size = 3.9mm3), this results in a 
matrix of 344 × 282.4 × 35.2. 
A 33.14 week fetus was scanned using the dynamic sequence parameters as detailed 
above, as well as with changes in the voxel size to 1.5mm × 1.5mm × 3.0mm (voxel size = 
6.75mm3), and to 1.1 × 1.1 × 2.2mm (voxel size = 2.66mm3). This resulted in a change in 
matrix size of  286 × 235 × 29.3 and 390.9 × 320.9 × 40 respectively. Due to time constraints, 
only 4 loops of data were acquired and used for reconstruction (as compared to the usual 8 
loops of  data), and the quality of  the reconstructions were moderate as there were less data 
points available for reconstruction.
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Voxel Size 1.5 × 1.5 × 3.0mm
Voxel size 1.25 × 1.25 × 
2.5mm
Voxel Size 1.1 × 1.1 × 2.2mm
Figure 6.3: Single loop dynamic dataset of a 33.14 week fetus at three different voxel sizes 
Reconstruction of the images revealed a reduction in image quality in the file acquired with 
the larger voxel size, and poorer contrast between gray and white matter (Figure 6.4). 
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Voxel size 1.25 × 1.25 × 
2.5mm
Voxel Size 1.5 × 1.5 × 3.0mm
Figure 6.4: Reconstructed dataset of the same fetus at two different voxel sizes
6.3.2 Approach 2:  Effect of increasing TE
The echo time used for dynamic sequence acquisition is usually 140ms. 
A 26 week fetus was scanned using the dynamic sequence as detailed above, with the echo 
time ranging from 120 - 200ms. Figures 6.5 demonstrates the signal intensity contrasts 
within the white and gray matter.
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Figure 6.5: Changes in image contrast as TE increases in a 26 week fetus
Visual assessment of  the images revealed an increase in contrast between gray and white 
matter as the TE increases.
As the TE increased, there was a reduction in noise and an increase in the contrast to noise 
ratio (figure 6.6 and 6.7).
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Figure 6.6: Changes in image noise as TE increases
Figure 6.7: Changes in the contrast to noise ratio as TE increases
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Our final approach was to combine both an increase of  in plane resolution (by using a 
smaller voxel size) and an increase in tissue contrast (by using a longer TE).
6.3.3 Approach 3: Using both a reduced voxel size and an increasing TE
A 37.14 week fetus was scanned using the voxel sizes 1.25mm × 1.25mm × 2.5mm and 
1mm × 1mm × 2mm, at the TE 140, 180, 280, and 420ms. 
Using a voxel size of 1.25mm × 1.25mm × 2.5mm, the scan time increased as the TE 
increased from 1 minute to 2.25 minutes per loop of dynamic data (figure 6.8).
TE: 140ms, 
scan time: 1 min 
voxel: 1.25 x 1.25
TE: 180ms
scan time: 1 min 
voxel: 1.25 x 1.25
TE: 280ms
scan time: 1.5 
min voxel: 1.25 x 
1.25
TE: 420ms
scan time: 2.25 
min min voxel: 
1.25 x 1.25
Figure 6.8: Changes in image quality as the TE increases with a voxel size of 1.25mm × 1.25mm × 2.5mm
At the shortest TE and longest TE (140ms and 420ms), the contrast between gray and white 
matter was reduced and a comparison between the voxel sizes 1.25mm × 1.25mm × 2.5mm 
and 1mm × 1mm × 2mm at TE 180 and 280ms was done (figure 6.9).
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TE: 180ms
scan time: 1 min
voxel:1.25 x 1.25
TE: 180ms
scan time: 1.25min
voxel: 1 x 1
TE: 280ms
scan time: 1.5 min
voxel:1.25 x 1.25
TE: 280ms
scan time: 1.5 min
voxel:1 x 1
Figure 6.9: Changes in image quality at TE 180 and 280 with voxel sizes 1.25mm × 1.25mm × 2.5mm and 1mm 
× 1mm × 2mm
The image contrast at TE 180ms provided the best image contrast between tissues whilst 
increasing signal to noise ratio, and didn’t translate to a significant increase in acquisition 
time. The final step was to acquire data using a TE of 180ms at a voxel size of 1mm × 1mm 
× 2mm and compare the efficacy of the automated segmentation programme at these 
parameters to the standard acquisition parameters.
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6.3.4 Changes in reconstruction quality across gestation
Reconstruction of a 24 week 
fetal brain with the standard 
parameters (voxel size = 1.25 
x 1.25 x 2.5, and TE = 140ms) 
on the left and with the new 
parameters (voxel size = 1 x 1 
x 2, and TE = 180ms on the 
right)
Reconstruction of a 30 week 
fetal brain with the standard 
parameters (voxel size = 1.25 
x 1.25 x 2.5, and TE = 140ms) 
on the left and with the new 
parameters (voxel size = 1 x 1 
x 2, and TE = 180ms on the 
right)
Reconstruction of a 30 week 
fetal brain with the standard 
parameters (voxel size = 1.25 
x 1.25 x 2.5, and TE = 140ms) 
on the left and with the new 
parameters (voxel size = 1 x 1 
x 2, and TE = 180ms on the 
right)
Figure 6.10: Visual appearance of reconstructed fetal brains (8 data loops) at 24, 30 and 36 weeks gestation, 
demonstrating increased image resolution and delineation between gray and white matter in the images acquired 
with the new parameters.
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At all three gestational ages, reconstruction of the fetal brain with the new  parameters 
resulted in better image contrast between the gray and white matter, and an increase in 
tissue definition. The automated segmentation programme was tested on all three 
gestational age groups at three levels: the top third of  the brain at the top of the ventricles, 
the middle third of the brain through the thalamus, and the bottom third of the brain through 
the cerebellum.
Figure 6.11: Application of the automated segmentation on a 24 week reconstructed fetal brain with the standard 
parameters on the top, and new parameters on the bottom. The black arrows in the top row point out areas of 
obvious improvement with the new acquisition parameters. The black arrows int he bottom row point out areas of 
obvious improvement with the old acquisition parameters.
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Figure 6.12: Application of the automated segmentation on a 30 week reconstructed fetal brain with the standard 
parameters on the top, and new parameters on the bottom. The black arrows in the top row point out areas of 
obvious improvement with the new acquisition parameters. The black arrows in the bottom row point out areas of 
obvious improvement with the old acquisition parameters.
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Figure 6.13: Application of the automated segmentation on a 36 week reconstructed fetal brain with the standard 
parameters on the top, and new parameters on the bottom. The poor gray : white matter contrast hinders the 
automated segmentation methods in both instances
At earlier gestations, image acquisition with the new  dynamic sequence parameters led to 
an improvement in the ability of the automated segmentation programme to delineate gray 
matter and white matter in some areas of  the image, but a worsening in other areas. 
However, the poor gray : white matter contrast at advanced gestation still hindered the ability 
of the use of automated segmentation methods that work based on signal intensity 
differences. 
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In the examples described above, the segmentation of both deep gray and cortical gray 
matter was included, however, the technique can be extended further through the application 
of a deep gray matter mask to enable volumetric quantification of the cortical gray matter 
alone (figure 6.14)
Figure 6.14: Application of a deep gray matter mask to enable volumetric quantification of the cortical gray matter
6.4 Discussion
This  pilot optimisation study demonstrated limited improvements in the application of 
an automated segmentation method when the new acquisition parameters  were 
used prior to reconstruction of fetal brain images up to 30 weeks gestation. At 36 
weeks gestation, the improvement in gray : white matter delineation was not 
sufficient to enable successful application of the automated segmentation 
programme. 
Further optimisation of the dynamic sequence, especially in fetuses at later 
gestations is required before the automated segmentation programme becomes  a 
routine part of all fetal MRI scans.   
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6.5 Summary
This  chapter describes the optimisation of the dynamic sequence acquisition and the 
application of automated segmentation approaches on the optimised image files. 
Due to time limitations, further optimisation of the sequence was not possible within 
the time frame of the PhD, however, this pilot study has highlighted possible 
approaches to improving data acquisition in fetal MRI.
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CHAPTER 7: STUDY OUTCOME
7.1 Introduction
Growth restricted fetuses are known to be at increased risk of perinatal demise, and of 
neonatal complications such as intraventricular haemorrhage, periventricular leucomalacia, 
respiratory distress syndrome, and necrotising enterocolitis 31-33. In the longer term, these 
children are at further risk of  developmental delay and behavioural problems 34. As part of 
this study, neonatal outcome data of all the fetuses recruited into the study was collected. 
7.2 Neonatal Outcome
7.2.1 Birthweight
A total of  30 growth restricted and 48 normally grown pregnancies were recruited into the 
study. 21 out of  the 30 growth restricted pregnancies resulted in a livebirth, and delivered at 
a mean gestational age of  32.1 weeks (range = 26.57 - 37.56), with a mean birthweight of 
1199g (range = 615 - 2346g). All of  the fetuses were delivered with a birthweight below  the 
5th centile on customised growth charts. The male : female ratio was 11 : 10.  Of these 21 
fetuses, 3 did not require admission to the neonatal unit (gestational ages = 36, 37, and 
37.56 weeks). Of  the 18 fetuses admitted to the neonatal unit, 3 did not survive to discharge 
(Gestation ages = 26.57, 27, and 29.86 weeks).
The mean gestational age at delivery among the normally grown pregnancies was 39 weeks 
(range = 34 - 43 weeks), with a mean birthweight of  3227g (range = 1956 - 4420g). The 
male : female ratio was 23 : 25. All of  the fetuses were delivered with a birthweight above the 
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5th centile on customised growth charts. None of  the fetuses required admission to the 
neonatal unit.
Figure 7.1 presents the outcome data of the fetuses in this study
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RP2163 IUGR-4 20.43 F 21.57 122 SB
ED2379 IUGR-4 20.86 ? 26 340 SB
PO1148 IUGR-3 22.28 F 23.86 332 SB
EM2248 IUGR-4 23.71 F 28.14 750 LB
ventriculomegaly, 
germinal matrix 
haemorrhage, 
jaundice, sepsis, 
pneumonia, 
hypoglycaemia, 
paralytic ileus
not yet 1 year
DCL1108 IUGR-4 23.86 M 25 400 TOP
FK784 IUGR-3 24 ? 24 SB
BP1104 IUGR-5 24 M 33 1160 LB
intraventricular 
haemorrhage, 
necrotising 
enterocolitis, 
ileostomy, sepsis
problems with language 
and independence
SR858 IUGR-6 24.57 M 36.28 LB declined
MB2396 IUGR-6 24.86 M 28 578 SB
SH1585 IUGR-3 25.43 M 34.86 1870 LB
jaundice, 
hypoglycaemia, 
transient 
tachypnoea of the 
newborn
normal
DD2494 IUGR-4 25.57 M 27 615 NND
periventricular 
flares, 
hypoglycaemia, 
necrotising 
enterocolitis
JS1014 IUGR-6 26.43 F 28 500 TOP
MZ1126 IUGR-2 26.43 M 28 526 SB
RM2265 IUGR-6 26.57 F 26.57 690 NND
hypoglycaemia, 
necrotising 
enterocolitis
HY577 IUGR-6 27.29 F 28 475 SB
AA1417 IUGR-4 27.57 M 27 815 LB
intraventricular 
haemorrhage, 
respiratory distress 
syndrome, 
hypoglycaemia
normal
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RV2322 IUGR-3 28 F 29.28 680 LB
germinal matrix 
haemorrhage, 
subependymal 
cysts, sepsis, 
hypoglycaemia, 
paralytic ileus, 
retinopathy of 
prematurity, skin 
infection
not yet 1 year
IR2293 IUGR-4 28 F 30.14 980 LB
germinal matric 
haemorrhage, 
periventricular 
flares, jaundice, 
hypoglycaemia
not yet 1 year
TB2481 IUGR-4 28 F 32 1020 LB ventriculomegaly, hypoglycaemia, not yet 1 year
SD1265 IUGR-3 29 F 33.14 1260 LB
periventricular 
flares, 
intraventricular 
haemorrhage
normal
CS2547 IUGR-4 29 M 31 1045 LB not yet 1 year
KN629 IUGR-4 29.14 F 29.86 690 NND
periventricular 
flares, sepsis, 
hypoglycaemia, 
thrombocytopenia, 
necrotising 
enterocolotis, bowel 
perforation, 
hepattis, renal 
dysfunction
BC1307 IUGR-4 31.56 M 32.56 1205 LB
respiratory distress 
syndrome, jaundice, 
sepsis, 
normal
ML2140 IUGR-5 32 M 32 1250 LB
periventricular 
flares, jaundice, 
hypoglycaemia, 
thrombocytopenia
not yet 1 year
RF2017 IUGR-3 32.28 F 37.56 1888 LB normal
FH932 IUGR-4 32.57 F 32.57 1300 LB normal
SS2546 IUGR-4 32.57 F 33 1340 LB not yet 1 year
NOD1107 IUGR-2 33 M 37 2346 LB declined
ZN598 IUGR-3 34.14 M 34.28 1062 LB
jaundice, 
hypoglycaemia, skin 
infection
language and visual 
problems
AO1174 IUGR-2 35.71 M 36 2032 LB normal
TR2508 Normal 23.86 F 39 3492 LB
CM1830 Normal 24.57 F 39.28 3240 LB
ER821 Normal 24.71 M 40 3342 LB
KM2381 Normal 24.71 F 40.28 3094 LB
LH1586 Normal 25 F 43 4420 LB
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AF2201 Normal 25.14 F 39 3228 LB
ABT1055 Normal 25.42 M 41.43 3196 LB
CC115 Normal 26.71 M 39.28 2790 LB
VTR1173 Normal 26.86 F 39.71 2868 LB
SN1206 Normal 27 F 34 1956 LB
PW2540 Normal 27 F 41.28 3610 LB
MW2429 Normal 27.42 M 38 2984 LB
LG2283 Normal 27.56 F 37 2496 LB
NM1935 Normal 27.57 F 40 3408 LB
TF2063 Normal 27.86 F 38 2942 LB
SA1901 Normal 28 F 41.14 3526 LB
AK2284 Normal 28.56 F 36.42 2178 LB
CK1101 Normal 29 F 39 3010 LB
FI2425 Normal 29 F 41.14 3856 LB
LD1149 Normal 29.14 M 37.14 2550 LB
KM1861 Normal 29.28 F 37.71 2602 LB
SOM2557 Normal 29.28 M 35 2360 LB
TD1382 Normal 29.43 M 36 2826 LB
CG1130 Normal 29.57 M 38 3394 LB
MU2312 Normal 29.71 M 39.28 2608 LB
SM2154 Normal 29.86 M 40 3600 LB
TB2159 Normal 29.86 M 40.43 3760 LB
MG2316 Normal 30.28 M 41 3168 LB
MW2313 Normal 30.28 F 38.71 3040 LB
FJ2351 Normal 30.42 M 41 3862 LB
CT2180 Normal 31.43 M 39 3450 LB
SG1999 Normal 31.71 F 39 3090 LB
KK1887 Normal 32.14 F 39 3420 LB
JT2493 Normal 32.14 F 37 3526 LB
SB2365 Normal 32.28 M 37 2910 LB
AP2401 Normal 32.57 M 29 3732 LB
JS1637 Normal 33 F 37 2920 LB
CR2339 Normal 34.14 F 38 3245 LB
MS2206 Normal 34.43 F 40 3606 LB
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Figure 7.1: Fetal outcome data
7.2.2 Neonatal Respiratory Complications
3 out of 21 growth restricted fetuses that were delivered alive suffered respiratory 
complications following birth. All three fetuses were male and delivered by Caesarean 
Section. 1 fetus delivered at 34.86 weeks gestation with a birth weight of  1870g developed 
transient tachypnoea of the newborn, while the other two fetuses delivered at 27 weeks and 
32.56 weeks gestation developed respiratory distress syndrome requiring respiratory 
support. The APGAR scores at 1 and at 5 minutes for these fetuses were 6 and 10, 9 and 9, 
and 6 and 9 respectively. 
The remaining 18 growth restricted fetuses did not develop respiratory distress syndrome, 
and were all born at a mean gestational age of 31.9 (range = 26.57 - 37.56). The average 
birthweight was 1182.8g (range = 615 - 2346g). The male : female ratio of these 18 fetuses 
was 8 : 10 (p = 0.07). 
AM2324 Normal 35.43 M 41 3232 LB
AH1973 Normal 35.85 M 40 2800 LB
LE2538 Normal 35.85 M 41 3289 LB
NH2116 Normal 36 F 40.8 3685 LB
KO1992 Normal 36 M 40 3024 LB
LV2560 Normal 36.14 M 41 3520 LB
CB1327 Normal 36.28 F 41 4398 LB
NS1953 Normal 37 M 41 4016 LB
CF1671 Normal 37.71 F 40 3664 LB
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7.2.3 Neonatal Metabolic Complications
12 out of  21 growth restricted fetuses that were delivered alive suffered neonatal 
hypoglycaemia that required treatment with a dextrose infusion. These twelve fetuses were 
delivered at a mean gestational age of 30.61 weeks (range = 26.57 - 36.28), with a mean 
birthweight of 947.45g (range = 615 - 1870g). The 9 fetuses that did not develop neonatal 
hypoglycaemia were delivered at a mean gestational age of 33.98 weeks (range = 31 - 
37.56), p = 0.008 when compared to the fetuses that developed hypoglycaemia, and with a 
mean birthweight of 1508g (range = 1045 - 2346), p = 0.003 when compared to the fetuses 
that developed hypoglycaemia.
7 out of 21 growth restricted fetuses that were delivered alive suffered neonatal jaundice 
requiring phototherapy. These 7 fetuses were delivered at a mean gestational age of  32.60 
(range = 28.14 - 36.28). The mean birthweight was 1186g (range = 750 - 1870g). The 
remaining 14 growth restricted fetuses that did not develop neonatal jaundice were delivered 
at a mean gestational age of  31.78 weeks (range = 26.57 - 37.56), with a birthweight of 
1205g, (range = 615 - 2346g). 
 
7.2.4 Neonatal Sepsis
6 out of 21 growth restricted fetuses that were delivered alive developed sepsis that 
required treatment with antibiotics. These 6 fetuses were born at a mean gestational age of 
31.18 (range = 28.14 - 34.28). The mean birthweight at delivery was 924.5g (range = 680 - 
1205g).
The 15 growth restricted fetuses born alive that did not develop sepsis postnatally were 
delivered at a mean gestational age of 32.4weeks (range = 26.57 - 37.56), with a mean 
birthweight of 1317g (range = 615 - 2346g).
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7.2.5 Neonatal Gastrointestinal Complications 
2 out of 21 growth restricted fetuses that were delivered alive developed a paralytic ileus 
that resolved after feeds were withheld.  These two fetuses were born at 28.14 and 29.28 
weeks gestation, with a birthweight of 750 and 680g respectively.
A further 4 out of  21 growth restricted fetuses that were delivered alive developed 
necrotising enterocolitis that resulted in death in three cases. These three fetuses had been 
delivered at 26.57, 27, and 27.81 weeks, with a mean birthweight of 665g (range = 615 - 
690g). The one fetus that survived had been delivered at 33 weeks with a birthweight of 
1160g, and a defunctioning ileostomy was performed following development of NEC.
The 15 growth restricted fetuses born alive that did not develop gastrointestinal 
complications postnatally were delivered at a mean gestational age of  33.29 (range = 27 - 
37.56), with a mean birthweight of 1386g (range = 815 - 2346g).
7.2.6 Intracranial Complications
8 out of 21 growth restricted fetuses that were delivered alive had evidence of abnormal 
findings on neonatal imaging undertaken with either cranial ultrasound or neonatal MRI. Of 
these 8 fetuses, the first born at 27 weeks gestation had evidence of  grade 1 intraventricular 
haemorrhage, the second born at 28.14 weeks gestation had mild ventriculomegaly and 
evidence of  germinal matrix haemorrhage, the third born at 29.28 weeks gestation had 
evidence of germinal matrix haemorrhage and subependymal cysts, the fourth born at 30.14 
weeks gestation had evidence of germinal matrix haemorrhage, the fifth born at 32 weeks 
had mild ventriculomegaly, the sixth born at 33 weeks had grade 2 intraventricular 
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haemorrhage, the seventh born at 33.14 weeks had grade 1 intraventricular haemorrhage, 
and the eight born at 36.28 weeks had subependymal cysts on MR imaging. 
Long term follow  up at 1 year was available for the sixth and seventh of these fetuses, with 
deficiencies with language and independent playing in one and normal neurodevelopmental 
assessment in the other. Of the remaining fetuses, 5 were not yet 1 year at the time of  the 
project being written up, and one declined long term follow up.
7.3 Perinatal Mortality
7.3.1 Stillbirths
7 out of 30 growth restricted pregnancies recruited into this study resulted in intrauterine 
death. In all cases stillbirth was the result of an consultant led decision for conservative 
management (following lengthy discussions with the parents) not to intervene until the 
pregnancy reached a stage where the long term prognosis for the infant was one that was 
acceptable to the parents. Unfortunately in these cases fetal demise occurred prior to the 
fetus reaching a gestation or estimated fetal weight that was above the threshold that had 
been agreed from these discussions. 
The mean gestational age at fetal death was 25.63 weeks (range = 21.57 - 28 weeks). The 
mean birthweight was 395.5g (range = 122g - 578g). The severity of fetal growth restriction 
at the time of the last ultrasound scan was venous Doppler abnormalities in all cases. 
Postmortem examination was performed in 3 fetuses, and demonstrated no additional 
abnormalities apart from those associated with oligohydramnios due to fetal growth 
restriction and placental histopathological changes associated with fetal growth restriction. 
Postmortem examination was declined by 4 patients.
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7.3.2 Termination of pregnancy
Termination of pregnancy by intracardiac injection of  Potassium Chloride was performed in 2 
out of 29 growth restricted pregnancies recruited into this study. The decision to perform 
termination of  pregnancy was not taken lightly and was a consultant led decision that was 
reached following lengthy discussions with the parents on more than 1 occasion. Input was 
also sought from the paediatric team regarding likely long term prognosis for these children 
prior to termination of pregnancy.
Both cases demonstrated severe fetal growth restriction with anhydramnios,  and evidence 
of venous Doppler changes, one at 25 and another at 28 weeks gestation, with an estimated 
fetal weight of 400 and 500g respectively. Postmortem examination was declined by the 
parents of  the first fetus. Postmortem examination was performed in the second of these 
fetuses and demonstrated no additional abnormalities apart from those associated with 
oligohydramnios due to fetal growth restriction..
7.3.3 Neonatal Death
1 out of 21 growth restricted fetuses that were delivered alive resulted in an early neonatal 
death at 7 days of  age. The pregnancy was in a nulliparous mother with evidence of pre-
eclampsia and no other complications of pregnancy. This female fetus was delivered at 
26.57 weeks gestation by elective Caesarean Section with a birthweight of 690g. The last 
ultrasound scan showed evidence of  venous Doppler abnormalities. Her APGAR scores 
were 5 and 4 at 1 and at 5 minutes. Her neonatal course was uncomplicated until she 
developed necrotising enterocolitis and bowel perforation at 6 days of age. Despite intensive 
care and resection of  the infarcted bowel, her condition worsened and intensive care was 
withdrawn at day 7 of life following discussion with the parents.
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7.3.4 Infant Death
2 out of  21 growth restricted fetuses that were delivered alive resulted in an infant death. 
The first of these was at 29 days of age. This pregnancy was to a nulliparous mother and 
was not complicated by pre-eclampsia or other complications of pregnancy. This male fetus 
was delivered at 27 weeks gestation by elective caesarean section with a birthweight of 
615g. His APGAR scores at 1 and at 5 minutes were 8 and 9. His neonatal course was 
complicated initially by difficulties achieving control in his glucose levels, and finally by the 
development of necrotising enterocolitis at day 28 of life. Although arrangements had been 
made for transfer to a neonatal surgical unit, his condition deteriorated prior to transfer and 
care was withdrawn at day 29 of life following discussion with the parents.
1 out of 21 growth restricted fetuses that were delivered alive resulted in an infant death at 
44 days of  age. The pregnancy was in a multiparous mother and was complicated by fetal 
growth restriction with no accompanying pre-eclampsia. The previous pregnancy had been 
uncomplicated and resulted in a delivery at term. This male fetus was delivered at 29.86 
weeks gestation by elective Caesarean Section with a birthweight of 690g. The last 
ultrasound scan had showed reversed end diastolic flow  in the umbilical artery. His  APGAR 
scores at 1 and at 5 minutes were 7 and 4. 
His neonatal course was complicated by the presence of neonatal hypoglycaemia, sepsis 
requiring antibiotics, thrombocytopenia and anaemia requiring blood transfusions, the 
presence of periventricular flares on cranial ultrasound, hepatitis of unknown origin, renal 
failure, and bowel perforation secondary to necrotising enterocolitis resulting in infant death.
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7.4 Long term outcome data
9 out of the 18 growth restricted fetuses that survived to discharge attended for 
neurodevelopmental assessment at 1 year. Of the remaining 9 fetuses, 7 had provisionally 
agreed to long term follow  up but were not yet 1 year of  age at the time of the project being 
written up. The parents of the other 2 fetuses declined long term follow up.
Neurodevelopmental assessment at 1 year was normal in all but 2 fetuses. The first of  these 
fetuses was a fetus delivered at 33 weeks that developed a grade 2 intraventricular 
haemorrhage in the neonatal period. Assessment at 1 year showed deficiencies in language 
and independent playing.
The second of  these fetuses was delivered at 34.28 weeks gestation. The neonatal period 
was complicated only by neonatal jaundice, hypoglycaemia, and the development of a skin 
infection from a cannula site. Assessment at 1 year showed deficiencies in language and 
visual perception.
7.5 Discussion
7.5.1 Increased risk of poor APGAR scores at birth in growth restricted fetuses
Fetal growth restriction is a progressive disease. Fetal auto-regulatory mechanisms put into 
effect a re-distribution of the fetal circulation to ensure continual supply to the vital organs. 
However, chronic fetal hypoxaemia leads to decompensation and eventually to circulatory 
failure 187. These hypo-perfused, under nourished fetuses have few  reserves and are poorly 
equipped to deal with further oxygen deprivation during labour and delivery. Consequently, 
they are often born in poor condition and have low  APGAR scores at birth. These neonates 
are also inadequately prepared for the stresses of  neonatal life, and often succumb to the 
complications of prematurity, leading to the increased incidence of neonatal death.
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7.5.2 Increased risk of ICH in growth restricted fetuses
The hypoxic ischaemic and haemorrhagic lesions found in neural tissue of infants with fetal 
growth restriction corresponds to the alterations in the structure and composition of neural 
tissue as a result of  cellular, metabolic, and vascular responses that are part of the attempt 
to maintain homeostasis in the presence of  chronic hypoxia. This leads to a predisposition to 
white matter injury in the form of echodensities, periventricular leucomalacia, and 
haemorrhagic intraventricular lesions. 
In the normal fetus, the cerebral arteries are capable of  undergoing autoregulation to 
preserve cerebral blood flow  and function in the presence of  hypoxia 188. The growth 
restricted fetus however, is believed to have a hypotensive cerebral circulation, which 
reduces the fetus’s ability to compensate to the changes in blood pressure that occur in the 
neonatal period. This decompensation of the autoregulatory mechanism in cerebral 
circulation may be the cause of the increased incidence of ICH in growth restricted neonates 
189.
7.5.3 Increased risk of sepsis and NEC in growth restricted fetuses
Growth restricted neonates have been shown to have compromised humoral and cellular 
immunocompetence as well as neutropenia190. All these factors contribute to the added risk 
of sepsis, and of infections such as NEC. NEC is the most common potentially fatal 
gastrointestinal emergency in neonates. 
As a result of cerebral redistribution, blood flow  is also diverted away from the splanchnic 
beds in the growth restricted fetus. Cardiovascular instability and fluctuations in volume 
status and oxygen delivery following delivery of  the growth restricted preterm fetus leads to 
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reperfusion injury and the induction of inflammatory cascades 191. This in combination with 
the chronic hypoxia may lead to hypoxic-ischaemic injury to the gastrointestinal mucosa 
even before birth, or to an alteration in mucosal function, both of which could increase the 
susceptibility of these neonates to episodes of NEC192.
The ischaemic intestinal wall is also further predisposed to bacterial penetration which 
further compromises the integrity of the tissue, amplifying the inflammation and vascular 
damage that occurs, resulting in necrotising enterocolitis.
7.5.4 Increased risk of RDS in growth restricted fetuses
The chronic hypoxic and hypo-perfusion state in fetal growth restriction results in a 
dysfunction of  the alveolar-capillary membrane in the lung, making it leak in response to 
hypoxia and ischaemia193. Animal models of  fetal growth restriction have also shown 
decreased lung development and function as part of the disease process194. Animal models 
of fetal growth restriction have also shown a reduction in in the thickness of the walls of the 
larger airways, reduced glucose transport to the lung, as well as reduced oxygen delivery to 
the lung due to redistribution of  cardiac output and the reduction in pulmonary blood flow. 
These factors may explain the compounding of RDS risk in preterm neonates who are 
already vulnerable as a result of structural immaturity and surfactant insufficiency 195.
7.5.5 Increased risk of metabolic complications in growth restricted fetuses
The redistribution phenomenon and asymmetric fetal growth results in a reduction in 
umbilical venous flow  as a result of a reduction in fetal cardiac output to the placenta. This 
reduction in umbilical venous flow  leads to increased ductus venosus shunting away from 
the liver towards the heart. There is also a concurrent redistribution of intrahepatic flow  away 
from the right lobe of the liver, which is associated with downregulation of the glucose-
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insulin-IgF growth axis, and decreased glycogen stores in the liver196. In combination, these 
factors lead to the predisposition of growth restricted fetuses towards neonatal 
hypoglycaemia and metabolic complications.
7.6 Summary
This Chapter details the short term and some long term outcome data of the fetuses 
recruited into this study. The collection of long term outcome data was performed at 1 year of 
age and as a result it was an incomplete dataset as not all fetuses had reached a year at the 
end of the study period. 
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CHAPTER 8: META-ANALYSIS OF THE OUTCOME OF PRETERM GROWTH 
RESTRICTED FETUSES
8.1 Introduction
Preterm growth restricted fetuses are at increased risk of  perinatal mortality, and of neonatal 
complications such as respiratory distress syndrome, sepsis, necrotising enterocolitis, and 
intraventicular haemorrhage when compared to their normally grown counterparts 197, 198. 
Quantification of this risk is difficult due to the small size of  many studies and the lack of 
appropriate controls. In addition, the data from previous studies is compromised by 
variations in the definition of fetal growth restriction, and the confounding effect of 
prematurity. The clinical relevance of many older studies to modern practice is also obviated 
by advances in neonatal intensive care, the use of  surfactant and antenatal steroids, as well 
as improvements in ventilation strategies.
The primary aim of  this meta-analysis was to quantify the perinatal risks of preterm (<37 
weeks) growth restricted fetuses when compared with an appropriately grown preterm 
cohort.  The secondary aim was to perform a meta-regression and detect the additional 
effects of  gestational age at birth and the severity of  fetal Doppler abnormality on specific 
neonatal outcomes.
This meta-analysis was undertaken as part of  this thesis due to a paucity of outcome data in 
preterm growth restricted fetuses with severe Doppler abnormalities such as those studied in 
this thesis.
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8.2 Materials and Methods
Search Strategy
The Meta-Analysis of  Observational Studies in Epidemiology (MOOSE) consensus 
statement was followed199.
Studies were identified using a variety of techniques including bibliographic searches and 
reviews of  references of appropriate articles. The first search strategy was to identify studies 
that assessed the outcome of preterm growth restricted fetuses. The Medline Database 
(1966 through December 2009) was searched using the exploded MESH terms 
‘Ultrasonography’ AND ‘Fetal Growth Retardation’ as the first search, and the exploded 
MESH terms ‘Ultrasonography’’ AND ‘Infant Premature’ as the second search. To ensure 
comprehensive retrieval of all relevant articles, a search for recent studies that had not been 
indexed on PubMed was done using the keywords ‘Doppler’ AND ‘growth’. All searches were 
restricted to those published from 1997 onwards to ensure a reasonably contemporary 
cohort with relatively standardised neonatal care. The reference sections of  all included 
studies were also searched manually for other relevant studies. 
The second search strategy was to identify studies that reported the outcome of normally 
grown preterm fetuses.  Published studies on the Medline Database (1966 through 
December 2009) were searched using the exploded MESH terms (‘Infant Premature’ OR 
‘Infant Premature, Diseases’ OR ‘Obstetric Labour, Premature’) AND (‘Infant, Small for 
Gestational Age’ OR ‘Fetal Growth Retardation’). Again, all searches were restricted to those 
published from 1997 onwards, and the reference section of all included studies was 
searched manually. Studies identified from the first strategy, which had an appropriate cohort 
of fetuses with no fetal growth restriction were included.
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Two reviewers (M.D and S.K) independently screened the titles and abstracts of  the studies 
that were identified. Full text articles were obtained for relevant studies, and both reviewers 
independently assessed whether or not the studies met the inclusion criteria. Disagreements 
were resolved by discussion. Further information was sought from the authors where papers 
contained insufficient information to make a decision about eligibility or quality of the study. 
No identified papers were in languages other than English.
Study Selection
Observational, case-control and cohort studies investigating the outcomes of interest from 
the first search strategy were included only if  the study cohort consisted of preterm 
(<37weeks) growth restricted fetuses with clearly documented antenatal Doppler 
abnormalities. This was done to ensure that only true growth restricted fetuses were 
included. Studies were excluded if they included multiple gestations, and fetuses were 
identified as having structural abnormalities or aneuploidy. They were also excluded if the 
gestational age range was not defined, or the mean gestational age + 2 standard deviations 
was greater than 37 weeks.
Case-control and cohort studies from the second search strategy were included if  the study 
cohort was preterm fetuses with no fetal growth restriction. Studies were again excluded if 
the gestational age range was not defined, and the mean gestational age + 2 standard 
deviations was greater than 37 weeks.
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Data Extraction  
A data collection spreadsheet was used to collect raw  data. All data was coded into a pre-
designed data collection spreadsheet. Study information including demographic data, year of 
study, potential confounding factors and summarised outcome data were also collected. 
Increasing severity of  fetal growth restriction was graded by the presence of abnormal 
umbilical artery Doppler indices, absent or reversed end diastolic flow  in the umbilical artery, 
and the presence of venous Doppler abnormalities. 
Outcome Measures
The perinatal outcome measures that were investigated were intrauterine and neonatal 
death (IUD and NND), APGAR scores at 5 minutes <7, and the incidence of neonatal 
complications, namely intracranial haemorrhage (ICH), sepsis, necrotising enterocolitis 
(NEC) and respiratory complications. Table 8.1 details the total sample size and incidence 
for each outcome.
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Outcome
Studies of 
preterm fetuses 
with fetal growth 
restriction  
(n; ref)
Total 
preterm 
fetal 
growth 
restricted 
fetuses (n)
Affected 
preterm 
fetal 
growth 
restricted 
fetuses (n) 
Studies of 
preterm fetuses 
without fetal 
growth 
restriction
(n; ref)
Total 
preterm 
normally 
grown 
fetuses 
(n)
Affected 
preterm 
normally 
grown 
fetuses 
(n)
Intrauterine 
Death (IUD)
8;
200, 203-206, 229-231 461 47 - - -
Neonatal Death 
(NND)
11; 
198, 200-202, 204-208, 229, 
231
1419 252
8;
198, 212, 216, 217, 223, 
224, 232, 233
494893 3924
APGAR <7 at 5 
min
8; 200-202, 204, 206, 208, 
209, 229 1175 319
5;
217, 223-226 2920 443
Intracranial 
Haemorrhage 
(ICH)
13;
198, 200-211 1348 200
16;
32, 198, 203, 212-224 174235 6301 
Sepsis 5;200, 201, 207, 208, 210 393 117
5;
213, 215, 216, 220, 224 9190 253
Necrotising 
Enterocolitis 
(NEC)
7;
200-202, 205, 206, 208, 209 1001 120
12;
32, 212-218, 221-224 173847 2815
Respiratory 
Complications 
10;
200, 201, 203, 205-211 516 233
13;
32, 203, 212-217, 221, 
223-226
153807 17798
Table 8.1: Outcome Measures studied
There was a degree of variability in the definition of some of  the outcome measures. In the 
case of  intracranial haemorrhage, three studies of  preterm fetuses with fetal growth 
restriction198, 200, 201 defined it as any of  Papile’s grades of ICH, one 202 defined it as Papile’s 
grades 3 and 4, one 203 according to the criteria of  the Vermont Oxford Network Database, 
and the remaining eight 204-211 failed to define the criteria used. Among the studies 
investigating outcome in preterm fetuses without fetal growth restriction, five 198, 212-215 
defined it as any of  Papile’s grades of  ICH, seven 216-222 defined it as Papile’s grades 3 and 
4, one 203 according to the criteria of  the Vermont Oxford Network Database, and the 
remaining three 32, 223, 224 failed to define the criteria used.  
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In the case of sepsis, one study of  preterm fetuses with fetal growth restriction207 defined it 
as the presence of a positive blood culture in addition to clinical signs, one 210 as the 
presence of  early onset sepsis, two 200, 201 as the presence of septicaemia, and one 208 failed 
to define the criteria used. Of the studies investigating outcome in preterm fetuses without 
fetal growth restriction, two 216, 224 defined it as the presence of  a positive blood culture, one 
215 by the presence of septicaemia, pneumonia or meningitis, one 220 by clinical suspicion 
alone, and one 213 as the presence of a positive blood culture or white cell differential in the 
presence of a clinical suspicion. 
In the case of necrotising enterocolitis, one study of preterm fetuses with fetal growth 
restriction 202 defined it as the presence of  clinical and radiological signs. The other studies 
200, 201, 205, 206, 208, 209 failed to explain their diagnostic criteria.  Of the studies investigating 
outcome in preterm fetuses without fetal growth restriction, two 221, 223 defined it as the 
presence of Bell’s criteria 2 and above, one212 by any of Bell’s criteria, one 222 by the need 
for medical or surgical treatment, one 216 by the need for surgical treatment, one 219 by the 
presence of  one clinical and one radiological sign, and the others 32, 213, 215, 217, 218, 224 did not 
define the criteria used.
In the case of respiratory complications, three studies of preterm fetuses with fetal growth 
restriction 200, 201, 211 defined it as the need for intubation, one 207 as the presence of clinical 
and radiological signs and six 203, 205, 206, 208-210 failed to define the criteria used. Among the 
studies investigating outcome in preterm fetuses without fetal growth restriction, six 212-214, 
221, 224, 225 defined it by the presence of  clinical and radiological signs, two 217, 223 by the 
presence of  radiologic criteria, one 216 by the need of  mechanical ventilation in the first 24 
hours, and four 32, 203, 215, 226  failed to define the criteria used.
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Quality Assessment
Two reviewers (M.D and S.K) performed quality assessment of the studies independent of 
each other, based on the Cochrane Handbook for Systematic Reviews of  Interventions 227. 
Disagreements were resolved by discussion. Performance, attrition, and detection bias were 
not felt to have had a major influence on any of the studies. 
Statistical Analysis
Statistical analysis was done with the R statistical language 228, by a senior statistician (Dr. 
Elena Kulinskaya, director of the Statistical Advisory Service of Imperial College London).
Statistical heterogeneity was assessed with the Cochran Q test. A significant amount of 
heterogeneity was found in the meta-analysis for each outcome (data not shown) mainly due 
to differences in gestation. Because of this, a meta-regression analysis was performed as it 
allowed the amplification of regression techniques for the prediction of study outcomes so 
that the relationship of other variables of  interest could be evaluated. This allowed the effects 
of several variables in combination to be correlated and corrected for.
The objective of  this study was to compare perinatal outcome of preterm fetuses with fetal 
growth restriction with that of preterm fetuses with no evidence of fetal growth restriction. 
The dependent variable was the variance stabilized risk of an outcome. The factor of  interest 
was ‘type’ (FGR vs. non-FGR), and, where possible, ‘severity’ (arterial Doppler abnormalities 
alone vs. both arterial and venous Doppler abnormalities). The ‘gestation from’ and 
‘gestation to’ from each study were used as the two covariates (confounding variables). 
Following meta-regression analysis, the predicted risk for each outcome for the gestational 
age ranges ≥24 to <28 weeks, ≥28 to <32 weeks, and ≥32 to ≤37 weeks were calculated. 
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Publication bias  
The standard methods of  checking for publication bias, such as a funnel plot, are not 
appropriate when the covariates, such as the gestation limits in this study, could affect the 
effect size. Although publication bias could exist in comparative studies included in this 
paper, this was difficult to ascertain. 
8.3 Results
Description of Studies  
Sixteen studies 198, 200-211, 229-231 involving 1611 premature fetuses with fetal growth restriction 
defined by the presence of Doppler abnormalities (Table 8.2) were identified. The criteria for 
Doppler abnormalities were variable- two studies 202, 209 had cohorts with a raised umbilical 
artery pulsatility index, seven studies 200, 201, 203, 207, 210, 211, 230 had cohorts with absent or 
reversed end diastolic flow, two studies 198, 231 had multiple cohorts with both increased 
umbilical artery pulsatility index or S/D ratio, as well as absent or reversed end diastolic flow 
in the umbilical artery, four studies 204, 205, 208, 229 had multiple cohorts with abnormal umbilical 
artery Dopplers (raised pulsatility index in one study and absent or reversed end diastolic 
flow  in three studies) as well as venous Doppler abnormalities, and one study206 had a 
cohort with venous Doppler abnormalities.
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Study Name Definition of IUGR Cohort Year N Gestational Age
Baschat et al.202 
2007
Abnormal Umbilical Artery 
Dopplers 2000-2006 604 24 - 32
Mari et al.231 2007 Abnormal Umbilical Artery Dopplers & AREDF - 29 24 - 33
Gerber et al.200 2006 AREDF 1990 - 1997 62 24 - 37
Malhotra et al.210 
2006 AREDF 2001 - 2005 35 24 - 37
Cosmi et al.2292005
Abnormal Umbilical Artery 
Dopplers & Venous Doppler 
Abnormalities
2001 - 2004 145 26 - 32
Schwarze et al.204 
2005
AREDF & Venous Doppler 
Abnormalities 1999 - 2004 74 24 - 34
Spinillo et al.198 
2005
Abnormal Umbilical Artery 
Dopplers & AREDF 1994 - 2000 178 24 - 35
Sezik et al.207 2004 AREDF 1997 - 2000 32 28 - 35
Madzali et al.230 
2002 AREDF - 45 25 - 36
Muller et al.205 2002 AREDF & Venous Doppler Abnormalities 1996 - 2001 34 25 - 37
Gramellini et al.209 
2001
Abnormal Umbilical Artery 
Dopplers 1998 - 1999 27 28- 37
Sterne et al.211 2001 AREDF 1996 - 1998 8 24 - 34
Ozcan et al.206 1998 Venous Doppler Abnormalities 1994 - 1997 12 27 - 32
Hartung et al.203 
2005 AREDF - 60 24 - 34
 Alves et al.208 2008 AREDF & Venous Doppler Abnormalities 1997 - 2004 103 25 – 36
Yildirim et al.201 
2008 AREDF 2002 - 2006 163 30 - 32
Table 8.2: Characteristics of Included Studies of preterm fetuses with fetal growth restriction
Twenty studies 32, 198, 203, 212-226, 232, 233 involving 659439 premature fetuses without fetal 
growth restriction were included (Table 8.3). Two of these studies198, 203 also had cohorts of 
premature growth restricted fetuses with Doppler abnormalities that were used in the 
analysis. The definition of not having fetal growth restriction varied between studies, with 
eleven 198, 212, 214, 217, 219, 220, 222-224, 226, 232 defining being normally grown as being at least over 
the 10th centile, two 216, 233 defining it as being between the 25th and 75th centile, three 215, 
218
221, 225 defining it as being above the lower limit of  the 95% Confidence Interval of the mean, 
and four 32, 203, 213, 218 failing to define it.
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Study Name Definition of AGA Cohort Year N Gestational Age
Lee et al.232 2006 10 – 90th Centile 1999 - 2000 481540 26 - 36
Spinillo et al198 2005 >10th Centile 1994 - 2000 234 24 - 35
Aucott et al.218 2004 - 1991 - 1998 41 24 - 32
Garite et al.222 2004 10th - 90th Centile 1997 - 2001 22798 23 - 34
Gilbert et al.32 2003 - 1994 - 1996 119482 26 - 37
Regev et al.221 2003 Above lower limit of 95% CI of mean 1995 - 1999 2358 24 - 31
Reiss et al.217 2003 >10th Centile 1990 - 1996 1182 24 - 32
Zaw et al.212 2003 10th - 90th Centile 1993 - 2001 857 25 - 34
Bernstein et al.214 2000 >10th Centile 1991 - 1996 18039 25 - 30
Gutbrod et al.220 2000 >10th Centile 1985 - 1986 230 25 - 37
Simchen et al.224 2000 10th - 90th Centile 1994 - 1997 209 27 - 36
Bardin et al.213 1997 - 1983 - 1992 147 24 - 27
Cooper et al.219 1997 >10th Centile - 74 30 - 32
Gortner et al.223 1999 >10th Centile 1995 - 1996 258 27 - 32
Ley et al.225 1997 Above lower limit of 95% CI of mean 1985 - 1994 596 25 - 33
McIntire et al.216 1999 25th - 75th Centile 1988 - 1996 8594 24 - 36
Strauss et al.226 1997 > 10th Centile 1985 675 27 - 35
Amin et al.215 1997 Above lower limit of 95% CI of mean 1985 - 1989 62 25 – 33
Hartung et al.203 2005 - - 44 24 - 34
Lal et al. 2007233 25th - 75th Centile 1995 - 1999 2019 24 - 32
Table 8.3: Characteristics of Included studies of preterm fetuses without fetal growth restriction
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Meta-Regression Analysis: Gestational Age
The predicted risk and confidence intervals for 3 gestation subgroups (≥24 - <28 weeks, ≥28 
- <32 weeks, ≥32 - ≤37 weeks) for fetuses with and without fetal growth restriction for all 
perinatal outcomes of  interest are tabulated in Table 8.4. The difference in risk of adverse 
outcome between both groups was significant (p<0.01) for all outcomes. This difference was 
also significant among the gestational age groups for all outcomes (p<0.01). As expected, 
the risk of  adverse outcome decreased as gestation increased, however, this was to a lesser 
extent in the fetal growth restricted group, resulting in a relative multiplication of risk. 
Outcome Group
≥24 - <28 w 
Risk
(95% C.I)
≥28 - <32 w 
Risk
(95% C.I)
≥32 - <37 w 
Risk
(95% C.I)
p (IUGR 
vs. AGA)
p 
(gestation 
limits)
NND
IUGR 21.8%(19.7 – 24.0)
15.5%
(13.6 – 17.4)
9.5%
(8.0 – 11.1)
<0.01 <0.01
AGA 6.1%(5.8 – 6.3)
2.8%
(2.7 – 2.9)
0.6%
(0.5 – 0.7)
APGAR <7 at 
5min
IUGR 38.6(34.2-43.2)
25.0
(22.4-27.7)
12.0
(8.4-16.1)
<0.01 <0.01
AGA 25.6(21.6-29.8)
14.0
(11.5-16.6)
4.5
(2.3-7.4)
ICH
IUGR 32.0%(29.5 – 34.6)
14.8%
(12.9 – 16.7)
2.1%
(1.4 – 3.0)
<0.01 <0.01
AGA
19.6%
(19.1 – 20.2)
6.2%
(6.1 – 6.4)
0.0%
(0.0 – 0.0)
Sepsis
IUGR 42.1%(32.7 – 51.9)
40.3%
(35.1 – 45.7)
34.9%
(26.6 – 43.7)
<0.01 <0.01
AGA 16.9%(11.5 – 23.1)
15.5%
(11.8 – 19.7)
11.7%
(5.7 – 19.6)
NEC
IUGR 20.5%(18.1 - 23.1)
11.6%
(9.7 – 13.7)
4.1%
(3.0 – 5.5)
<0.01 <0.01
AGA 8.1%(7.7 – 8.5)
2.8%
(2.7 – 2.9)
0.1%
(0.0 – 0.1)
Respiratory 
complications
IUGR 75.6%(71.7 – 79.2)
53.4%
(49.0 – 57.7)
26.7%
(23.0 – 30.6)
<0.01 <0.01
AGA 41.3%(40.6– 42.0)
20.0%
(19.7 – 20.2)
3.5%
(3.3 – 3.6)
Table 8.4: Predicted risk of outcomes with 95% confidence limits by Gestational Age resulting from meta-
regression
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The incidence of  NND was investigated in eleven studies involving fetuses with fetal growth 
restriction 198, 200-202, 204-208, 229, 231 (n = 1419) and eight studies 198, 212, 216, 217, 223, 224, 232, 233 
involving fetuses without fetal growth restriction (n = 494893). The risk of NND was 
approximately 3.5 × higher (21.8 vs. 6.1%) from ≥24 - <28 weeks, 5.5 × higher (15.5 vs. 
2.8%) from ≥28 - <32 weeks, and 15.8 × higher (9.5 vs. 0.6%) from ≥32 - <37 weeks in the 
fetuses with fetal growth restriction. 
Low  APGAR scores (<7 at 5 minutes) was investigated in eight studies involving fetuses with 
fetal growth restriction 200-202, 204, 206, 208, 209, 229 (n = 1175) and five studies involving fetuses 
without fetal growth restriction 217, 223-226 (n = 2,920). The risk of  low  APGAR scores at 5 
minutes was approximately 1.5 × higher (38.6 vs. 25.6%) from ≥24 - <28 weeks, 1.7 × higher 
(25.0 vs. 14.0%) from ≥28 - <32 weeks, and 2.6 × higher (12.0 vs. 4.5%) from ≥32 - <37 
weeks in the fetuses with fetal growth restriction. 
Thirteen studies involving fetuses with fetal growth restriction 198, 200-211 (n = 1348) 
investigating the incidence of ICH were compared with sixteen studies involving fetuses 
without fetal growth restriction 32, 198, 203, 212-224 (n = 174235). The risk of ICH was 
approximately 1.6 × higher (32.0 vs. 19.6%) from ≥24 - <28 weeks, 2.3 × higher (14.8 vs. 
6.2%) from ≥28 - <32 weeks, and 2.1 × higher (2.1% vs. 0.0%) from ≥32 - <37 weeks in the 
growth restricted group. 
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Figure 8.2: Risk of Intracranial Haemorrhage in Growth Restricted and Normally Grown Preterm Fetuses across 
Gestation (mean and 95% C.I. depicted)
Five studies involving fetuses with fetal growth restriction 200, 201, 207, 208, 210 (n = 393) and five 
studies involving fetuses without fetal growth restriction 213, 215, 216, 220, 224 (n = 9190) 
assessed the incidence of sepsis during the neonatal period. The risk of sepsis was 
approximately 2.4 × higher (42.1 vs. 16.9%) from ≥24 - <28 weeks, 2.6 × higher (40.3 vs. 
15.5%) from ≥ 28 - <32 weeks, and 2.9 × higher (34.9% vs. 11.7%) from ≥32 - <37 weeks in 
the growth restricted group. 
Seven studies involving fetuses with fetal growth restriction 200-202, 205, 206, 208, 209 (n = 1001) 
and twelve studies involving fetuses without fetal growth restriction 32, 212-218, 221-224 (n = 
173847) investigated the incidence of NEC. The risk of  NEC was approximately 2.5 × higher 
Normally Grown 
Preterm fetuses
Growth Restricted 
Perterm Fetuses
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(20.5 vs. 8.1%) from ≥24 - <28 weeks, 4.1 × higher (11.6 vs. 2.8%) from ≥28 - <32 weeks, 
and 41 × higher (4.1 vs. 0.1%) from ≥32 - <37 weeks in the growth restricted group.
Respiratory complications were investigated in ten studies involving fetuses with fetal growth 
restriction 200, 201, 203, 205-211 (n = 516) and thirteen studies involving fetuses without fetal 
growth restriction 32, 203, 212-217, 221, 223-226 (n = 153807). The risk of respiratory complications 
was approximately 1.8 × higher (75.6 vs. 41.3%) from ≥24 - <28 weeks, 2.6 × higher (53.4 
vs. 20.0%) from ≥28 - <32 weeks, and 7.6 × higher (26.7 vs. 3.5%) from ≥32 - <37 weeks in 
the growth restricted group. 
Meta Regression Analysis: Severity of fetal growth restriction
Meta-regression analysis was also performed based on the type of  Doppler abnormality- 
umbilical artery abnormality alone vs. both umbilical artery and venous Doppler 
abnormalities. This was only possible for three outcome measures (NND, IUD, and ICH) due 
to paucity of data for the other outcomes.
Eight studies involving pregnancies with fetal growth restriction (n = 461) looked at the 
incidence of IUD 200, 203-206, 229-231. The risk of IUD in growth restricted pregnancies with both 
arterial and venous Doppler abnormalities was 14.0 (6.6 - 23.5%) compared with 8.4 (5.9 - 
11.3%) in growth restricted pregnancies with arterial abnormalities alone (p > 0.05).  
Eleven studies involving fetuses with fetal growth restriction 198, 200-202, 204-208, 229, 231(n = 1419) 
investigated the incidence of  NND. Across gestations, the risk of NND in growth restricted 
pregnancies was significantly increased in pregnancies with both arterial and venous 
Doppler abnormalities compared to those with arterial abnormalities alone (p<0.01). This risk 
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was increased from 34.3% (95%CI = 28.7 – 40.2) to 73.3 % (95%CI = 63.0 – 82.5) at ≥24 - 
<28 weeks, from 13.5% (95%CI = 11.5 – 15.7) to 49.3% (95%CI = 39.6 – 59.1) at ≥28 - <32 
weeks and from 0.7% (95%CI = 0 – 2.8) to 21.9% (95%CI = 12.6 – 32.8) at ≥32 - <37 
weeks.
Growth Restricted 
Fetuses with 
Arterial and 
Venous Doppler 
abnormalities
Growth Restricted 
Fetuses with Arterial 
Doppler abnormalities 
alone
Normally Grown 
Preterm Fetuses
Figure 8.3: Risk of Neonatal Death across gestational age by increasing severity of fetal growth restriction (mean 
and 95% C.I depicted)
Thirteen studies involving fetuses with fetal growth restriction 198, 200-211, (n = 1348) 
investigated the incidence of  ICH. Across all gestational ages, the risk of  ICH was 
significantly higher in pregnancies with both arterial and venous Doppler abnormalities, 
compared to those with arterial abnormalities alone (p<0.01). This risk was 47.6% vs. 24.3% 
(95% CI = 31 – 64.4% vs. 19.3 – 29.6%) for the gestational age range ≥24 - <28 weeks, 
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30% vs. 10.7% (95%CI = 16.6 – 45.4% vs. 8.9 – 12.7%) for the gestational age range ≥28 - 
<32 weeks, and 14.3% vs. 2.0% (95%CI = 4.7 – 28% vs. 0.4 – 4.7%) for the gestational age 
range ≥32 - <37 weeks. 
8.4 Meta-Analysis Discussion
This large meta-analysis / meta-regression demonstrates with significant power the perinatal 
risks faced by the preterm growth restricted fetus. Preterm growth restricted fetuses are at 
significantly increased risk of being born in a poorer condition (having an APGAR <7 at 5 
minutes), as well as having an increased risk of  ICH, sepsis, NEC and respiratory 
complications compared with a normally grown preterm fetus (p<0.01). In addition, these 
fetuses are also at significant risk of death in the neonatal period. Although the risk in both 
groups fell as gestation increased, the fall was more pronounced in the normally grown 
group. This resulted in a relative amplification of risk for the growth restricted group. 
The chronic hypo-perfusion and hypoxic state in fetal growth restriction is a result of  the 
abnormal and dysfunctional placentation that occurs. The chronic hypoxia, decreased 
delivery of nutrients, and alterations in the hormonal growth axis prohibits normal growth and 
development 194 and leads to the susceptibility to disease processes in the various organ 
systems. It is unsurprising that my results have shown that growth restricted fetuses are at 
substantially higher risk of neonatal complications, and that although their risk of these 
complications is inversely related to gestation, they remain at considerable risk of 
complications even at advanced gestations.
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Increased risk of adverse outcome in fetuses with venous Doppler abnormalities
In this study, growth restricted fetuses that had both arterial and venous Doppler 
abnormalities were at significantly higher risk of NND and ICH compared to those with just 
arterial Doppler abnormalities (p<0.01). Again, that these fetuses are at increased risk of 
perinatal complications is unsurprising, given that the presence of venous Doppler 
abnormalities indicates increasing compromise of the fetal condition - the disease process 
leads to progressive fetal haemodynamic failure which is characterised by increased 
pressure in the right atrium, and subsequent abnormal venous Doppler waveforms204.
Importance of this study
An important confounding factor when trying to assess the risks faced by growth restricted 
fetuses is the effect of prematurity. Many growth restricted fetuses are delivered preterm to 
prevent further deterioration in the fetal condition against a background of worsening 
intrauterine milieu.  There is no doubt that pre-term neonates do worse in many outcome 
variables when compared to term neonates, however, trying to quantify the additional risks 
when intrauterine growth restriction is present is difficult because many older studies have 
been imprecise with regards to the definition of fetal growth restriction. In general, it is 
accepted that growth restricted fetuses have much poorer outcome when compared to 
normally grown cohorts. In addition, many older assumptions about accelerated lung 
maturation  leading to decreasing respiratory morbidity in growth restricted fetuses are not 
borne out by the results of this study.
Timing of delivery in these growth restricted fetuses is generally determined by a composite 
evaluation of fetal Doppler severity and gestation. However, given that preterm birth 
accounts for up to 60% of  perinatal death and that it carries a significant risk of  both 
neonatal morbidity, and long term neurological disability234, clinicians have to strike a 
delicate balance between the perinatal complications of being born too early versus the 
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increasing risk of intrauterine death.  Results from the Growth Restriction Intervention Trial 
(GRIT) trial indicate that altering current management strategies with respect to timing of 
delivery for these growth restricted fetuses does not improve short term mortality, however, 
they are still at considerable risk of neonatal and long term morbidity235. 
This meta-analysis demonstrates that infants who have experienced intrauterine growth 
restriction face considerable hurdles not just in the in-utero period but also immediately after 
birth. Counselling of parents with good up to date data is essential and difficult ethical 
decisions about continuing or ending the pregnancy are sometimes made without a real 
appreciation of the risks that a growth restricted fetus faces. It has always been difficult to 
quantify this risk and this meta-analysis to some extent addresses this limitation. 
There has been no previous meta-analysis evaluating the outcome of growth restricted 
fetuses in comparison with normally grown preterm controls to compare my results. 
However, as is the case with older systematic reviews, recent systematic reviews have 
focussed on the outcome of the growth restricted fetus diagnosed by a low  birth weight, and 
these findings of  increased risk of  IUD, NND, and other perinatal morbidity in the growth 
restricted population concur with many of these reviews 88, 235, 236 .
Limitations
The selection of an appropriate control group posed challenges as there were only two 
included studies that compared preterm growth restricted fetuses to preterm AGA fetuses. 
The comparison of growth restricted fetuses and AGA fetuses from two entirely different 
subsets of studies could potentially result in an amplification of any bias present.
Studies that were published prior to 1997 were excluded in the hope that this would result in 
cohorts that were reasonably contemporary in terms of the obstetric and neonatal care 
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received at least in terms of antenatal steroid and surfactant use. Despite this limitation, 
cohorts from as early as 1983 were included in some studies published after 1997. However, 
as the cohorts for the growth restricted group were more recent, these fetuses should have 
benefited more from any improvement in neonatal care over the years. Their poorer 
outcome compared to the AGA group despite this discrepancy in study period indicates that 
the difference in outcome may in fact be larger than what has been shown.
There was a degree of variation in the diagnostic criteria of some the outcome measures 
with some studies only including more severe adverse events, and others including even 
minor adverse events. However, as this variability applied to both the growth restricted and 
AGA studies this should result in minimisation of any resultant bias. These studies where the 
diagnosis was felt to be reasonably robust were included as this reflected contemporary 
practice and was  of relevance to the practising clinician. 
8.5 Summary
The first part of this chapter details the immediate neonatal and longer term outcome of both 
growth restricted and normally grown fetuses that were recruited into this study. The 
pathophysiology behind the predisposition of growth restricted fetuses to increased perinatal 
morbidity and mortality was also discussed. The second part of this chapter details the 
results of  a meta-analysis and meta-regression that investigated the outcome of preterm 
growth restricted fetuses when compared to preterm fetuses that were appropriately grown. 
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CHAPTER 9: CONCLUSIONS AND FUTURE RESEARCH
This thesis set out to characterise the changes that occur within the fetus and aberrations in 
the development of various organs within the fetus in the presence of placental insufficiency 
and cerebral redistribution. This was done using conventional MRI fetal imaging, 3D 
reconstruction of MRI images using a technique known as Snapshot Volumetric 
Reconstruction, and 3D ultrasound flow imaging. 
Chapters  1 and 2 described the background to fetal growth restriction and the techniques 
that were used in this thesis.
Chapter 3 of this thesis described the use of MRI to identify a specific placental phenotype 
within growth restricted pregnancies. We found that MRI was able to quantify normal and 
diseased placental volume in growth restriction, and that it was capable of identifying areas 
of placental pathology. The use of placental MRI in fetal growth restriction has been limited 
to date, but MRI confers the benefits of  being able to visualise the placenta as a whole and 
quantification of  areas of diseased placenta, as well as the ability to provide an estimate of 
the metabolic status of  tissue through the use of MR spectroscopy and an estimate of 
placental flow  through modification of techniques such as functional MRI. Further 
longitudinal MR studies investigating placental function and its correlation to disease severity 
could involve the use of these techniques. 
Chapter 4 of this thesis described the use of MRI to quantify organ growth within the growth 
restricted fetus. We found smaller intra-thoracic and intra-abdominal organ volumes in the 
growth restricted fetus, and that in certain instances, this correlated to neonatal outcome. 
Growth restriction carries a significant long term burden with an increased risk of the 
metabolic syndrome and in utero programming is thought to play an important role in the 
development of this response. MR spectroscopy could be used to
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identify the presence of  hypoxic tissue within the growth restricted fetus and may provide an 
indication of  the severity of the longer term sequelae.  Quantification of  flow  using MRI could 
also be used to understand further the redistribution phenomenon and to study the pattern of 
blood flow changes in organs other than the brain. 
Chapter 5 of this thesis described the use of 3D reconstruction of MRI images to perform 
regional segmentation of the fetal brain in an attempt to identify the presence of aberrant 
development that may predispose the fetus to developmental delay in childhood. We found a 
smaller global and regional brain volumetry in growth restricted fetuses, and evidence of 
delayed development of the cerebellar vermis. The use of  automated segmentation software 
applied to the reconstructed MRI images would enable rapid and accurate regional 
segmentation of the fetal brain. The development of  fetal automated segmentation software 
and of a fetal atlas is in progress at Imperial College London and  the application of these 
techniques would allow further regional analysis of the fetal brain.
Chapter 6 of  this thesis described attempts to optimise the dynamic acquisition sequence 
and the use of automated segmentation methods on optimised reconstruction images.
Chapter 7 of this thesis describes the neonatal outcome data of  the fetuses in this 
study.Follow  up of  the children recruited into this study to school age with both 
neurodevelopmental and imaging assessments would prove useful in understanding the 
post natal changes that occur within the brains of  growth restricted fetuses and to identify 
the areas that maintain aberrant development postnatally. This may be the key to 
understanding the neurostructural correlates of developmental delay in these children.
Chapter 8 describes the results of  a meta-analysis that looked at the neonatal outcome of 
all preterm growth restricted fetuses as a group.
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This thesis showed evidence of changes in regional and global organ growth in growth 
restricted fetuses using high resolution fetal MRI.  It is hoped that future imaging studies 
could offer useful insights into the origins and clinical significance of these findings and its 
consequences for later neurodevelopment.
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